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General Introduction 

General Introduction 
1.1 CHROMOSOME ABERRATIONS IN HUMAN CANCER 
Cancer can be defined as a result of somatically acquired genetic changes that 
usually occur in a single clone of cells affecting a limited number of highly specific 
genes: the proto-oncogenes and tumor suppressor genes. Moreover, within each 
individual cancer several mutations may accumulate. According to this multi-hit 
concept (reviewed by Vogelstein and Kinzler, 1993), tumor development may be 
regarded as a process of clonal evolution driven by mutation. The first mutation 
predisposes a cell to neoplastic transformation, whereas each additional mutation 
drives a gradual increase in tumor size, disorganization and malignancy. For the 
identification of the genes affected by these mutations cytogenetic analysis has been 
shown to be of crucial importance. 
The notion that cancer is a genetic disease at the cellular level was first proposed by 
Boveri in 1914, and in his monography (Boveri, 1914) he suggested that 
chromosome alterations may play a causal role in tumor growth. Cytogenetically, 
these alterations may be visible as 1) numerical changes, resulting from gains or 
losses of whole chromosomes, 2) structural changes, i.e. translocations, inversions 
or deletions of particular chromosomal regions, and 3) intrachromosomal 
rearrangements, such as double minutes (DMs), homogeneously staining regions 
(HSRs) or aberrantly banding regions (ABRs), resulting from the amplification of 
specific (sets of) genes. These anomalies usually occur de novo, but some of them 
may also be inherited. 
It was not until 1960 that the first consistent tumor-specific chromosomal aberration 
was recognized (Nowell and Hungerford, 1960) and identified (Rowley, 1973), i.e. 
the Philadelphia translocation in chronic myeloid leukemia. This discovery marked 
the beginning of a prosperous era for cytogenetics. Since then, many karyotypic 
anomalies have been described in various neoplasms, including more than 100 
recurrent translocations (Mitelman, 1994). Next to primary changes, that are 
consistently associated with particular disease types and that may be present as the 
sole chromosomal abnormality, also secondary aberrations were identified. These 
latter presumably play a role in tumor progression by conferring a selective growth 
advantage to the tumor cells. 
1.1.2 TRANSLOCATIONS 
In 1981, Klein proposed a model for the direct involvement of chromosomal 
translocations in human oncogenesis: the expression of growth regulating genes, 
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located close to the chromosomal breakpoints, may be deregulated under the 
influence of a new chromosomal environment, thus leading to cell transformation 
(Klein, 1981). Based on subsequent molecular studies, it was found that 
chromosomal translocations may, essentially, have one of two effects: 
1. Deregulation of gene expression resulting from juxtaposition to immunoglobulin, 
Τ cell receptor- and/or other loci that are active in the cell types from which the 
tumors arise. 
2. Deregulation of gene function via gene fusion, resulting in the production of 
chimeric transforming oncoproteins. 
Deregulation by juxtaposition. 
A classical example of gene activation by juxtaposition is found in Burkitt's 
lymphomas. Here, the MYC gene on chromosome 8 is translocated to either one of 
the different immunoglobulin heavy or light chain genes on chromosomes 2, 14 or 
22 (Croce and Nowell, 1985; Kurzrock et ai, 1988). The MYC protein plays a 
prominent role in cell cycle control since it is part of a transcriptional network 
involving at least three other factors (MAD, MAX and Mxi-1) (Ayer et al., 1993; 
Zervos et al., 1993; Amati and Land, 1994). All these factors contain basic helix-
loop-helix (b-HLH) DNA binding domains and leucine zipper (ZIP) protein 
dimerization motifs, necessary for specific protein-protein interactions. Presumably, 
activation of MYC results in a shift in the normal monomer-dimer equilibrium of 
these factors leading to transcriptional activation of downstream target genes, such 
as the genes encoding cyclins A, D and E (see Hunter and Pines, 1994). This, in 
turn, may result in cell cycle progression and ultimately in oncogenic 
transformation. Also structural changes in the MYC gene may occur, presumably 
interfering with the specific protein-protein interactions. Supporting evidence for an 
oncogenetic role of MYC was provided by experiments by which deregulated MYC 
genes were introduced into transgenic mice, invariably resulting in neoplastic 
transformation (Adams et al., 1985; Eick el al., 1985). 
Also other cell cycle regulators may be involved. Through the chronic lymphocytic 
leukemia-specific t(14;19) the expression of the BCL3 gene on chromosome 19 is 
enhanced, resulting in progression through the cell cycle, whereas t(ll;14), 
involving the BCL1 locus on chromosome 11 in non-Hodgkin lymphomas, most 
likely results in a deregulation of the CCNDl cyclin gene. Other genes involved in 
juxtapositions were found to encode homeobox- (HOX-11), basic helix-loop-helix-
(LYL-1, SCL/TAL-l/TCL-5, and TAL-2), LIM-domain- (RBNT-1/Ttg-l, and RBNT-
2/Ttg-2), growth- (IL-3) and other (BCL-2) factors (for review see Solomon et al.. 
1991; Rabbits, 1991; Rabbits, 1994; Rowley, 1994). 
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Deregulation bv pene fusion. 
A classic example of deregulation of gene function by gene fusion is found in 
chronic myeloid leukemia (CML). Through the Philadelphia translocation (Rowley, 
1973) the c-ABL gene on chromosome 9q34 is fused to the BCR gene on 
chromosome 22qll. This fusion results in a novel chimeric BCR/ABL gene (Geurts 
van Kessel et al., 1981; de Klein et al., 1982; Groffen et ai, 1984) which, in tum, 
encodes a CML-specific chimeric mRNA and protein (Shtivelman et ai, 1985; 
Grosveld et al., 1986). Thus, the tyrosine kinase activity of ABL is activated by 
fusion to BCR sequences (Konopka et al., 1984; Ben-Neriah et ai, 1986). Also 
here, the introduction of different BCR/ABL fusion gene constructs in transgenic 
mice induces neoplastic transformation, presenting as leukemias with different 
pathologies (Daley et ai, 1990; Heisterkamp et ai, 1990). 
These observations paved the way for the isolation and characterization of various 
other fusion genes involved in different types of hematologic disorders (Reviewed 
by Solomon et al., 1991; Rabbits, 1994; Rowley, 1994). However, the leukemias 
and lymphomas represent only about 10% of all human malignancies. Solid tumors, 
accounting for more than 80 % of the human neoplasms, contribute to a much 
greater extent to morbidity and mortality. Compared to the hematologic disorders, 
the genetic analysis of solid tumors is difficult to perform. This is due to the fact 
that these tumors yield relatively low numbers of viable cells in tissue culture. In 
addition, they yield relatively poor quality chromosome spreads and are frequently 
'contaminated' with normal lymphocytes and/or fibroblasts. Secondly, their 
karyotypes are often very complex and additional anomalies may be acquired during 
cell culturing. Significant improvements were accomplished through the 
introduction of new chromosome banding (Patii et ai, 1971; Yunis, 1981) and cell 
culture techniques (Limon et al, 1986; Thompson, 1991; Mandahl, 1992). So far, 
cytogenetic analyses, in conjunction with positional cloning and/or candidate gene 
approaches, have resulted in the isolation of a limited number of solid tumor-
associated translocation breakpoints (Reviewed by Solomon et al., 1991; Trent and 
Meltzer, 1993; Rabbits, 1994). Due to the unique nature of DNA recombination 
processes in differentiating B- and T-lymphocytes, perhaps one would not expect to 
encounter juxtaposition events in solid tumors. However, in parathyroid adenoma, 
inv(ll) appears to result in a deregulation of the CCND1 gene by juxtaposing the 
BCLl region on chromosome 11 q to the parathyroid hormone (PTH) gene on 
chromosome lip (Arnold et αι., 1989). In general, however, chromosomal 
translocations in solid tumors appear to result in the fusion of genes, mostly 
encoding chimeric transcription factors. 
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1.1.3 DELETIONS 
Next to proto-oncogene activation, also inactivation or loss of tumor suppressor 
genes may lead to tumor development. One way to identify such genes is to search 
for chromosomal deletions. This is exemplified by the cloning of the first tumor 
suppressor gene, the retinoblastoma succeptibility (RBI) gene (reviewed by 
Goodrich and Lee, 1993). Although Knudson postulated already in 1971 that 
retinoblastoma development may be triggered by two successive mutations leading 
to the inactivation of both normal alleles (Knudson 1971), it was not until 1978 
before a consistent interstitial deletion of chromosome band 13ql4 was identified in 
these tumors (Yunis and Ramsay, 1978). RFLP studies and genomic walking 
strategies finally resulted in the isolation of the RBI gene, which encodes a nuclear 
phosphoprotein with DNA binding capacities (Friend et al., 1986; Lee et ai, 1987; 
Fung et al., 1987). The subsequent identification of RBI-associated proteins 
suggests that RB1 may have a role in regulation of the expression of other cellular 
genes and, as such, may function as a cell cycle regulator. Interestingly, the RBI 
gene has been shown to be involved in other malignancies as well. These include 
osteosarcoma, soft tissue sarcomas, breast carcinoma and small cell lung carcinoma. 
Ultimate proof of the tumor suppressor capacity of RBI was obtained by 
transfection of wild-type RBI genes into retinoblastoma, osteosarcoma and prostate 
carcinoma cells (Huang et al., 1988; Bookstein et al., 1990). In all these cases 
reversion of the tumorigenic properties of the RBI-deficient tumor cells was 
obtained. Likewise, the discovery of constitutional deletions at 11 ρ 13 in a subset of 
patients with Wilms' tumors marked the localization of the WT1 gene (Riccardi et 
al., 1978; Francke et al., 1979). Again, RFLP studies in conjunction with positional 
cloning strategies resulted in the cloning of the WT1 gene (Call et al., 1990; Gessier 
et al., 1990). The observed growth suppression, following the introduction of a 
wild-type WT1 gene in Wilms' tumor cells, again unambiguously identifies WT1 as 
a tumor suppressor (Haber et al., 1993). 
Clearly, the chromosomal localization of tumor suppressor genes cannot in all cases 
be revealed via gross, cytogenetically visible deletions. However, the development 
of new molecular markers, i.e. RFLPs and highly polymorphic micro-satellites, 
allows for a genome-wide scan of non-randomly deleted chromosomal regions. 
Recently, this approach has resulted in the identification and cloning of several 
additional tumor suppressor genes, e.g. the APC gene on 5q (Groden et al., 1991; 
Nishisho et al, 1991) and the DCC gene on 18q (Fearon et al., 1990), both 
involved in colorectal cancers, and the pi6 gene on 9p (Kamb et ai, 1994) 
involved in melanoma and various other cancers. 
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1.1.4 AMPLIFICATIONS 
Another step in the process of transformation of a normal cell into a cancer cell 
may be the amplification of specific (sets of) genes (for review see Brison, 1993). 
This amplification confers a growth advantage to the cell in which it occurs and is, 
as such, specifically encountered in the tumor cells. Gene amplification is not 
thought to be an initiating event, but rather appears to be selected for during the 
progression of a neoplastic cell towards a cell with a more malignant phenotype. 
Accordingly, several studies have shown that such amplifications are significantly 
more frequent in metastatic tumors and tumors with a relatively poor differentiation 
status. In neuroblastoma, for example, DMs and HSRs are common findings. These 
DMs and HSRs are associated with amplification of the MYCN gene. Furthermore, 
it was shown that MYCN amplification correlates closely with advanced stages of 
the disease: amplification is found in 10-30% of the tumors (Brison, 1993) and 
these are almost exclusively of a high malignancy grade (stage III and IV; Brodeur 
at el., 1984; Grady-Leopardi et ai, 1986). There are at least two explanations for 
the late occurrence of DNA amplifications during tumor development: (i) normal 
cells are refractory to DNA amplification; in contrast, neoplastic cells may have 
acquired a certain degree of genomic instability and thus may be vulnerable to 
DNA amplification, (ii) the amplification of specific genes is only advantageous to 
cells which have progressed to a status by which they have escaped normal growth 
control mechanisms. In human tumor cells the amplified genes most frequently 
belong to the class of proto-oncogenes. The primary driving force for the 
amplification process is not always easily determined since very large DNA 
segments may be affected. A typical example is the amplification of 1 lql3-derived 
sequences observed in breast cancer cells which may encompass several megabases 
(sec Lammie and Peters, 1991). 
1.1.5 ISOCHROMOSOMES 
The occurrence of isochromosomes was first noted by Fraccaro et ai, who found an 
i(Xq) in patients with Turner syndrome (Fraccaro et al., 1960). Since then, 
isochromosomes have frequently been observed, also in neoplastic cells (Reviewed 
by Mertens et al., 1994). Little is known about the generation of isochromosomes. 
They may result from misdivisions of the centromere, nonsister chromatid 
exchanges or translocation events. The most frequently observed isochromosomes in 
tumor cells are i(17q), i(8q) and i(lq), but also i(7q), i(6p) and i(12p) are often 
encountered. In general, isochromosome formation leads to both gain and loss of 
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chromosomal material. Consequently, both amplification of oncogenes and loss of 
tumor suppressor genes have been implicated in the pathogenesis of 
isochromosome-bearing tumors. For instance, the crucial effect of i(17q) formation 
in hematologic disorders might be the loss of 17p, including the TP 53 tumor 
suppressor gene. In Philadelphia translocation-positive CML patients i(17q) does 
appear during an accelerated phase of the disease (Mitelman, 1993). Mutational 
analysis of the TP 53 gene revealed rearrangement in 14% of the cases (Ahuja et ai, 
1989; Kelman et al, 1989; Mashai et al., 1990; Feinstein et al, 1991), suggesting 
that TP53 mutation may be one of the steps leading to the progression of CML. 
Also in solid tumors i(17q) may be present as a secondary chromosomal aberration. 
In various tumor cases TP53 mutations have been found. However, these results 
were not always combined with cytogenetic analyses and, thus, the existence of a 
direct correlation remains hypothetical. The same holds for i(6p). This anomaly is 
frequently encountered in retinoblastomas, where it is almost always supernumerary 
without loss of 6q, indicating that here the gain of 6p sequences is of crucial 
importance. In contrast, in most malignant melanomas both gain of 6p and loss of 
6q are observed. Together with the frequent observations of 6q loss in malignant 
melanomas through other mechanisms, this suggests that here i(6p) formation acts 
as a mechanism to accomplish loss of important (suppressor) genes on 6q. 
Furthermore, clinical data have shown that cancers with isochromosomes usually 
have a poorer prognosis. Thus, the occurrence in CML of an i(17q) is indicative for 
an accelerated phase of the disease or even a blast crisis. In analogy, the presence 
of one or more copies of i(12p) in germ cell tumors appears to be associated with a 
poor treatment response (Bosl et al., 1989). Together, these findings support the 
hypothesis that isochromosome formation may confer a growth advantage to (pre-) 
neoplastic cells. 
1.2 HUMAN GERM CELL TUMORS 
Human germ cell tumors (GCTs) comprise a heterogeneous group of neoplasms of 
high complexity and morphologic diversity which, as implicated in their name, all 
originate from germ cells. They are found at several anatomical locations, 
predominantly in the gonads but also in extragonadal sites (Mostofi and Price, 
1973; Scully, 1979; Gonzales-Crussi, 1982). Germ cell tumors exhibit 
characteristics that in many ways mimic early embryonal development (Fig. 1.2.1). 
As such, they provide a model system to study both growth and differentiation 
processes. 
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Figure 1.2.1: A. Schematic representation of a 9 days old embryo. B. Embryoid body 
from a nonseminomatous germ cell tumor. 
Morphologically, two categories of germ cell tumors can be distinguished 
(Oosterhuis et al., 1990): 
1. Tumors of neoplastic germ cells: the seminomas (SE) of the testis, the 
dysgerminomas of the ovary, and the extragonadal germinomas. 
2. Tumors composed of embryonic and/or extra-embryonic tissues: the 
nonseminomatous GCTs (NS). Sometimes these tumors also contain a seminoma 
component, in which case they are classified as combined tumors (CT). 
The distinction between SE and NS is important with respect to prognosis and 
treatment of the cancer. Generally, NS are more aggressive than SE and, therefore, 
more likely to metastasize. This has consequences for patient treatment: in case of 
low grade SE, surgical resection may suffice. For treatment of NS and malignant 
SE, increasing doses of radiotherapy and/or chemotherapy are applied. To prevent 
the metastasis of NS, retriperitoneal lymph nodes are resected. To date, succesful 
treatment of about 80-90% of the tumors is accomplished. For the remaining 
unresponsive cases, other chemotherapeutic regimens, in conjunction with 
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autologous bone marrow transplantation, are currently under trial (Grigor and 
Schmoll, 1993). 
At present, a fundamental role for specific chromosomal anomalies in the process of 
neoplastic transformation has been well established (see Chapter 1.1; Stubblefield 
and Sandford, 1987; Geary, 1991). This notion has led us to characterize two 
different classes of human germ cell tumors at the molecular level: (1). testicular 
germ cell tumors (TGCTs) of adolescents and young adults, characterized by the 
occurrence of an i(12p) chromosome and/or other rearrangements involving 12p, 
and (2). extragonadal germ cell tumors (EGCTs), characterized by a complex 
recurring chromosomal translocation involving chromosomes 6 and 11, respectively. 
1.2.1 TESTICULAR GERM CELL TUMORS 
1.2.1.1 HISTOLOGY AND EPIDEMIOLOGY 
Testicular cancer is a relatively rare disease, representing only 1-3% of all 
neoplasms in men. However, together with hematologic disorders and gliomas of 
the central nervous system, it is the most common cancer in young (15 to 45 years 
of age) adults, comprising about one third of all malignancies in this life span 
(Brodsky, 1991; Swerdlow, 1993). TGCTs display the entire histologic spectrum of 
GCTs. Both SE and NS elements, presenting as embryonal carcinoma, (immature) 
teratoma, yolk sac tumor, or choriocarcinoma, can be found. In total, SE constitutes 
45%, NS 40% and CT 15% of the tumors. The incidence of TGCTs has increased 
considerably since 1940, and is still increasing. This increase affects both SE and 
NS, pointing towards a related pathogenesis (Moller, 1993). As yet, however, this 
pathogenetic route remains obscure. 
Malignant transformation is characterized by distinct stages including initiation, 
promotion and progression to invasive growth (Pitot, 1991). By now it is generally 
accepted that both the seminomatous and the nonseminomatous TGCTs are derived 
from transformed (neoplastic) primordial germ cells (Skakkebaek et ai, 1987) (Fig. 
1.2.2). These so called carcinoma in situ (CIS) cells were reported for the first time 
in 1896 as abnormal cells in the seminiferous tubules adjacent to a TGCT (Wilms, 
1896). Here they are found at sites normally occupied by spermatogonia. 
Apparently, these sites provide the specialized conditions required for the survival 
and proliferation of the CIS cells. It was not until 1972 that the pathogenetic 
relationship between these CIS cells and TGCTs was acknowledged 
(Skakkebaek, 1972). Furthermore, the occurrence of contralateral TGCTs (Loy and 
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Dieckmann, 1993) indicates that the initiation of TGCTs may take place as early as 
in utero, before the primordial germ cells have finished their migration to the 
gonadal ridges (see Chapter 1.2.2.3). 
Although TGCTs are sometimes observed in young boys, the peak incidence occurs 
in juveniles and young adults. This apparrent activation during puberty suggests a 
possible role for hormones that are active during this period, i.e. sex and/or growth 
hormones (Rajpert-De Meyts and SkakkebaEk, 1993), in the promotion of these 
tumors. Other (genetic) elements involved in promotion and progression of GCTs 
(Fig. 1.2.2) such as polyploidization, i(12p)-formation and chromosome losses, will 
be discussed below. 
PRIMORDIAL GERM CELL 
Initiation 
I 
M u t a t i o n 
ACTIVATED GERM CELL 
Promotion 
Progression 
p o l y p l o i d i z a t i o n 
1 2 p - a m p l i f i c a t i o n 
h o r m o n e s 
c h r o m o s o m e l o s s e s 
Seminomas Nonseminomas 
Figure 1.2.2: Histogenesis and classification of testicular germ cell tumors. 
1.2.1.2 CYTOGENETIC CHARACTERISTICS. 
Initial ploidy measurements, using flow cytometry, showed that TGCTs are virtually 
always aneuploid, with the SE in the hypertriploid range, the NS in the hypotriploid 
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range, and CT with intermediate DNA indices (Atkin and Baker, 1983; Delozier-
Blanchet et al., 1987; Oosterhuis et al., 1989a; de Jong et ai, 1990). A large study 
carried out by de Graaff et al. showed in CIS a hypertriploid DNA content as for 
SE (de Graaff et al., 1992). Interestingly, in patients that did not yet develop 
invasive tumors peritetraploidy was observed (Müller and Skakkebaek, 1981; Müller 
et al., 1987). Therefore, Oosterhuis et al. (1989a) suggested that polyploidization of 
a dysplastic precursor cell must be an early step in the oncogenesis of TGCTs. This 
notion was further substantiated by molecular studies (Geurts van Kessel et al., 
1989). Subsequent progression towards SE or NS may result from a net loss of 
DNA. Cytogenetic analysis confirmed the aneuploid nature of TGCTs. Moreover, a 
striking pattern of nonrandom changes was found: chromosomes 7, 8, 12 and X are 
consistently overrepresented, whereas chromosomes 11, 13, 18 and Y are 
underrepresented (Castedo et al., 1989a-c; de Jong et al., 1990). This is found in 
both SE and NS. This observation again favors the idea that SE and NS have a 
common origin. The only significant difference between SE and NS is the presence 
of more copies of chromosome 15 in SE as compared to NS (de Jong et al., 1990; 
Looijenga et al., 1993). Accordingly, chromosome 15 may harbor genes necessary 
for the SE developmental pathway and, upon loss, may permit differentiation into a 
NS stage. The involvement of both the X and Y chromosomes in aneuploidization 
implies that TGCTs are of premeiotic origin. 
Apart from numerical alterations, structural anomalies are frequently observed. 
Many studies were aimed at the identification of specific consistent chromosomal 
aberrations. Samaniego et al. found, reviewing the literature, that there is a 
difference in chromosomal rearrangements when comparing SE and NS (Samaniego 
et al., 1990). In SE rearrangements tend to cluster in l p l l , 12pll, 12q24 and 
chromosome 17 leading to i(17p), while in NS Ip32-p36, lq 11 -q 12, 12pll, 12ql3-
q22, 7pll-p22 and 17q25 appear to be frequently involved. Others have indicated 
that lp-deletion may represent a predominant characteristic (Wang et al., 1980; 
Delozier-Blanchet et ai, 1987; Rodriguez et al., 1992), also suggesting a 
relationship between the chromosome 1 alterations and the metastatic potential of 
these tumors. This latter was contradicted by others (Castedo et al., 1989a). 
Moreover, chromosome 1 rearrangements are generally encountered in all kinds of 
neoplasms (Mitelman, 1985). 
So far, the only consistent specific chromosomal anomaly identified in TGCTs is an 
isochromosome of the short arm of chromosome 12, first described by Atkin and 
Baker (Atkin and Baker, 1982). This i(12p) chromosome has been found in over 
80% of all TGCTs, in all histologic variants (reviewed by de Jong et al., 1990 and 
Rodriguez et al., 1992). I(12p) has also been found in ovarian and extragonadal 
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GCTs and, in addition, in CIS (Vorechovsky and Mazanec, 1989; Vos et ai, 1990). 
In other solid neoplasms i(12p) has been described only occasionally (Rodriguez et 
al., 1990; van der Riet-Fox et al, 1979; Sreekantaiah et ai, 1992). Conclusively, 
i(12p) must be considered as a highly specific marker chromosome for TGCTs and, 
as such, is thought to play an important role in the oncogenesis of these tumors. 
Formation of i(12p) has been shown to be preceded by polyploidization and, at 
present, there is a consensus that its presence correlates with tumor progression and 
therapy resistance (Delozier-Blanchet et al., 1987; Castedo et al., 1989b; Bosl et al., 
1989). In the more aggressive NS a higher copy number of i(12p) was found as 
compared to SE, again suggesting a link with malignant behaviour. In the remaining 
group of i(12p)-negative TGCTs cytogenetic analyses have revealed other structural 
abnormalities involving chromosome 12 (de Jong et al., 1990; van Echten et al., 
1995). 
1.2.1.3 PATHOGENETIC MODELS. 
As yet, there is no solid evidence for the existence of one common or more 
independent precursors for SE and NS. Basically, this leaves open at least two 
alternative pathogenetic pathways. The first variant (Fig. 1.2.ЗА), originally 
proposed by Ewing and developed further by others, is based on one common 
precursor for SE and NS (Ewing, 1911; Friedman, 1951; Oosterhuis et al., 1989a). 
According to this hypothesis SE represents an intermediate stage between CIS and 
NS. Immunohistochemical and cytogenetic similarities between CIS and SE are in 
agreement with this notion. Also the occurrence of NS metastases upon treatment of 
a pure SE (Bredael et al., 1982) is suggestive for this model. In the second variant 
(Fig. 1.2.3B) multiple populations of precursor CIS, theoretically derived from one 
activated primordial germ cell, exist for SE and NS (Pierce and Abell, 1972; 
Skakkebaek and Berthelsen, 1981; Mostofi et ai, 1987). 
In this latter scenario it must be excluded that NS develops through a SE stage. 
Alternatively, in his thesis Looijenga combines elements of both variants by 
integrating a role for genomic imprinting (Fig. I.2.3C). In this model the 
developmental potential of CIS cells depends on their genomic imprinting status. 
Thus, primordial germ cells activated prior to erasement of the imprint give rise to 
pluripotent CIS which, subsequently, can progress to either NS or SE. If the 
activation takes place later in the maturation pathway towards spermatogenesis 
(associated with loss of its pluripotent potential), following erasement and possibly 
new paternal imprinting, the CIS cells will retain the phenotype of primitive germ 
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cells and develop into SE. Finally, by subsequent chromosome losses, SE cells may 
become pluripotent again and progress to NS. Obviously, more experimental data 
are required to allow a clear-cut discrimination between these alternative 
hypotheses. 
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Figure 1.2.3: Pathogenetic models for the origin of testicular germ cell tumors. 
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1.2.2 EXTRAGONADAL GERM CELL TUMORS 
1.2.2.1 HISTOLOGY AND EPIDEMIOLOGY. 
Extragonadal germ cell tumors (EGCTs) are relatively rare and account for only 
about 5% of GCTs. EGCTs most frequently occur in the midline of the body: 
sacrococcyx, retroperitoneum, anterior mediastinum and midline of the brain. They 
display the same histologic heterogeneity as the TGCTs (see Gonzales-Crussi, 1982; 
Nichols and Fox, 1991). 
The sacrococcygeal tumors are the most frequently occurring extragonadal germ cell 
tumors. Their histology ranges from rather benign teratomas, via more aggressive 
immature teratomas, to malignant yolk sac tumors (YSTs) (Gonzales-Crussi, 1982; 
Dehner, 1983; Hawkins, 1990). Retroperitoneal GCTs are rare and occur mostly in 
adults. Based on their histology and the finding of CIS of the testis in addition to 
the retroperitoneal tumor, they are generally regarded as metastases of occult 
primary TGCTs (Daugaard et al., 1987). The most common site for EGCTs in 
adults is the anterior mediastinum. The majority of these tumors consists of benign 
cystic teratomas. The malignant tumors, including the intracranial GCTs, resemble 
the TGCTs: both SE and NS components can be found. However, these GCTs are 
not associated with CIS of the testis. 
Malignant EGCTs are observed more frequently in males than in females. 
Analogous to the TGCTs, patients presenting with extragonadal SE have a relatively 
good prognosis: regardless of the site of presentation, the five-year-disease-free 
survival rate is over 80%. In contrast, for patients with extragonadal NS the 
prognosis is much poorer with an initial estimated survival rate of approximately 
50%, whilst the remainder have a life expectancy of less than two years (Toner et 
al., 1991; Goss et ai, 1993). So they seem to be more malignant than their 
testicular counterparts, indicating a possible biological difference. 
Interestingly, there seems to be an association between mediastinal NS and some 
specific clinical disorders. The first recognized relation involves Klinefelter 
Syndrome with a predominance of 20% of the cases (reviewed by Lachman et al., 
1986). Also, a biological association between mediastinal and intracranial NS and 
hematological disorders has been documented (reviewed by Woodruffs/ al., 1995). 
1.2.2.2 CYTOGENETIC CHARACTERISTICS. 
Most tumors of the sacrococcyx, retropritoneum and anterior mediastinum are 
diploid. Only the YSTs may exhibit tetra- or aneuploid chromosome numbers 
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(Silver, 1994; Stock, 1994). In addition to the histologic similarities with TGCTs, 
malignant nonseminatomous EGCTs of the anterior mediastinum and the midline of 
the brain often display karyotypes similar to those found in TGCTs, including the 
presence of the i(12p) chromosome (Oosterhuis et ai, 1990; Chaganti et al., 1994). 
When associated with Klinefelter syndrome, the malignant cells accordingly have a 
XY,+X chromosomal constitution (Casalone et al., 1994). Also, when associated 
with hematological disorders, cytogenetic analysis has revealed the presence of the 
i(12p) chromosome in the leukemic cells in addition to other chromosomal 
aberrations frequently found in TGCTs, as well as trisomy 8, the most common 
chromosomal abnormality in childhood AML (Woodruff et ai, 1995). This latter 
suggests that both malignant cell populations most likely originate from a common 
precursor cell. 
In addition to the i(12p)-positive EGCTs also i(12p)-negative tumors have been 
identified. Recently, this led to the definition of a new subgroup of malignant 
EGCTs that are characterized by a complex t(6;6;ll) (van Echten et al., 1995: 
Chapter III. 1). 
1.2.2.3 PATHOGENETIC MODELS. 
Based on both pathological and cytogenetic characteristics, the extragonadal germ 
cell tumors can be divided in two major groups: (1) tumors resembling the GCTs of 
the infantile testis. These tumors are thought to originate mitotically from either a 
primordial germ cell or another pluripotent stem cell (Linder et ai, 1975; Hoffner 
et ai, 1994). (2) tumors resembling the TGCTs of adolescents and young adults. As 
it has been hypothesized that TGCTs originate from dysplastic primordial germ 
cells that follow the normal migratory tract to the gonads (see Wylie, 1993), the 
observed similarities, including the presence of i(12p), favor the idea that the 
TGCT-resembling EGCTs may also be derived from neoplastic primordial germ 
cells. Thus, they can be the result of (i) an abnormal migration of the activated 
PGCs to extragonadal sites with a permissive environment allowing survival and 
subsequent progression to EGCTs (Friedman, 1947), or (ii) PGCs that normally 
migrate to extragonadal sites where they may function as important regulators and 
that, subsequently, become neoplastic (Friedman, 1987). 
The migration of primordial germ cells (PGCs) starts at the allantois, where they 
become visible among the endodermal cells of the yolk sac early during 
embryogenesis. From there they migrate to the hind gut epithelium and via the 
dorsal mesentery where they split into two populations which pass to the left and 
right genital ridges, respectively (Fig. 1.2.4). During this migration the PGCs divide 
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constantly: in mouse embryos their numbers increase from less than 100 cells at day 
7.5 to about 25.000 cells at day 12.5 post coitum, when they reach the genital 
ridges. In human embryos the PGCs reach these ridges around week 6 of 
development. This migratory pattern accounts for the location of the EGCTs along 
the midline of the body. The occurrence of EGCTs away from the midline of the 
body must hence be explained by assuming that the migration may also be mediated 
by other tracts as e.g. the bloodstream so that activated PGCs may occasionally get 
targeted to other sites as well. 
Figure 1.2.4: The migratory tract of primordial germ cells during embryogenesis (Gilbert, 
1988). 
Also the association with i(12p)-positive hematological disorders suggests a 
common yolk sac derived origin, since hematopoietic progenitor cells also originate 
from that embryonic site. However, here the situation seems more complex. 
Basically, two models concerning the biological basis for this association have been 
proposed in the literature (DeMent et al., 1985; Ladanyi and Roy, 1988; Nichols et 
ai, 1988): (1) the leukemia arises as a malignant differentiation of the GCT, and 
(2) both malignancies arise independently via the aberrant migration of their 
corresponding precursor cells. The observed clonal relationship, however, strongly 
favors the first model. Consistent with this notion, Orazi et al. have been able to 
demonstrate the presence of hematological cells within the yolk sac tumor 
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component of mediastinal GCTs (Orazi et al, 1993, 1994). 
In constrast to the above discussed mechanisms, Chaganti et al. proposed that 
mediastinal EGCTs may arise from disseminated gonadal lesions which then 
migrate, putatively through the bloodstream, to the thymic and pineal regions where 
they survive and where tumor formation occurs (Chaganti et al., 1994). However, in 
such a model one would expect to find gonadal GCTs more often in addition to the 
EGCTs, which is not the case. 
In conclusion, EGCTs may originate from different cell types depending on their 
anatomical site. Detailed analysis of more cases is necessary to obtain a better 
classification for these tumors and to provide the critical information to discriminate 
between the different pathogenetical pathways. 
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1.3 SCOPE OF THIS THESIS 
The studies described in this thesis are aimed at the molecular characterization of 
specific chromosomal aberrations occurring in human germ cell tumors. Here we 
focus on two subgroups of germ cell tumors: (1) the testicular germ cell tumors of 
adolescents and young adults, and (2) the malignant extragonadal germ cell tumors. 
In Chapter II, data are presented dealing with different aspects of chromosome 12 
aberrations in testicular germ cell tumors: Chapter II. 1 describes the generation of a 
panel of radiation-reduced somatic cell hybrids containing different fragments of 
12p, that can be used for the precise delineation of tumor-associated 12p-anomalies; 
In Chapter II.2 the identification of such 12p abnormalities in i( 12p)-negative 
TGCTs is documented using chromosome painting techniques, whereas in Chapter 
II.3 a specific chromosomal region within 12p, possibly involved in the progression 
of TGCTs, is identified using comparative genomic hybridization; Chapter II.4 deals 
with the molecular nature of the i(12p) chromosome, providing additional clues on 
the origin of this isochromosome. In Chapter III data are presented dealing with the 
characterization of a recurrent complex chromosomal translocation, involving 
chromosomes 6 and 11, in a subgroup of human extragonadal germ cell tumors: 
Chapter III. 1 describes the definition of EGCTs carrying this type of chromosomal 
anomaly as a new entity; In Chapter III.2 a physical map of the l l q l3 breakpoint 
region using both FISH and molecular strategies is presented; Chapter III.3 
describes the precise localization of the FOSL1 and PLCB3 genes relative to the 
breakpoint within the 11 ql3 region; Chapter III.4 deals with a more refined 
molecular characterization of the l l q l3 breakpoint region by preparative pulse field 
gel electrophoresis, subcloning and subsequent chromosome walking strategies. The 
relevance of these studies for obtaining further insight into germ cell tumor 
development and some future perspectives are discussed in Chapter IV. 
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ABSTRACT 
We have employed an irradiation and fusion procedure to generate somatic cell 
hybrids containing various fragments of the short arm of human chromosome 12 
using a 12p-only hybrid (M28) as starting material. For the initial identification of 
hybrids retaining human DNA, non radioactive in situ hybridization was performed. 
Seventeen cell lines appeared to contain detectable amounts of human material. 
Detailed characterization of these hybrids by Southern blot analysis and 
chromosomal in situ suppression hybridization (chromosome painting), using hybrid 
DNAs as probes after Л/м-element-mediated PCR, resulted in a hybrid panel 
encompassing the entire chromosome 12p arm. This panel will provide a valuable 
resource for the rapid isolation of region-specific DNA markers. In addition, this 
panel may be useful for the characterization of chromosome 12 aberrations in e.g. 
human germ cell tumors. 
INTRODUCTION 
Somatic cell hybrids containing well defined human chromosomal fragments on a 
rodent background can be used for high-resolution physical gene mapping. In 
addition, they may provide a valuable resource for the isolation of DNA fragments 
that map to a specific chromosomal region. More than a decade ago, Goss and 
Harris (1975) introduced a method for the generation and transfer of chromosomal 
fragments. This method, based on irradiation and gene transfer via cell fusion, was 
used for mapping loci on the human X chromosome. However, the hybrids they 
obtained from fusion of lethally irradiated human lymphocytes with recipient 
hamster cells often contained fragments from multiple human chromosomes. Cox et 
al. (1989) circumvented this problem by using a human-rodent hybrid containing a 
single human chromosome 4 as irradiated donor. They found a high frequency of 
retention of nonselected human chromosome 4-derived fragments in the resulting 
hybrids. This technique was also used by Benham et al. (1989), Goodfellow et al 
(1990) and Zoghbi et al. (1991) to isolate fragments of the human chromosomes X, 
10 and 6, respectively. In this study, we have used a similar approach to generate 
somatic cell hybrids containing fragments of human chromosome 12p. This newly 
developed hybrid panel may be used as a resource for the development of new 
probes from particular regions of 12p. Furthermore, we intend to use this panel for 
the investigation of chromosome 12 aberrations in human neoplastic disorders such 
as testicular germ cell tumors (TGCTs). 
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In 1982, Atkin and Baker reported the occurrence of an isochromosome of the short 
arm of chromosome 12 [designated i(12p)] in TGCTs. Until now i(12p) appears to 
be one of the few known consistent chromosomal abnormalities in human solid 
tumors (for review see: de Jong et al, 1990). The i(12p) marker has been observed 
in more than 80% of adult TGCTs, but also in dysgerminomas and some 
extragonadal GCTs. Since i(12p) formation does not lead to gross loss of 
heterozygosity of the long arm of chromosome 12, we argued previously that 
formation of this marker must be a secondary event following a polyploidization 
step (Geurts van Kessel et al 1989). In both i( 12p)-negative and -positive TGCTs 
other chromosome 12 aberrations are frequently found (Gibas et al, 1986; Castedo 
et al, 1988; Suijkerbuijk et al, 1991). Together with the observation that the 
occurrence of additional copies of 12p appears to be associated with a significant 
greater likelyhood of treatment failure of patients with GCTs (Bosl et al., 1989), a 
prominent role for certain chromosome 12 sequences in the development of 
malignant GCTs is implicated. To investigate whether particular chromosome 12p 
regions are indeed specifically involved in GCT development, new probes must be 
developed. As a first step toward this goal we here report the generation of a panel 
of radiation reduced 12p hybrids. As starting material we used a mouse-human 
hybrid cell line (M28), which contains a human i(12p) chromosome as its only 
human constituent. The i(12p) chromosome in this cell line is derived from a 
patient with Pallister-Killian syndrome in which this marker was present as a 
constitutional aberration (Zhang et ai, 1989). 
MATERIALS AND METHODS 
Cell lines and culture 
M28 is a mouse-human hybrid cell line containing a Pallister-Killian derived 
isochromosome 12p as its only human component (Zhang et al, 1989). Wg3-h is a 
hamster cell line deficient in hypoxanthine phosphoribosyl transferase (HPRT) 
activity. M28 and Wg3-h cells were cultured in FIO or Dulbecco's modified Eagles 
medium (DMEM), supplemented with antibiotics, glutamin and 10% fetal calf 
serum (FCS). 
X-ray irradiation and cell fusion 
M28 cells, 8xl06 were harvested, washed with 5 ml FIO medium and resuspended 
in 5 ml FIO medium. The cell suspension was then exposed to a lethal dose of 
40,000 rads of X-ray irradiation. The irradiated cells were fused at a ratio of 5:1 
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with Wg3-h cells by means of polyethylene glycol 1500 (Boehringer-Mannheim) or 
Sendai virus (1000 HAU) procedures. The cell suspension resulting from each 
fusion was seeded into 60 mm petridishes with 4 ml FIO medium + 15% FCS each 
and incubated at 37 °C. After 1 day, the medium was replaced by selective 
medium. Due to the fact that the iso(12p) marker, present in the original M28 cell 
line, contains several copies of a dominant neomycin resistance marker, selection 
with both HAT (100 μΜ hypoxanthine, 1 μΜ aminopterin, 12 μΜ thymidine) and 
G418 (400 μg/ml, Life Technologies) was carried out. Controls included Wg3-h 
and irradiated M28 cells in FIO + HAT and/or G418. No colonies were observed in 
either case. The medium in all dishes was refreshed about every 3 days. Hybrid 
colonies were visible 2-4 weeks following fusion and care was taken that they were 
isolated separately (two to three colonies/dish). 
Characterization of Radiation Reduced Hybrids 
To select those hybrid clones that have retained fragments of 12p, we first 
performed non radioactive in situ hybridization experiments using biotinylated total 
human DNA as a probe (Pinkel et al., 1986). Clones showing clear positive signals 
were selected for further analysis and designated as WgM hybrids. 
Further characterization of the 12p component of the WgM hybrids was 
accomplished by Southern blot analysis following standard protocols. Hybrid and 
control DNAs, 10-15 μg, were digested to completion using EcoRl, electrophoresed 
in 0.7% agarose gels and transferred to nylon membranes. Blots were hybridized 
with chromosome 12p-specific DNA markers labeled by random priming (Feinberg 
and Vogelstein, 1984). 
in situ hybridization with Л/и-PCR products 
In addition, we performed chromosomal in situ suppression hybridization 
(chromosome painting: Cremer et al. 1988; Lichter et al. 1988; Pinkel et al. 1988), 
using Л/н-element mediated PCR products of the WgM hybrids as a probe 
(Lengauer et ai, 1990, Lichter et al, 1990), in conjunction with fluorescent R-
banding (Cherif et ai, 1990) on metaphase spreads obtained from normal human 
blood lymphocytes. 
The Л/и-PCR was carried out following standard procedures with 1.5 μg Λ/«-ΒΚ33 
primer (5'-CTGGGATTACAGGCGTGAGC-3') and 500 ng (hybrid)DNA digested 
with Xhol at 37 °C for 1 hour. The reaction mixture was heated at 96 °C for 10 
min and 2.5 U Taq DNA polymerase (Cetus) was added to start cycling for 1 min 
at 92 °C, 1 min at 55 °C and 4 min at 70 °C on a DNA thermal cycler (Perkin 
Elmer; Cetus) for 30 cycles. Prior to labeling, the PCR products were purified by 
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phenol/chloroform extraction and eluted through a Sephadex G50 column. The 
eluted fraction was then precipitated with ethanol and dissolved in TE (10 mM Tris, 
1 mM EDTA, pH 7.0). 
For in situ hybridization, 1 μg of purified PCR product was labeled with biotin-11 -
dUTP (Sigma) using a nick-translation kit (Life Technologies). The labeled DNA 
was purified through a Sephadex G50 column and precipitated in the presence of 
sonicated sperm herring DNA (50 μg) and Cot-1 DNA (25 μg, Life Technologies). 
Subsequently, this DNA mixture was dissolved in a hybridization solution (50% 
[v/v] deionized formamide, 10% [w/v] dextrane sulphate, 2xSSC, 1% [v/v] Tween-
20, pH 7.0) to a final concentration of 25 ng probe DNA per microliter. Prior to 
hybridization, the probe was denatured at 80 °C for 10 minutes, chilled on ice and 
incubated at 37°C for 1-2 hours allowing preannealing. 
Chromosomal preparations were made from human blood lymphocytes (BrdU-
incorporated), derived from healthy donors. These preparations were pretreated with 
RNase A (100 μ§/ηι1 in 2xSSC at 37°C for 1 hr) before denaturation in 70% 
formamide, 2xSSC, pH 7.0 at 70°C for 2-3 minutes. Then, 10 μΐ of the preannealed 
probe was added to each slide under a 18x18 mm coverslip. Hybridization was 
performed in a moist chamber at 37°C for 1-3 days. After immunocytochemical 
detection of the hybridized probes and simultaneous R-banding of the chromosomes, 
the slides were mounted in antifade medium containing propidium iodide (0.5 
μg/ml, Sigma) as DNA counterstain and di-azobicyclo-(2, 2, 2)-octane (1.4% [w/v], 
Merck) as antifade agens. 
Slides were viewed under a Zeiss Axiophot epifluorescence microscope, equipped 
for the visualization of fluorescein isothiocyanate (FITC) and propidium iodide 
fluorescence. Digital images were captured with a Bio-Rad MRC 500 confocal laser 
scanning microscopy workstation. Photographs were taken from the computer 
screen using Kodak EPP 100 color slide film. 
RESULTS 
Generation of human-hamster hybrids containing fragments of human 
chromosome 12p 
Fusions were carried out between the hamster cell line Wg3-h and the mouse-
human cell line M28, which contains the Pallister-Killian-derived isochromosome 
12p as its only human component, using both PEG 1500 or Sendai virus. Prior to 
the fusion with the Wg3-h cells, M28 cells were irradiated with a lethal dose of 
40,000 rads. Initially, hybrid cells were selected in HAT medium, which selects for 
the rescue and retention of the murine HPRT gene from the irradiated M28 cell 
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line. After HAT selection 50 colonies were isolated. Due to the presence of multiple 
copies of the neomycin resistance gene in the i(12p) chromosome of M28 cells, 
selection following fusion with the Wg3-h cells could also be carried out using 
G418. By application of G418 selection another 10 colonies were isolated. 
Selection of hybrids containing human chromosomal fragments 
The 60 isolated second-generation hybrids were tested for the retention of human 
chromosomal fragments by non radioactive in situ hybridization with biotinylated 
total human DNA as a probe. Seventeen hybrids, designated as WgM hybrids, gave 
a clear positive hybridization signal (not shown) and were selected for further 
characterization. Two types of signal could be distinguished in the positive 
hybridizing WgM hybrids: 
a. Loose, apparently centromere-containing, fragments varying in size from very 
small to fragments as large as half an i(12p) chromosome. 
b. Incorporated fragments, visible as one or more bands in the hamster 
chromosomes, or as telomeric-associated pieces. 
In most of the hybrids, the human specific signals were visible in the majority (but 
not all) of the metaphases. In some instances a combination of loose and 
incorporated signals was observed. 
Characterization of the human chromosome 12p content of the WgM hybrids 
1. Southern blot analysis. 
The WgM hybrids were tested for the presence or absence of 12p sequences using 
Southern blot analyses with chromosome 12p-specific probes. These probes and 
their chromosomal localizations are listed Table 1. It is apparent (see also Human 
Gene Mapping 10, 1989) that the currently available 12p probes are not very 
evenly distributed along 12p. In all hybridizations a parental control (M28) was 
included and also a total chromosome 12 containing hybrid (A3TE7b, Looijenga et 
al, 1990). 
Examples of the Southern blot analyses are shown in Fig. 1, while a summary of 
these results is given in table 1. The chromosome 12-specific pericentromeric 
alphoid repeats (D12Z3; probe: pal2H8) are retained in 10 of the 17 hybrids tested. 
Six of the 17 hybrids give a clear positive hybridization signal with FGF.6 (probe: 
pV3), which seems to be the most distal marker of the ones we tested. Two hybrids 
(WgM7A and WgM 1.1-neo) appear to contain the major part of a 12p arm derived 
from the original isochromosome, since they hybridize to all but one of the probes 
tested, pV3 and ScIAP8, respectively. Two hybrids do not hybridize with any of the 
probes used (WgM22A and 28A). Based on these analyses, 10 hybrids seem to 
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contain more than one human 12p fragment as, delineated from the known probe 
order (table 1), they show gaps in these Southern blot analyses (WgM8B, 10A, 
22C, 23A, 23B, 1.1 neo, lO.lneo, ІЗ.Іпео, 23.1neo and 28.1neo). 
2. Chromosome painting. 
Further characterization of the human chromosome 12p content of the WgM hybrids 
was accomplished by using suppression in situ hybridization (chromosome painting) 
techniques in conjunction with fluorescent chromosomal R-banding. Since the 
human component in radiation-reduced somatic cell hybrids may be relatively small, 
Alu element-mediated PCR was carried out prior to the in situ hybridization, in 
order to specifically amplify the human component in these hybrids.The primer we 
chose (BK33), is located at the 3' end of the Alu consensus sequence.. 
m < ш 
CO CO CO T-
CM CM CNJ . -
CM CM CM . -
Figure 1: Southern blot analysis of the radiation-reduced (WgM) hybrids. DNAs of 
WgM hybrids, M28 (mouse-human hybrid cell line containing i(12p)) and 
A3TE7b (hamster-human hybrid cell line containing a complete #12) were 
digested using EcoRI. The resulting blots were hybridized with pPRP-1, 
pal2H8, p640, ρ 12-16, pha2ml and pV3 (panels A to F, respectively). The 
arrow indicates the human-specific signal. 
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By doing this, we were able to precisely localize the human fragments present in 
the WgM hybrids on chromosome 12. Examples of such non radioactive in situ 
hybridization experiments with Alu-PCR products as a probe hybridized to normal 
human lymphocyte metaphase spreads are given in Fig. 2. These chromosome 
painting results confirm the presence of chromosome 12p fragments in the WgM 
hybrids. Furthermore, some of the hybrids appear to contain fragments of 
chromosome 12p that had not been detected before via Southern blot analysis: 
WgM6B, for instance, gave a signal only with the pal2H8 and ρ 12-16 probes. 
However, besides this 12pll region, chromosome painting clearly shows the 
presence of part of the 12pl3 region in this hybrid cell line (Fig. 2A). Similar 
results were obtained with WgM7C and WgM22B. 
By combining the results from both Southern blot analysis and in situ hybridization 
experiments, a consensus physical map as depicted in Fig. 3 is proposed. 
DISCUSSION 
We employed a radiation-induced method to generate human-rodent somatic cell 
hybrids containing various fragments of the short arm of chromosome 12. This 
strategy was very similar to the one used by Cox et al. (1989), who isolated 
fragments of the distal short arm of human chromosome 4, containing the region 
for the Huntington's disease gene. In their procedure they did not specifically select 
for the retention of human material. Similar techniques were also used by Benham 
et al. (1989) and Goodfellow et al. (1990) to isolate fragments of human 
chromosomes X and 10, respectively. They showed that a higher irradiation dose 
leads to a higher frequency of retention of human sequences in the hybrids 
(Benham, 50,000 rads: 100%; Goodfellow, 50,000 rads: 75%), which may be 
explained by the notion that more extensive chromosome fragmentation facilitates 
the association with rodent chromosomal material. To identify those hybrids that 
had retained human chromosomal fragments, we used non radioactive in situ 
hybridization with total human DNA as a probe. In 17 of 60 hybrids (designated as 
WgM hybrids) tested the presence of human material could be demonstrated. This 
retention frequency of 28% at an irradiation dose of 40,000 rads is lower than those 
reported by other groups. This may be due to the relatively small size of the i(12p) 
chromosome as compared to e.g. chromosomes 10 and X and the possibility that 
minor fragments may have been missed in the original screening. 
Characterization of the human 12p content of the WgM hybrids was performed by 
Southern blot analysis. It is difficult to correlate the chromosome 12p content of the 
WgM hybrids, as assessed by the Southern blot analyses and by the fluorescence in 
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situ hybridization experiments using total human DNA as a probe. For example, not 
all hybrids with loose positive-reacting fragments hybridize with the pal2H8 probe. 
These fragments probably contain a rodent centromeric region. The applied dose of 
40,000 rads of irradiation appears to induce chromosomal breaks with high 
frequency as may be concluded from the observation that only two hybrids 
(WgM7A and WgMl.lneo) seem to contain an almost entire 12p arm. The 
chromosome 12-specific pericentromeric alphoid repeats are retained in 10 of the 17 
hybrids (59%). This selective retention of alphoid repeats in somatic cell hybrids 
resulting from chromosome fragmentation experiments has been reported previously 
(Pritchard et al, 1987, 1989; Goodfellow et al, 1990), and is thought to reflect the 
inherent stability of centromeres in these hybrids. Furthermore, 9 of the 17 hybrids 
appear to contain more than one 12p fragment. The precise regional localization of 
several of the 12p-specific probes that we used is as yet unknown. On the basis of 
our Southern blot analyses we put them in a hypothetical order as shown in table 1. 
As there are relatively few 12p-specific probes available, the precise 
characterization of the human component in the WgM hybrids via Southern blot 
analysis is not possible. 
m < о m 
< < ш о ш < т
т
_ т -
12P 
* ИдМ2ЭЯ i s excluded from t h i s f i g u r e . 
Figure 3: Schematic representation of the human chromosome 12p contents of the 
WgM hybrids resulting from combining both Southern blot analyses and 
chromosome painting data. 
44 
#12 aberrations in TGCTs 
Chromosome painting, with Л/и-element-mediated PCR (BK33) products of the WgM 
hybrids as a probe, reveals the precise constitution of the human component in these 
hybrids Besides the localization of the 12p fragments present, it also reveals the gaps in 
the hybrids as determined before by Southern blot analysis (e g WgM8B table 1, Fig 
2B) Furthermore, some of the hybrids (e g WgM6B table 1, Fig 2A) appear to contain 
regions of chromosome 12p that remained undetected via the Southern blot analysis Also 
WgM22A and WgM28A, which do not hybridize to any of the 12p-specific probes tested, 
give a clear positive signal on the distal part of the 12pl3 region (not shown) However, 
WgM7A, which hybridizes to the probes tested from 12pl2, shows a gap in this region 
using chromosome painting Similarly, WgM13 Ineo and WgM28 lneo both hybridize 
with the ρ 12-16 probe Chromosome painting, however, does not reveal the putative 
presence of this particular region in these hybrids By using BK33, which is a primer 
complementary to one of the less conserved regions at the 3' end of the Alu repeat, as a 
primer for our PCR reactions, we previously found a rather even staining of the human 
chromosomes with some minor R-banding This R-banding effect is much more 
pronounced when the Л/ы-517 primer is used (Lichter et al, 1990) Still, however, we 
cannot exclude some preferential amplification of certain 12p-regions This might explain 
some of the discordancies found by comparing the results from Southern blot analyses and 
chromosome painting experiments Thus, a combined use of both Southern blot analysis 
and chromosome painting seems to be a prerequisite for a reliable characterization of 
radiation-reduced hybrids 
As a result of this dual characterization, a panel of radiation reduced hybrids has been 
assembled, encompassing the whole human chromosome 12p arm This panel will help us 
to identify regions of chromosome 12p which are specifically involved in the chromosome 
12 aberrations observed in, eg , human germ cell tumors Once established, new relevant 
probes may be isolated by using ^/«-element-mediated PCR techniques and/or by cloning 
the hybrids into cosmids or yeast artificial chromosomes To a limited extend, the hybrids 
may also be used for the ordering or linking of probes as is apparent for, e g , pvWFllOO 
and pß3r (see table 1) For this purpose further extension and subcloning of the panel of 
cell lines may be required 
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Note added in proof. Since submission of this manuscript, two additional 12p 
probes were tested: QR2 (locus EN02), kindly provided by I. Day, and C2 (locus 
TNF-Rl), kindly provided by D. Wallach. Both probes show hybridization patterns 
similar to those of F8VWF and GNB3 and are located at 12p 13. 
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ABSTRACT 
Human testicular germ cell tumors (TGCTs) comprise a heterogeneous group of 
solid neoplasms. These tumors are characterized by the presence of a highly specific 
chromosomal abnormality, i.e., an isochromosome of the short arm of chromosome 
12. At present, this i(12p) chromosome is found in more than 80% of TGCTs. 
Isochromosome 12p has also been observed in some ovarian and extragonadal germ 
cell tumors. In the remaining so-called i(12p)-negative TGCTs other abnormalities 
involving chromosome 12, mainly 12p, can be found. In order to establish whether 
12p abnormalities other than i(12p) are a common phenomenon in TGCTs, a panel 
of 11 i( 12p)-negative tumors was investigated using multicolor fluorescence in situ 
hybridization. All TGCTs examined appeared to contain chromosomal abnormalities 
involving 12p, resulting in a distinct overrepresentation of short arm sequences. In 
addition, indications were obtained for a clonal evolution in one of the tumors. Our 
data suggest that the occurrence of 12p abnormalities is a common phenomenon in 
i(12p)-negative TGCTs and that these abnormalities, analogous to i(12p), may 
contribute to the process of tumor development. 
INTRODUCTION 
Human testicular germ cell tumors (TGCTs) comprise a histogenetically heteroge-
neous group of neoplasms. Despite this heterogeneity, a highly specific structural 
chromosomal abnormality, i.e., an isochromosome of the short arm of chromosome 
12 [i(12p)], has been found in more than 80 % of all histologic varieties of TGCTs 
of the adult (see de Jong et al., 1990 for review). Moreover, i(12p) has been 
observed in five ovarian germ cell tumors (two dysgerminomas: Atkin and Baker, 
1987; Jenkyn and McCartney, 1987; two yolk sac tumors and one mature teratoma: 
Speleman et ai, 1990, 1992; Hoffner et al., 1992), a dysgenetic gonadal tumor 
(Hamers et ai, 1991), a metastasis from a testicular mixed stromal sex cord tumor 
(Oosterhuis et al., 1989), and in some extragonadal germ cell tumors (Chaganti et 
ai, 1989; Dal Cin et al., 1989; de Bruin et al., 1994; Kaplan et al., 1979; Ladanyi 
et al., 1990). So far, the occurrence of this marker chromosome in solid neoplasms 
other than germ cell tumors has been limited to only three isolated reports (van der 
Riet-Fox et ai, 1979; Rodriquez et al., 1990; Sreekantaiah et ai, 1992), thus 
demonstrating its specificity for germ cell tumors. Although little is known about 
the exact nature and role of i(12p) in tumor development, there is consensus that its 
presence correlates with the malignant character of the tumor (Delozier-Blanchet et 
al., 1987; Bosl et ai, 1989; Castedo et al, 1989a). 
A relatively small group of TGCTs lacks the i(12p). Instead, other abnormalities 
involving chromosome 12 are usually found (Gibas et al.. 1986; Castedo et al.. 
1988). Also, some extragonadal germ cell tumors without i(12p) have been 
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described (Mann et ai, 1983; Oosterhuis et al., 1985). Because there is general 
acceptance that i(12p) may play an important role in the oncogenesis of TGCTs, it 
has been suggested by Castedo et al. (1988) that i(12p)-negative and -positive 
TGCTs may represent different subtypes of germ cell tumors, with different clinical 
and pathological behaviors. Alternatively, a common underlying molecular 
mechanism leading to malignancy may be present in both groups of germ cell 
tumors. Clearly, more profound and detailed clinical as well as cytogenetic and 
molecular studies on both i(12p)-positive and -negative TGCTs are needed to clarify 
their possible pathogenetic interrelationship. 
Recently, fluorescence in situ hybridization (FISH) strategies were used to 
demonstrate the presence of genuine i(12p) chromosomes in a diverse group of 
gonadal and extragonadal germ cell tumors and their derived cell lines (Suijkerbuijk 
et ai, 1991, 1992). Similarly, other abnormalities involving chromosome 12, mainly 
12p, that could not be detected by conventional cytogenetic means were found to be 
present in both i(12p)-positive and -negative TGCTs using FISH, thus leading to a 
more detailed karyotypic description of these tumors. Here, we have applied FISH 
strategies to a group of i(12p)-negative TGCTs to examine them for the presence of 
chromosome 12 abnormalities other than i(12p), and to determine whether such 
aberrations are a common characteristic of i(12p)-negative TGCTs. 
MATERIALS AND METHODS 
Cells 
All tumors were collected under sterile conditions and karyotyped. Subsequently, 
parts of the tumors were shipped to the Nijmegen laboratory for FISH analysis. 
The samples were processed according to previously described methods (Limon et 
al., 1986; Parrington et al., 1992). Each tissue was disaggregated in collagenase 
(200 U/ml, overnight). The following day the suspensions were seeded in flasks and 
on coverslips containing RPMI-1640 medium supplemented with 17% bovine 
serum, 1% glutamine (2 mM) and penicillin/streptomycin (5000 U/ml, 5000 μg/ml) 
and placed in a humid environment with 5% C02 for a period of 3-15 days. 
Harvest was performed by overnight Colcemid exposure, hypotonic shock, and 
fixation with methanol:acetic acid (v/v, 3:1). Air-dried chromosome preparations 
were G-banded using trypsin and the karyotypes were expressed according to the 
ISCN 1991. 
In situ hybridization 
FISH experiments were carried out essentially as described before (Suijkerbuijk et 
ai, 1992) using three different types of probes, i.e., pBS12, M28, and pal2H8, 
which allow the specific identification of the entire chromosome 12, its short arm, 
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and pericentromeric region, respectively. In short, DNAs from the 
monochromosomal mouse-human somatic hybrid cell line M28 with an i(12p) as its 
sole human component (Zhang et al., 1989), kindly provided by Dr. J.J. Cassiman 
(Leuven, Belgium), and from the bluescribe plasmid chromosome 12-specific 
library pBS-12 (Collins et al., 1991), a generous gift from Dr. J.W. Gray (San 
Francisco, CA) were biotinylated with biotin-11-dUTP (Sigma, St. Louis, MO) 
following standard nick-translation protocols. Similarly, DNA from the chromosome 
12-specific alpha satellite sequence pal2H8 (D12Z1: Looijenga et ai, 1990), kindly 
provided by Dr. L.H.J. Looijenga (Rotterdam, The Netherlands), was labeled with 
digoxigenin-11-dUTP (Boehringer Mannheim, Germany). Bicolor double FISH 
hybridizations were performed using either biotinylated M28 and digoxigenin-
labeled pal2H8, or biotinylated pBS-12 and digoxigenin-labeled pal2H8 as a 
hybridization mix on metaphase spreads of tumor cells. 
Chromosomes and chromosomal segments hybridizing to biotin- or digoxigenin-
labeled probes were visualized using alternating layers of fluorescein isothiocyanate 
(FITC)-conjugated avidin and biotinylated goat anti-avidin antibodies (both from 
Vector Laboratories, Burl ingame, CA), or Rhodamin-conjugated sheep anti-
digoxigenin antibodies (Boehringer-Mannheim) and Texas Red-conjugated rabbit 
anti-sheep antibodies (Jackson ImmunoResearch, West Grove, PA), respectively. 
Counterstaining of the chromosomes was performed with the blue DNA-specific 
dye DAPI (Sigma). 
Chromosomes were studied under a Zeiss Axiophot epifluorescence microscope, 
equipped with appropriate filters for the visualization of FITC, Rhodamin/Texas 
Red, and DAPI fluorescence, as well as the simultaneous visualization of FITC and 
Texas Red fluorescence (Omega double filter, Battlesboro, VT). Photographs were 
made on Kodak EL 400 colorslide film using double and triple exposures. 
Alternatively, separate digital images (for Texas Red, FITC, and DAPI, respective-
ly) were recorded using a Photometries high-performance CH250/A cooled CCD-
camera (Photometries, Tucson, AZ) coupled to a Macintosh Ilei computer. The 
images were superimposed and displayed in red-green-blue pseudocolors on the 
computer screen using the image-analysis and -processing software program BDS-
image (Biological Detection Systems Inc., Rockville, MD). Photographs were made 
from the computer screen on Kodak EPP 100 plus colorslide film using a Polaroid 
Quickprint. 
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Figure 1: Representative GTG-banded karyotypes of the i(12p)-negative testicular 
germ cell tumors in case 7 (A) and case 5 (B). Numerical and structural 
chromosomal abnormalities are indicated by arrowheads, while 
chromosomes with 12p abnormalities as revealed by FISH (see Table 6) are 
denoted by asterisks. 
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RESULTS 
A group of ten primary i(12p)-negative testicular germ cell tumors (TGCTs) and 
two TGCT-denved cell lines was included in the present study A summary of the 
clinical, histopathologic, and cytogenetic data of these primary tumors and derived 
cell lines is given in Table 1 A representative karyotypic description of each tumor 
as revealed by GTG-banding is listed in Table 2 In addition, representative 
karyotypes of cases 7 and 5 are shown in Figs 1A and IB. respectively 
Table 1: Summary of the clinical and cytogenetic data on the primary tumors 
Case no 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10(tuj, 
Patient age 
tuc)b 
17 
28 
28 
26 
23 
36 
27 
64 
24 
25 
(yrs) Histology No 
EC/MT/YS 
EC/MT 
EC/IT 
SE/EC/MT 
SE/EC/IT 
EC 
EC/MT/YS 
SE/EC/IT/MT 
RMT 
SE/TIn 
of cells 
9 
20 
8 
10 
17 
4 
8 
9 
6 
29 
analyzed' Modal number 
53-57 
56 
65-66 
50-56 
58 
58-61 
54 
53 
58 
63-64 106-1081 
Abbreviations SE, seminoma, EC, embryonal seminoma, IT, immature teratoma, MT 
mature teratoma, Tin, intermediate teratoma, RMT, residual mature teratoma, YS, yolk sac 
tumor 
a
 Only abnormal metaphases 
ь
 Original tumor of the cell lines tuj and tue 
c
 Concerning tumor derived cell lines 
The identity of putative chromosome 12-denved marker chromosomes was 
established using multicolor fluorescence in situ hybridization (FISH) techniques 
By combining "chromosome paints" (either pBS-12 or M28) and a repetitive probe 
(pal2H8) in a double FISH assay, the simultaneous visualization of chromosome 
12- or 12p-denved sequences (green fluorescence) and chromosome 12-specific 
centromenc sequences (red fluorescence) was attained For contrast, nonhybndizing 
chromosomes or chromosomal segments were counterstained with the blue dye 
DAPI Evaluation of the FISH results was achieved, if possible, by comparing data 
on the relevant chromosomes from both FISH and GTG-analyses (Table 3) Fully 
or partly unidentified chromosomes containing chromosome 12-denved sequences 
were designated as marker (mar) chromosomes In all cases where the GTG-banded 
counterpart could not be identified as such, only those chromosome 12 arms with a 
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more or less normal size and DAPI staining pattern were considered to be normal. 
FISH analysis revealed that, without exception, all i(12p)-negative TGCTs included 
in this study exhibit abnormalities involving the short arm of chromosome 12 
These are described in detail in Table 3. The abnormalities appeared to vary 
Table 2: Karyotypic description from each case 
Case no Representative karyotype (number of neoplastic cells analyzed) 
1 53-57,XY,+X,+add(l)(p31),+3,+3,+6,H8,+8,-9,+ 12,-14,-15,-15,add(19)(ql3),+20,+2-6mar[9] 
2 5 6 ,X, + X , - Y , + a d d ( l ) ( p 3 6 ) , + 2 , + 6, + 7, + 8 , + a d d ( 9 ) ( q l 1 ), + dic( 1 2) t ( I 2 , ^ , 2 2 ) 
(p 13 ,?,p 11 2),+16,+17,+21 ,-22,+mar [20] 
3 6 5 < 2 n > , X Y , + X, + 3 , a d d ( 4 ) ( p l 4 ) , + 5, + a d d ( 7 ) ( q l 1 2 ) , + a d d ( 7 ) ( q 2 1 ), + a d d ( 8 ) 
(q24 3)x2,+add(9)(pl3),+ 10,+ 10,+ 12,+ 12,+ 14,+add(15)(q22),add(16)(pl3 1),+ I7,add-
(18)(pll 2),+der(22)t(13,22)(pll 2,ql2),+r,+ l-2mar [8] 
4 5 0 - 5 6 , XY, HX, d e r ( l ) t ( l , 13 ) (q25 , q l 2 ) , add(2) (p l 1 2) , + 3 , -7 , + add(8) (q24 1), 
+add(ll)(q23),der(14)t(14,14)(pll 2,qll 2),add(14)(pl 1 2),H6,+20,+add(20) (pi3),-21,-22,-
22,+2-6mar[10] 
5 58<2n>,XY,+X,+1 ,+2,+3,+add(6)(q 13),+7,+7,+8,+add( 12)(p 13),+ 14,add( 15)(q25),+20,+21 ,-
22,+mar[17] 
6 60-63<2n>,XY,+X,+Y,+2,+3,add(4)(pl6),+7,+der(7)t(7,l l)(ql 1 2,ql3),+8, 
-10,+12.+14,+ l 6,+17,-20,+21 ,+5-8mar [4] 
7 56,XY,+X,+der(2)t(2,21)(q37.qll 2)add(2)(p25),+3,H 6,+7,+7,+add(7)(ql 1 2),+8,+8,-
9 , d e r ( 9 ) t ( 9 ; ' \ 9 ) ( 9 q t e r - > 9 p 3 4 "> 9q l 3 ->9q te r ) , -1 1 , + add( 12)(p I 1 2 ) , + der 
(12)tC5,12)Cql3,q21),+ 16,-21,+mar[12] 
8 5 3,X,+add(X)(pl l ) , -Y,+add(l)(p35-36) ,+del( l )(ql2) ,+der( l )add(l)(p35-36)del( l ) 
(q32),+del(2)(q34),del(3)(q2l),der(3)t(3,7,'>3)(3qter->3p21 7q36->7ql I ^ 2 3 - » 
•>3qter), + d u p ( 3 ) ( q 2 1q27), + d e l ( 5 ) ( p l 2 ) , - 6 , + d i c ( 7 , 1 7 ) ( q 3 1 ,p l3) , + 8,+ 1 2 , - l 4 , 
+der( 14)l( 12,14)(q 13 ,p 11 ),+16,-18,+del(20)(q 12),-21 ,der(21 )t(21,22)(p 11 ,q 11 ), 
-22,+mar [9] 
9 5 8 < 2 n > , X Y . + X, + d e r ( l ) t ( l , 1 4 ) ( p l l , q l l ) , - 2 , + a d d ( 2 ) ( p 2 5 ) , + 3 , -6 , + d u p ( 7 ) 
(qll 2q21),+8,add(ll)(ql4),+ 12,+ 14.M5,+ 15,-16,+ 19,+20,+21,+22,+mar[6] 
10-tuc' 106-107<4ri>,XXYY,+X,+ l, + 2, + 3 ,add(4)(q3 5), + 6, + 7 ,+add(7) (q32) ,+8 , +8, 
+9,del( 11 )(q22),+12,+del( 12)(qV),+ > 4,add( 16)(q22),+add( 17)(p 13).-18, +19.+20 [4] 
lO-tuj" 63-64<2n>,XY, + X , + a d d ( l ) ( p 3 6 ) , + 2 , + 3 , + add (4 ) (q3 5 ) , ^ 6 , + 7, + a d d ( 7 ) ( q 3 2 ) , 
+8,+8,+9,+del(ll)(q22),+ 12,+del(12)(q9q''),+ 14,+ 15,+add(16)(q22),+add (17)(pl3),-
18,+ 19,+20 [9] 
* Tumor-derived cell lines 
considerably in complexity, from simple translocations of almost the entire 12p 
arm, to complex insertional translocations and/or marker chromosomes partly or 
fully consisting of 12p sequences, some examples of which are displayed in Fig. 2. 
In Fig. 2A a metaphase spread of a TGCT-derived cell line (case 10-tuj) is shown 
after hybridization with pal2H8 (red) and M28 (green); three copies of a normal 
chromosome 12 and three other chromosomes partly consisting of chromosome 12 
material (designated as marl-3) can easily be discerned. The marker chromosomes 
appear to contain one (marl-2) or two (mar3) copies of almost the entire 12p arm 
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translocated either onto a derivative chromosome 18 (marl), onto the terminal part 
of chromosome lq (mar2), or onto both lpter and Iqter (mar3). Based on 
conventional cytogenetic data only, marl was previously assumed to be a 
del(12)(q?q?) chromosome; now it can be described as add( 12)(q 11 ). Further FISH 
analyses using a variety of chromosome-specific libraries and centromeric probes 
(not shown), revealed that marl can best be interpreted as a complicated 
translocation product involving chromosome 12 and 18 in the following manner: 
der(12)dic(12;18)(pll;qll)inv(18)(ql0q22)addl8(ql0). Also the other two marker 
chromosomes, mar2 and mar3, could be identified as der( 1 )t( 1 ; 12)(q42;p 11) and 
der( 1 )t( 12 ; 1 ; 12)( 12pter-> 12p 11 : : 1 p3 6->cen-> 1 q42 : : 12p 11 -> 12pter), respectively. 
Case 1 shows a somewhat different picture (Fig. 2B). Besides three copies of a 
normal chromosome 12, two marker chromosomes are recognized. Marl consists of 
an apparently normal 12p arm (without centromeric alphoid sequences) translocated 
onto a derivative chromosome 19 with an unknown chromosomal fragment added 
onto its long arm: der(19)t(12;?;19) (12pter-»12pl?l::?::19ql3->cen->19pter). The 
other marker (mar2) appears to have a more complex composition: it contains two 
large adjacent 12p-positive regions that are interconnected by two chromosome 12-
specific, alphoid DNA blocks. In addition, segments of unknown chromosomal 
origin are present (see insert in Fig. 2B) on both chromosomal ends. 
Altogether, this mar2 can now best be considered as a 
der(12)idicdup(12p)add(12)(p?)(?::12p?::12pl3->12cen::12cen^-12pl3::12p?::?). 
Highly comparable results were obtained in all other cases and these are listed in 
Table 3. 
In addition, results suggesting karyotypic evolution within one tumor (i.e., case 5) 
were obtained (see Fig. 3). By using the above FISH techniques, which specifically 
reveal well-defined chromosome 12-specific regions, the delineation of a number of 
clonal lines differing in only one marker chromosome could be achieved. All 
representative tumor metaphases showed two copies of a normal chromosome 12 in 
addition to a der(15)t(12;15)(pl?0;q28), which includes a tiny chromosome 12-
specific alphoid region. The karyotypic evolution appears to be represented by a 
second derivative chromosome 12 - add(12)(pl3) - with, in a clonal manner, an 
increasing amount of extra chromosomal segments translocated onto the original 
56 
е
л
 
ι
-
Ο
 
В
 
_g 
13 
υ
 
<
υ
 
ο
ο
 
Lm
 
(
Ν
 
<U 
ε
 
о
 
(
Λ
 
О
 
E о Ui 
χ
: 
и
 
U-. 
О
 
С
 
о
 
о
.
 
Э
 
В
 
>> 
X) 
Т
З
 
U 
"
я
 
U > 
0>
 
k
-
і
л
 
cd 
j2 С! О) 
υ
 
>
 
с
е
 
о
с
 
υ
 
с
 
^
і^ 
о
,
 
(
Ν
 
И
 
Λ
 
С
 
о
 
е
л
 
"3 СЛ ω 
I t/3 
Ξ
 
L>
-
О
 
>->
 
u
 
CO
 
E ε
 
3 
t/3 
ri ν 
л
 
CN 
—
•
 
α> 
E о о о 
XI υ
 
<
+
-
О
 
С
 
о
 
в
-
υ
 
4) 
Ω
 
о
 
π
 
•
υ
 
с
 
-
σ
 
с
 
cd 
Х
>
 
6 О <υ
 
<t¡ 
ed 
VI 
С
 
<
υ
 
Ρ
 
to
 
С
 
О
 
Q
 
г
-
î
 
=f 
Τ
 
^
 
(
Ν
 
îî 
2
 
<N
 «2 
—
 
(d 
î
 
î 
(U
 (
Ν
 
_
rî 
Τ
 
—
 
^
 
^
a
l
-
^
i 
CL
 
—
 
—
 
a
 
—
 :_:
 
τ
~
,
 
с
 
«
 
σ
-
 
°
-
 
С
4
 
U
 
С
 ; 
—
.
 ^
Г
 
—
 
<
Ч
 £
 
Q
.
 (
Ν
 ?
Г
 
,
 
_
_
 
^
 
C
N
 
Ζ
Ζ
.
 
-
 
ω
 
ί
-
Ί
 2
 
-
.
 E
 
<
Ч
 _
"
 «
Ч
 
—
 t
 
Ь
 ^
 
^
-
Ι
 
<
Ν
 
Ό
~
Γ
 
_?
•
 
Λ
 
<
Ч
 
C
T 
(
Ν
 
C
-Γ
Ί
 
¡
я
 
κ
 
—
 2
.
 
(
Ν
 
CL
 
E 
¿
 
f
 
00 
CS
 
•
 
ο
ο
 
cd
 
г
а
 
С
 
с
т
<?
 
σ
"
 +
 
C
L 
О
 
(-!)
 
о
 
^
 CN
 
с
у
 
л
 
σ
*
 J^
-
 
А
 
^
-
 
я
 
—
 
CN
 
^
 
OS
 ¡£
 
о
.
 
—
 
—
 
ж
 
/
Ν
 
(
Ν
 
cd 
"
'
 
E 
о
.
' 
S
-
 Fi
 i¡
 L
 Ç-L 
-
 
^
 
f
 
«
 
-
Ä
 t 
.
 
.
 
.
 
,
 
„
 
.
 
.
 
,
.
 
CN
 
—
 
f
 
C
L^-cjv
 
-e
r
—
 
-e
r
 
й
 
"
С
-
Г
 
Т
Э
 
—
 
с
-
 
Îf
N
 
Ό
 
С
 
Τ)
 
M
 
+
 
г
 
+
 
—
 +
 
Г
 
+
 
—
 
r
i
 
р
ч
 
CS
 
c<ï
 
2
 
—
 
cN
 
u-S 
CN
 
—
S 
5
 
м
 
—
 
T3
 
—
 
rs
 
—
 
υ
 
—
 
υ
 
—
 
Ό
 
CN 
>
 
Ä
 
>
 
л
 
CN 
ρ
 
С
 
e
 
С
 
—
 
Τ
 
£
 S
e
 
•
=<
 S
e
 
«
 
—
 
'
 
cd
 
Ξ
 
,
.
,
 
Ξ
 
ρ
 
—
 
Γ
 
Ρ
 W
 
g
 
W
 
=
.
 
ο
.
 
ί
ν
 
CL
 
—
 
•
Ο
 £)(s
"
 
о
.
 
С
*
 
(
Ν
 
*
-
·
 
_
,
 
-—
*
 
(
Ν
 
G
.
^
 
<
Ν
 
Л
 
—
 
"
Ό
 î Γ*Ί
 
CL
,
 
CN 
ÍS 
^
 
</t 
ι
-
-
σ
 
+
 
Т
Э
 ÍN
 
,—
,
 (
Ν
 
—
 
^
 
—
 
5
3
—
-
r
n(N
i_
; 
+
 
^
 
<"-»
"
 <
Ν
 
—
 
2
 
U
 <
Ν
 
Ε
 
τ
 
:~
.
' 
^
.^
 \ •σ 
a
 
+
 
^
 
m
 
—
 
—
 
—
 
cN
 
—
 
•
•
з
·
 
—
 
(
Ν
 
—
 
°-1
 
ρ
 
-<
Ν
 
—
 £
ι?
Τ
 (
Ν
 
—
 
α
.
 
<
υ
 
3
 
-
ο
 
ë
 +
.
 
Λ
 
.
 
_
 
-
 
_
 
α
 
CN 
^
 
ÍÑ
4 
E-S 
•—
'
 
+
 
•
R
x 
C
L
—
 
CL
 
ζ) 
IN
 
π
-
 tN
 
σ
"
 
•
ч
-
 
-
 
-
ч
-
 
—
 
CT
 
—
 
CT
 
A 
!N
 
4
&
ÍN
 
с
 
1
 
,
 
ν
 
ι
 
1
 
U 
—
"
 °
°
 
—
"
 
«
 
^
 
Γ
Ν
 
-
^
 \D
 
"C
 ìj"
C
 
CL 
(u
 
_
—
 
ω
 
^
^
 
+
„
 
ΰ
 
+
.
 
-
E
 
+
.
 
Ε
 
Τ
 
'
 
'
 ÍN
 
'
 
'
 
α>
 
ο
"
 
™
 
о
4
 
о
.
 
—
 
κ
 
—
 (
Ν
 
CT
 
—
 
к
м
 
cd 
E 
r^ì CL 
ÍÑ
"
 
Т
З
 
E
,
 
(
Ν
 
C
L 
fS 
•
о
 
•
о
 
cd 
"
σ
 
^
Г
 
С
Ч
 
•
а
-
^
 
01 
t*ï
 
CN
 
2
 
Я
 
"
 
О
 
Zo 
о
 
ь
 
с:
 Ji
 
~
 
-
 
ja
 
Ξ
 
~
 
—
 £ 
2
 
я
 
£ 
•
 
ε
 
δ
 
и
 
(
Λ
 
Ϊ
 
CU
 
^
 
«
л
 
_
 
Cd
 
-
^
 
E
 
»
,
 
и
 
«
л
 
,
Ξ
 
о
 
ι
-
Ε
 
<2 
CL
 
с
 
S
3 
•
й
 
о
 
ε
 
E i g •U 
4
>
 
1
Ч
 
Э
 
t/i
 
і
л
 
(T
 
Я
 
Я
 
ω
 
χ
:
 
χ
: 
"
 B-S 
о
 
а
 
E
 E ω 
0
„
ü
|
 
CN
 
-
О
 
g
-
·
0
 
CL
 2
 
*
 
с
 
S
 
«
 
з
 
-
 
J 
-
^
 
л
 
L
 
υ
 
u
 
E 
"
 
J
1
 
я
 
Ç
 
.
с
 
3 
>
 
<
 
с
-
 
r
-
Э
 Q
 
#12 aberrations in TGCTs 
12p arm. At least five different stages (Figs. 3A-E), representing presumed 
individual steps in the evolution of the marker, could be distinguished by an 
increasing amount of 12p-derived and other, as yet unknown, chromosomal 
material. Specific FISH targeting of the separate bands on 12p by using region-
specific "paints" for 12p (see Sinke et ai, 1992) revealed no evidence for 
amplification of a specific (sub-)region on 12p (not shown). Instead, almost the 
entire 12p arm appears to be represented in each 12p-positive region of this marker, 
resulting in multiple (at maximum four) copies of 12p in the most advanced stages 
of its evolution. Strikingly, cells exhibiting the highest 12p copy number appeared 
to be represented most frequently within the tumor cell population (stage 3 and 4/5, 
42% and 36%, respectively). 
Taken together, our FISH results demonstrate the consistent presence of 12p 
abnormalities other than i(12p) in i(12p)-negative TGCTs. These abnormalities 
result in a clear overrepresentation of 12p sequences as compared to those from, 
e.g., 12q in each i( 12p)-negative TGCT examined so far (Table 3). 
DISCUSSION 
In the present study, we demonstrate that cytogenetically undefined or undetectable 
chromosome 12p abnormalities in human germ cell tumors of the testis (TGCTs) 
can be revealed by multicolor fluorescence in situ hybridization (FISH) using 
appropriate probes for the visualization of the whole length, the short arm, and the 
centromeric part of chromosome 12 (pBS-12, M28, and pal2H8), respectively. By 
doing so, we found that in the eleven i(12p)-negative TGCTs and -derived cell lines 
included in this study, a variety of 12p abnormalities could be revealed, most of 
which had remained undefined by previous conventional cytogenetic banding (GTG) 
analyses. Each 12p abnormality, resulting from either a translocation, an inversion, 
or a multiplication event, included nearly the entire 12p arm (12p 11 —>12pl3) and, 
as such, gave rise to a clear-cut overrepresentation of 12p-derived sequences as 
compared to, e.g., those from 12q (Table 3). Very similar conclusions were 
previously drawn from the analysis of i(12p)-positive TGCTs (de Jong et al., 1990). 
It seems likely that the appearance of 12p rearrangements must have been preceded 
by chromosomal breaks at or near the telomeric and/or centromeric regions, as the 
rearrangements usually include the entire 12p 11 —> 12p 13 region. Moreover, in some 
tumors (cases 9 and 5, see Table 3) minor stretches of alphoid satellite DNA 
specific for the centromeric part of chromosome 12 remained attached to the 
translocated 12p segment, probably as a result of a breakage-and-reunion process. 
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Exactly how the generation of additional 12p segments is accomplished in TGCTs, 
however, remains to be established. Of possible relevance in this respect may be the 
observation that in one primary tumor, case 9, a clearly elevated incidence of 
premature chromatid separation (PCS), leading to the formation of a kinetochore 
bridging two chromosome 12 sister chromatids, was present (Fig. 4). This 
"kinetochoric bridge" may span a distance of one chromosomal length or even 
more, and FISH analysis showed the presence of both chromosome 12-specific 
alphoid and non alphoid-derived DNA sequences within such bridges. The process 
of premature chromatid separation may, as an example of mitotic error, lead to 
chromosomal instability, breaks, and losses. In TGCTs, such a mechanism may 
account for the generation of "free" 12p arms that, after subsequent chromosomal 
rearrangement, may contribute to an overrepresentation of 12p-derived sequences as 
found here in the i(12p)-negative TGCTs. Since PCS occurs between sister 
chromatids, the result would be an overrepresentation of 12p arms which are of 
uniparental origin. Recently, we and others (Sinke et ai, 1993; Peltomäki et al., 
1992) obtained evidence supporting this origin of overrepresented 12p sequences in 
TGCTs. Whether this process of premature chromatid separation is a widespread 
phenomenon in TGCTs, and thus may account for a general mechanism, still needs 
to be verified. 
Another intriguing question is how the presence of 12p abnormalities in TGCTs 
contributes to the process of tumor development. It is well known that the presence 
of i(12p) is highly characteristic for most TGCTs (de Jong et al., 1990) and other 
germ cell tumors (Kaplan et al., 1979; Atkin and Baker, 1987; Jenkyn and 
McCartney, 1987; Chaganti et al., 1989; Dal Cin et al., 1989; Oosterhuis et al., 
1989; Ladanyi et al., 1990; Speleman et ai, 1990, 1992; Hamers et al., 1991; 
Hoffner et al., 1992; de Bruin et al., 1994). It has been suggested, therefore, that its 
prevalence points to an important role in the oncogenesis of TGCTs (Delozier-
Blanchet et ai, 1987; Bosl et ai, 1989; Castedo et ai, 1989a). Because 
aneuploidization appears to be an early event in the tumorigenesis of TGCTs 
preceding i(12p) formation (Geurts van Kessel et ai, 1989), it is tempting to 
suggest that i(12p) itself somehow contributes to tumor progression. No direct 
information supporting a possible interrelationship between the presence of 12p 
abnormalities and tumorigenesis in TGCTs could previously be found in the so-
called i(12p)-negative TGCTs. This result led others to presume that i(12p)-positive 
and -negative TGCTs may represent different subtypes of germ cell tumors, with 
different clinical behaviors (Castedo et al., 1988). Our present finding, however, 
that 12p aberrations do occur in every i(12p)-negative TGCT examined, favors the 
opinion that a common molecular mechanism may lead to malignancy in both 
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i(12p)-positive and -negative TGCTs. The overrepresentation of 12p-derived 
sequences in i(12p)-negative TGCTs may, analogous to one or more copies of 
i(12p) in i(12p)-positive TGCTs, contribute to the process of TGCT development. 
Another interesting observation in i(12p)-positive and -negative TGCTs is that 
virtually all 12p abnormalities involve the (almost) entire short arm of chromosome 
12 (i.e., 12p 11 —>12pl3). So far, the amplification of whole chromosomal arms has 
remained a rather infrequent event in (tumor) cytogenetics. The more frequently 
occurring so-called amplicons are usually restricted to very small chromosomal 
segments or, even less, single genes. The repeated appearance of multiple 12p arms 
in every germ cell tumor studied by FISH techniques so far, suggests the 
involvement of multiple DNA sequences spread along the length of 12p, and that 
each may play a role in tumor development, growth advantage and/or therapy 
resistance. Although no direct evidence has been accumulated to support this 
suggestion, the visualization of a - in a clonal manner "growing" - chromosome 12 
marker in one of the tumors leaves room for speculation in that direction. Each of 
the presumed clones may represent a further step in the ongoing process of tumor 
development, resulting in several extra copies of 12p. It will be worthwhile to 
screen these and other i(12p)-negative TGCTs in more detail using region-specific 
probes and "paints" to determine whether the short arm of chromosome 12 is 
entirely multiplied or to what extend indications can be found for a nonrandom 
involvement of particular (sub)band(s) on 12p. 
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ABSTRACT 
Cytogenetic analysis of a metastasis of a human testicular germ cell tumor 
(seminoma) revealed multiple numerical and structural anomalies, including an 
abnormally banding region (ABR) present on the short arm of one of the 
chromosome 12 homologs. Fluorescence in situ- and comparative genomic 
hybridization experiments revealed that the ABR results from amplification of 
12pl 1.2-pl2.1 derived sequences. We speculate that this particular region may 
harbor gene(s) relevant for testicular germ cell tumor progression. 
INTRODUCTION 
Duplication of the short arm of chromosome 12, resulting in i(12p), is the most 
consistent structural chromosomal aberration observed in the heterogeneous group 
of human germ cell tumors (GCTs), including seminomas and non-seminomas. 
About 80% of the subgroup of testicular GCTs (TGCTs) of adults carries one of 
more copies of i(12p), regardless of their histology (for review see de Jong et al., 
1990). In the remaining so-called i(12p)-negative TGCTs a consistent over-
representation of 12p, as compared to 12q, has recently been demonstrated using 
fluorescence in situ hybridization (FISH) techniques (Suijkerbuijk et al., 1992, 
1993; Rodriquez et al., 1993). So, in both i(12p)-positive and -negative TGCTs 
overrepresentation of 12p-derived sequences is encountered as a consequence of 
apparently distinct chromosomal rearrangements. Since it has been suggested that 
the occurrence of i(12p) correlates with the acquisition of malignant characteristics 
of TGCTs (Delozier-Blanchet et ai, 1987; Bosl et al., 1989; Castedo et al., 1989a), 
it may be assumed that similar mechanisms involving 12p could be at work in both 
types of tumors (Suijkerbuijk et ai, 1993). So far, the overrepresented 12p 
sequences appeared to encompass the (almost) entire short arm without any 
evidence for nonrandom involvement of a specific chromosomal sub-region 
(Rodriquez et ai, 1993; Suijkerbuijk et ai, 1993). These observations could 
indicate that more than one gene on 12p may be involved in the development of 
these tumors (e.g., malignant potential, growth advantage, tumor progression, 
treatment resistance) (Castedo et al., 1991). 
Here, we report the identification and preliminary characterization of a sub-region 
on the short arm of chromosome 12 which is amplified in a metastasis of an i(12p)-
negative seminoma. This TGCT case may, for the first time, delineate genomic 
sequences on 12p that are specifically involved in tumor progression. 
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MATERIALS AND METHODS 
Case History 
A testicular tumor, histologically a typical seminoma (hematoxylin-eosin staining), 
was obtained from a 35 yr-old Caucasian male after orchidectomy. There was no 
evidence for the presence of other germ cell derived components. Two years later 
the patient developed metastases in the latero-aortic lymph nodes which, 
subsequently, were surgically removed. Part of the tumor material was used for 
cytogenetic analysis and part of it was embedded in paraffin for sectioning. 
Thereafter, a chemotherapy regimen of bleomycin, etoposide and cis-platinum 
(BEP-4 cycles) was initiated. No evidence of residual disease was found until six 
months after lymph node removal as based on CT scans and serum biological 
markers. 
Immunohistochemistry 
Immunohistochemical stains were performed on paraffin sections (5 μηι) using an 
indirect immunoperoxidase procedure with a monoclonal antibody against 
cytokeratin 8 (CAM 5.2; Becton and Dickinson, Etten Leur, The Netherlands) and a 
peroxidase-anti-peroxidase procedure with polyclonal antibodies against human 
choriogonadotropin (hCG; ITK Diagnostics, Uithoorn, The Netherlands), placental-
like alkaline phosphatase (PLAP; ITK Diagnostics) and vimentin (Organon, Oss, 
The Netherlands). In the second incubation step rabbit anti-mouse and swine anti-
rabbit antibodies conjugated with horseradish peroxidase (Dakopatts, Glostrup, 
Denmark) were applied, respectively. Staining was performed using DAB (Sigma-
Aldwich, Bornem, Belgium) and hydrogen peroxidase as substrate. 
Cytogenetic analysis 
A small fresh and sterile tumor fragment was mechanically minced in RPMI 1640 
medium, supplemented with 17% fetal calf serum, glutamin and antibiotics. Tumor 
cells were harvested for karyotyping after addition of colcemid to a final 
concentration of 0.01 μg/ml and incubation of the cells in a rotating flask during 1 
hour. The resulting cell suspension was subjected to a hypotonic solution (0.06 M 
KCl, 15 min at 37°C) and, subsequently, fixed in methanolracetic acid (3:1). After 3 
washes in fixative, cells were applied to cold wet slides and air-dried. 
Chromosomes were GTG banded according to standard methods and the resulting 
karyotypes were described according to the International System for Human 
Cytogenetic Nomenclature (1SCN, 1991). 
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DNA extraction from paraffin embedded tissue 
Tissue was removed from paraffin blocks with a surgical blade or, alternatively, via 
thin sectioning (> 10 μτή). Excess of paraffine was removed. Then, the tissue was 
cut into small pieces and transferred to a 50 ml tube after which 5 ml lysis buffer 
(10 mM Tris pH 8.0, 100 mM NaCl, 1 mtí EDTA) was added, followed by an 
incubation of the tube at -70°C for 30 min. After thawing, 5 ml lysis buffer 
supplemented with 2% sarcosyl and 50-100 μg/ml proteinase К was added, 
whereupon the tube was set to rotate overnight at 65°C. Phenol extractions were 
carried out using a solution saturated with 0.5 M Tris (final pH between 6 and 7). 
An equal volume (10 ml) of phenol was added to the lysis suspension (65°C) and 
left to rotate at 37°C for 30 min. After removal of phenol, 10 ml phenolxhloroform 
(1:1) solution was added, followed by rotation at room temperature for 30 min. 
After removal of the organic phase, 10 ml chloroform was added and the tube was 
rotated again at room temperature. Finally, the DNA was precipitated using sodium-
acetate/isopropanol (-20°C, 30 min. or overnight). After washing once with 70% 
ethanol the pellet was dissolved in TE (10 mM Tris pH 7.6, ІтЛ/ EDTA) and, 
finally, the DNA concentration was estimated. 
In situ hybridization 
Fluorescence in situ hybridization (FISH) experiments were carried out using 
various different chromosome 12-specific probes: (1) chromosome 12-centromeric 
alphoid probe pal2H8 (Looijenga et ai, 1990); (2) chromosome 12-specific 
plasmid library pBS-12 (Collins et al., 1991: kindly provided by Dr. J. Gray, San 
Francisco, CA); (3) chromosome 12p-specific paint M28 (Suijkerbuijk et al., 1991) 
derived from a mouse-human hybrid cell line containing an i(12p) as sole human 
component (Zhang et ai, 1991: kindly provided by Dr. J.J. Cassiman, Leuven, 
Belgium); (4) the 12p region-specific paints (radiation-reduced somatic cell hybrids) 
WgM6B, WgM8B, WgM22C and WgM28.1, which together cover almost the entire 
12p-arm (Sinke et ai, 1992; (5) the 12p-specific YACs 5 and 17 (Craig et ai, 
1992: kindly provided by Dr. R. Gemmili, Denver, CO). 
Multicolor FISH was performed as described previously (Suijkerbuijk et al., 1992, 
1993; Sinke et al., 1992; de Leeuw et al., 1993, 1994) with some minor 
modifications. In short, DNAs were labeled with either biotin-14-dATP (Life Tech­
nologies, Gaithersburg, MA) or digoxigenin-11-dUTP (Boehringer-Mannheim, 
Germany) following standard nick-translation. All labeled probes, except the 
alphoid repeat probe pal2H8, were subjected to preannealing to compete out 
reiterated sequences using 25-50 fold excess of Cot.l DNA (Life Technologies, 
Gaithersburg, MA). For efficient hybridizations, 10 ng labeled pal2H8. 100-150 ng 
66 
#12 aberrations in TGCTs 
labeled pBS-12 and M28, 200 ng labeled BK33-PCR amplified WgM and 200 ng 
labeled YAC DNAs were applied under a 20x20 mm coverslip onto metaphase 
spreads of tumor cells as described elsewhere (Suijkerbuijk et al., 1991). 
Visualization of hybridizing DNAs was accomplished using Texas Red-conjugated 
avidin and biotinylated goat anti-avidin antibodies (both from Vector Laboratories, 
Burlingame, CA) for biotin-labeled probes and fluorescein-conjugated sheep anti-
digoxigenin (Boehringer-Mannheim, Germany) and fluorescein-conjugated donkey 
anti-sheep antibodies (Jackson Immunoresearch, West Grove, PA) for digoxigenin-
labeled probes. Slides were immersed in antifade-solution (Suijkerbuijk et al., 
1991), supplemented with the blue DNA-specific dye DAPI (Sigma, St. Louis, MO) 
for counterstaining of the chromosomes. 
Comparative Genomic In Situ Hybridization 
Comparative Genomic in situ Hybridization (CGH) experiments (see Kallioniemi et 
al., 1992; Du Manoir et al., 1993) were carried out as described before 
(Suijkerbuijk et ai, 1994). In short, 400 to 1000 ng of biotin labeled tumor DNA, 
extracted from paraffin blocks, was used as test DNA. Since testicular germ cell 
tumors usually have a hypo- to hypertriploid (i.e., peri-triploid) chromosomal 
complement, a similar amount of differentially labeled DNA isolated from a 
69,XXY triploid cell line was used as reference DNA to facilitate the CGH 
analyses. Hybridization patterns of both test and reference DNAs were visualized as 
described above. 
Evaluation of FISH and CGH results 
Evaluation of the resulting slides was performed using a Zeiss Axiophot 
epitluorescence microscope, equipped with appropriate filters for the visualization 
of fluorescein, Texas Red and DAPI fluorescence. Digital images were recorded 
using a Photometries high-performance CH250/A cooled CCD-camera 
(Photometries, Tucson, AZ) interfaced onto a Macintosh Quadra 950 computer. 
Image-acquisition, -processing, -superimposement, and -display (in red-
green/yellow-blue pseudocolors) was accomplished using the BDS-image1M FISH 
software package (Oncor Image, Gaithersburg, MD). Photographs were made from 
the computer screen on Kodak EPP 100 Plus color slide film using a Polaroid 
Quick-Print. 
Results of CGH experiments were analyzed using the Comparative Genomic 
Hybridization applications within the BDS-image™ FISH software package. These 
applications allow the direct reproduction of fluorescence ratios (tumor DNA-
versus-normal DNA) of normalized Texas Red (e.g., tumor DNA hybridization 
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pattern) and fluorescein (e.g., normal DNA hybridization pattern) fluorescence 
intensities of each chromosome within a recorded metaphase spread by pseudocolor 
indication. In this way, at least 10 metaphase spreads were studied and 
chromosomal homologs consistently showing (regions of) over- or 
underrepresentation of tumor DNA as compared to reference DNA were subjected 
to further examination. 
Figure 1: Histology of the seminoma metastasis after hematoxylin-eosin (HE) staining 
(150x). The inset shows details of the tumor cells at higher magnification 
(500x). 
These chromosomes were isolated and longitudinally stretched, whereupon 
chromosome fluorescence intensity profiles for each fluorochrome were generated. 
By doing so, both the identification of a given chromosome by DAPI fluorescence 
and the detection of genomic regions that are over- or underrepresented in the 
tumor DNA on that very same chromosome were established. Photographic 
recordings of these results were performed as described above. 
RESULTS 
Histologic, Immunohistochemical and Karyotypic analyses 
Histologically, the tumor was characterized by sheets of uniform large polygonal 
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cells separated by thin fibrovascular septa into lobules (Fig. 1). In these septa, lym­
phocytic infiltrates of variable density were present. The tumor cells contained clear 
cytoplasms and large nuclei with irregular chromatin structures and prominent 
nucleoli. Mitotic figures were frequent. No syncytiotrophoblastic giant cells or other 
non-seminoma components were observed. Immunohistochemical staining for 
placental-like alkaline phosphatase (PLAP) and vimentin were positive. In contrast, 
cytokeratin, alpha fetoprotein (AFP) and human choriogonadotropin (hCG) were 
negative (not shown). Together, these characteristics are indicative for pure 
seminoma. 
Cytogenetic analyses were carried out after direct harvesting of the tumor cells. 
Twenty metaphases were analysed. The chromosomal counts ranged from 46 to 64. 
One of the representative karyotypes was interpreted as follows (see also Fig. 2): 
64, X, -Y, +X, +del(l)(p36), +2,+3, +5, +6, +7, +dic(7;21)(ql0;p22), +8, +8, +10, 
+i(12)(pl0), +add(12)(pl3), +15, add(17)(q25), +add(17)(pll), +19, +19, +20, +22. 
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Figure 2: GTG-banded karyotype of the seminoma metastasis. The add(12)(pl3) 
chromosome is marked by an arrowhead and the add(17)(q25) by an small 
arrow. 
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Chromosome painting 
Metaphase spreads were subjected to fluorescence in situ hybridization (FISH) 
analyses using DNAs extracted from plasmid libraries specific for chromosomes 12, 
17 and 21 (pBS-12, -17, and -21; chromosome painting), in order to confirm and 
clarify the constitution of some of the rearranged chromosomes observed (in 
particular, those involving chromosome 12). By doing so, the presumed i(12p) was 
found to lack chromosome 12-derived sequences all together. Instead, it fully 
consists of chromosome 21-derived material and, finally, could be recognized as an 
isochromosome of the long arm of chromosome 21, i.e., i(21q) (Fig. 2, and results 
not shown). The chromosome described above as add(17)(q25) consists of 
chromosome 17 material, as expected (not shown), and additional chromosome 12 
material added onto band 17q25 (Fig. ЗА). The add(12)(pl3) chromosome appeared 
to be composed almost entirely of chromosome 12 material except for its distal 
part, of which the origin was not elucidated (Fig. ЗА). Based on these data, further 
experiments with the chromosome 12p-specific paint M28 (in combination with the 
chromosome 12-specific centromeric repeat probe pal2H8) were carried out. 
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Figure 4: Diagrammatic representation of the 12p content of the WgM radiation-
reduced hybrid probes used in this study, and their hybridization results on 
the add(12)(pl3) chromosome (marked by +/-). 
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The results obtained (Fig. 3B) indicated that the chromosome 12-positive part of the 
add(17)(q25) chromosome contains 12p-positive material only. The most likely 
interpretation of the combined GTG-banding and FISH results is that three copies 
of an almost entire 12p-arm have been translocated onto 17q25. In case of the 
add(12)(pl3) chromosome, the additional segment that was previously shown to 
consist of extra chromosome 12 material only, appeared to be 12p-positive over its 
whole length (Fig. 3B). Although the size of this extra 12p-positive segment was 
large enough to potentially contain at least 8-10 copies of an entire 12p-arm, careful 
re-examination of the GTG-banding pattern of this particular segment failed to 
indicate that 12p copies were present in such a configuration. Instead, it can best be 
defined as an abnormally banding region (ABR). Altogether, the FISH analyses led 
to a correction of the original karyotype as follows: 64, X, -Y, +X, +del(l)(p36), 
+2, +3, +5, +6, +7, +dic(7;21)(ql0;p22), +8, +8, +10, +add(12)(pl3), +15, 
d e r ( 7 ) t ( 1 7 ; 1 2 ; 1 2 ; 1 2 ) ( 1 7 p t e r - H 7 q 2 5 : : 1 2 p l 3 - > 1 2 p l l : : 1 2 p l l - > 
12pl3::12pll->12pl3), +add(17)(pll), +19, +19, +20, +i(21)(ql0), +22 (Fig. 2). 
Detailed FISH analysis of the add(12)(pl3) chromosome 
Since the above cytogenetic and FISH analyses provided no definite clues about the 
chromosomal constitution of the ABR on the 12p+ chromosome, further FISH 
analyses were carried out to delineate this segment in more detail. Therefore, 
region-specific probes that in total cover the almost entire length of the short arm of 
chromosome 12 were used. Specifically, (1) WgM6B: the entire 12pll band and the 
distal part of the 12pl3 band; (2) WgM22C: most of the 12pl2 band, except for its 
proximal part; (3) WgM8B: a small distal part of the 12pll band and most (if not 
all) of the 12pl3 band; (4) WgM28.1: the almost entire 12pl3 band. Hybridization 
with the WgM6B probe resulted in complete painting of the extra 12p-positive 
material. In contrast, the WgM8B probe was only partially positive and the 
WgM22C and WgM28.1 probes gave no hybridization signals at all in this 
particular chromosomal segment (diagrammed in Fig. 4). These results indicate that 
the additional material on the 12p+ marker most likely originates from the 12pll-
pl2 boundary region. 
Further focussing on 12pll-pl2, using as probe a yeast artificial chromosome (i.e., 
YAC5) that we previously mapped in the region 12pll.2-pl2.1 (Craig et al., 1992), 
revealed that multiple, but non-contiguous, copies of YAC5 hybridizing DNA 
sequences are present in the additional segment (Fig. 3C). These results clearly 
agree with the above FISH data obtained with the WgM probes. In addition, YAC5 
hybridization patterns were visible as scattered fluorescent signals within confined 
regions of interphase nuclei (Fig. 3D). Since the YAC hybridizations do not result 
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in even "painting" of the entire additional 12p+ segment, the chromosomal sub-
region that constitutes this segment must contain human sequences in addition to 
those present in YAC5. FISH with another YAC (YAC 17), which we previously 
mapped in band 12pl 1.1-pl 1.2 (Craig et ai, 1992), did not reveal any hybridization 
signal on the 12p+ segment (not shown), indicating that the corresponding 12p 11 
sequences must be excluded from it. Taken together, we conclude that the 
additional segment on the 12p+ chromosome comprises sequences that originate 
from the more distal sub-region of band 12pll and/or the proximal part of 12pl2. 
These sequences appear to be present in multiple copies (i.e., as amplicon). 
Comparative Genomic in situ Hybridization 
In order to more exactle define the localization (and size) of the amplified 12p-
segment in the genome of the seminoma metastasis more exactly, comparative 
genomic in situ hybridization (CGH) analysis was performed. This novel FISH 
approach provides information on over- and underrepresented chromosomes or 
chromosomal segments in test (tumor) genomes. Therefore, DNA extracted from a 
paraffin-embedded formalin-fixed tumor specimen, which was the only source of 
tumor DNA available, was used as test DNA and hybridized simultaneously with 
reference DNA onto BrdU-incorporated high-resolution metaphase spreads derived 
from a healthy 46,XY male. The hybridization patterns of test and reference DNAs 
were visualized using two different fluorochromes, recorded by digital imaging 
microscopy, normalized and, subsequently, analyzed using the Comparative 
Genomic Hybridization applications within the BDS-image™ FISH software 
package as described in Materials and Methods. By doing so, an obvious 
overrepresentation of only one genomic region, ranging from 12pll.2 to 12pl2.1, 
was identified in the tumor DNA (Figs. 3E, F). The size of this region may even be 
smaller because its precise localization was partly hampered by the slight overall 
overrepresentation of 12p sequences in the tumor DNA (see above). However, some 
metaphase spreads gave relatively bright hybridization signals in the 12p 11.23 
subband only, indicating that this particular segment is predominantly amplified in 
the tumor DNA. No other (sub-)chromosomal segment was found to be amplified, 
although some chromosomes appeared slightly over- or underrepresented (not 
shown) as might be expected from the cytogenetic constitution of the tumor (Fig. 
2). Control CGH analyses using constitutional DNA of the patient, isolated from 
peripheral leucocytes, as test DNA and reference (i.e., 46,XY) DNA did not reveal 
any genomic region that was subjected to genomic imbalance (not shown), 
indicating that the 12p-derived amplicon is indeed tumor-specific. 
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DISCUSSION 
A metastasis of a testicular germ cell tumor (TGCT) occurring in the latero-aortic 
lymph nodes was subjected to histologic, cytogenetic, fluorescence in situ 
hybridization (FISH) and comparative genomic hybridization (CGH) analyses. The 
tumor was recognized as a metastasis of a seminoma, that did not display the 
standard marker chromosome of TGCTs, i.e., i(12p), but instead, exhibited two 
other chromosomal abnormalities involving the short arm of chromosome 12. 
Further FISH and CGH analyses revealed amplification of a specified region on the 
short arm of chromosome 12, i.e., 12pll.2-pl2.1, within the tumor genome which 
occurred as an abnormally banding region (ABR) in one of the two rearrangements. 
This amplification was not found in constitutional DNA of the patient, indicating 
that it is tumor-specific. 
Most cases (> 80%) of TGCT display one or more copies of an i(12p) chromosome 
(de Jong et al., 1990. To a lesser extent, other chromosomal rearrangements 
involving 12p can be found (Sandberg. 1990; Dmitrovsky et al., 1991; Reilly et ai, 
1993). In addition, i(12p) has been observed in some ovarian and extragonadal germ 
cell tumors, indicating that its prevalence may point at an important role in the 
pathogenesis of germ cell tumors (Delozier-Blanchet et al., 1987; Castedo et al., 
1989a). Furthermore, the occurrence of i(12p) may be correlated with the malignant 
character of TGCTs (Delozier-Blanchet et ai, 1987; Castedo et ai, 1989a; 
Dmitrovsky et al., 1991), possibly via a relative increase of certain 12p-derived 
gene(s). If so, such a correlation may exist for i(12p)-negative TGCTs as well, since 
also in this group of TGCTs overrepresentation of 12p has consistently been found 
(Suijkerbuijk et al., 1992, 1993; Rodriquez et al., 1993). In this view, the iden-
tification and characterization of a 12p-derived amplicon in a metastasis of a 
seminoma, as described in this study, could provide a first clue to the chromosomal 
sub-localization of gene(s) that contribute to tumor progression. 
Genes that are most frequently found to be amplified in tumor cells belong to the 
class of proto-oncogenes. These amplifications are always specifically encountered 
in the tumor genomes and are absent from constitutional DNAs of patients, 
indicating that the genes involved are selected for during tumor growth. Various 
molecular studies on several tumor models (e.g., colon carcinomas, neuroblastomas, 
gliomas, gastric adenocarcinomas, lung carcinomas, breast tumors) provided 
evidence that proto-oncogene amplifications may occur late in tumor development, 
and that associations between tumor progression and the extend of proto-oncogene 
amplification can be established (reviewed in Brison, 1993). Our observation of a 
12p-derived amplicon in a metastasis of a seminoma may very well fit into this 
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scheme. Unfortunately, there was no material of the primary tumor available for our 
studies. Therefore, no retrospective comparisons could be made between the 
primary tumor and its metastases to definitely correlate amplification to tumor 
progression. However, an association between i( 12p) (i.e., increase in copy number 
of 12p-derived sequences) and malignancy (i.e., tumor progression) in TGCTs has 
been stated more than once (Delozier-Blanchet et al., 1987; Bosl et al., 1989; 
Castedo et al., 1989a; Dmitrovsky et al, 1991; Suijkerbuijk et ai, 1993). 
Moreover, molecular studies on TGCTs and -derived cell lines (Geurts van Kessel 
et ai, 19891) and cytogenetic analyses of primary carcinoma-in-situ (CIS) lesions 
(Vos et al., 1990) have indicated that i(12p) formation may be a secondary genetic 
event and, thus, not associated with tumor initiation. Teleologically, therefore, it is 
tempting to assume that the occurrence of a 12pll.2-pl2.1 amplicon in a metastasis 
of a seminoma is correlated with metastatic progression of the primary tumor, and 
that this process may be associated with the amplification of a gene(s) in this region 
that has the characteristics of a proto-oncogene. In this respect, the KRAS2 
oncogene (12pl2.1) (see HGM 11, 1991) can be excluded as a candidate, the gene 
is located outside the 12p-derived fragment present in the radiation-reduced hybrid 
cell line (i.e., reverse paint probe) WgM6B (Sinke et al., 1992). On the other hand, 
a gene like the one encoding parathyroid hormone-related peptide (gene symbol: 
PTHLH) (Moseley et al., 1987; Stewart et al., 1987; Pausova et ai, 1993), which 
maps in the 12pll.2-pl2.1 region, must be considered as a candidate. This 
suggestion is strengthened by the recent observation that this same gene, whose 
product is an onco-fetal hormone with endocrine and probably autocrine/paracrine 
functions (Martin et ai, 1989), is specifically expressed (nuclear localization) in 
seminomas (but not in non-seminomas; Shimogaki et ai, 1993), and was found to 
be amplified (together with KRAS2) in a human lung cancer cell line (Rudduck et 
al., 1993). Obviously, such a putative association requires further investigation. 
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ABSTRACT 
We present molecular data to demonstrate that the isochromosome 12p, specific for 
human germ cell tumors (GTGs), is of uniparental origin. Eight GCT-derived cell 
lines, containing one or more copies of i(12p) and/or other 12p anomalies, were 
analyzed with different 12p-derived polymorphic markers. The results from Ma-90, 
a near-diploid cell line with only one i(12p) in addition to two copies of a normal 
chromosome 12, clearly show an allelic 12p ratio of approximately 3:1, indicating 
that both 12p arms are of identical parental origin. These results were further 
substantiated by data obtained from the other i(12p)-positive GCT-derived cell lines. 
Therefore, we conclude that the i(12p) chromosome in GCTs constitutes a genuine 
isochromosome with genetically identical arms. The isochromosome most likely 
originates from a misdivision of the centromere rather than from a translocation or 
a non-sister chromatid exchange as proposed by others. We also found that 
supernumerary 12p copies, as obseved in i( 12p)-negative GCTs, are of uniparental 
origin. These observations seem to point to an important role for certain 12p-
derived sequences in the development of human GCTs. 
INTRODUCTION 
The isochromosome of the short arm of chromosome 12, i(12p), is the most 
common structural cytogenetic aberration found in gonadal and extragonadal germ 
cell tumors (GCTs) of human adults (Atkin and Baker, 1982, 1983; Gibas et al. 
1986). This isochromosome occurs in all histologic varieties of germ cell tumors in 
about 80% of all cases (Castedo et ai, 1989; de Jong et al., 1990; Suijkerbuijk et 
ai, 1991; Rodriguez et al. 1992). 
We have argued that i(12p) formation must be preceded by an aneuploidization 
event during early stages of GCT development (Geurts van Kessel et al., 1989). 
Furthermore, it has been suggested by others that an increase in i(12p) copy number 
may be associated with tumor progression and increased resistance to therapy 
(DeLozier-Blanchet et al., 1987; Bosl et ai, 1989). So far, however, little is known 
about the origin and mechanism of formation of this highly characteristic 
cytogenetic anomaly. Recently, Mukherjee et al. (1991) suggested that in GCTs the 
i(12p) chromosome may originate from a translocation or a non-sister chromatid 
exchange. We present a molecular study that provides evidence for a uniparental 
origin of the i( 12p) (and other supernumary 12p sequences) in human GCT-derived 
cell lines, using chromosome 12-specific polymorphic markers. 
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MATERIALS AND METHODS 
Cell Lines and Culture 
Eight human germ cell tumor-derived cell lines were used. Detailed analysis of the 
chromosome 12 contents, as determined by bicolour double in situ hybridization, is 
described elsewhere (Suijkerbuijk et al. 1991, 1992). Ma-90: Dysgenetic gonad 
tumor-derived (combined tumor, Hamers et al., 1991), containing two copies of a 
normal chromosome 12 and one i(12p); in total four 12p copies. NT2/D1: 
Testicular germ cell tumor (TGCT)-derived (embryonal carcinoma, Andrews, 1984), 
containing three copies of a normal chromosome 12 in addition to two i(12p) 
chromosomes; in total seven 12p copies. KDK: TGCT-derived (embryonal 
carcinoma, J.M. Parrington, unpublished results), containing three copies of a 
normal chromosome 12, three i(12p) chromosomes and one abnormal chromosome 
containing 12p sequences (presumably a translocated 12p); in total ten 12p copies. 
Germa-1: TGCT-derived (embryonal carcinoma, Hofmann et al., 1989), containing 
two copies of a normal chromosome 12, one i(12p) and two derivative 
chromosomes including 12p sequences; in total six 12p copies. Scha-1: TGCT-
derived (embryonal carcinoma, Andrews et al, 1987); TT34DA Tue and TT34DA 
Tuj: TGCT-derived (combined tumors, J.M. Parrington, unpublished results), all 
i(12p)-negative but containing several derivative chromosomes including 12p 
sequences in addition to two to five copies of a normal chromosome 12; in total 
approximately six, eight and seven copies of 12p, respectively. Haz-1: Extragonadal 
GCT-derived (mediastinal teratocarcinoma, Oosterhuis et al., 1985), without 
chromosome 12 abnormalities, but positive for other cytogenetic anomalies; this cell 
line was included as a negative control for our studies. 
Cells were cultured in F-10 medium, RPMI-1640 medium or Chang medium 
supplemented with glutamin, antibiotics and 15% fetal calf serum. By the time of 
harvesting, all lines were checked cytogenetically for their chromosomal 
constitution. 
RFLP-analysis 
RFLP analysis of chromosome 12 alleles was performed using probes for both 12p-
and 12q-specific loci (Table 1; see Human Gene Mapping 11, 1991 and Sinke et 
ai, 1992 for references). 
Cell line DNAs, 10-15 μg, were digested to completion with restriction 
endonucleases (Life Technologies), electrophoresed in 0.7-1.0% agarose gels, and 
transferred to Gene Screen Plus nylon membranes (DuPont) using standard 
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procedures (Sambrook et al., 1989). Filters were hybridized with chromosome 12-
specific DNA markers labeled by random priming (Feinberg and Vogelstein, 1984) 
and exposed for 1-5 days using Kodak X-ray films (X-OMAT S). Densitometrie 
scanning of the X-ray films was performed with an Ultroscan XL densitometer 
(LKB, Sweden). 
Table 1. Chromosome 12-specific polymorphic markers 
and their regional localization. 
Locus 
F8VWF 
PRBl 
A2M 
IAPP 
KRAS2 
D12S2 
D12S4 
D12S6 
1GF1 
Probe 
pvWFUOO 
pPRP-1 
pha2ml 
ScIAP8 
pK42 
pl2-16 
p9Fll 
pi 1-1-111 
pKT218 
Localization 
1213.3-pl3.2 
12pl3.2 
12pl3.3-pl2.3 
12pl2.3-pll.2 
12pl2.1 
12pter-pl2 
12cen-ql4 
12ql4 
12q23 
VNTR-analysis 
The von Willebrand factor gene (F8VWF) contains two highly polymorphic regions 
that can be analyzed by PCR techniques (Ploos van Amstel and Reitsma, 1990 and 
references therein). Primer sets for both regions were used to amplify the F8VWF 
alleles present in the DNAs isolated from the different cell lines. The PCR was 
carried out, after end-labeling of the 5'-primers with y-32P-dATP, in a DNA thermal 
cycler (Perkin-Elmer Cetus). After denaturation of the reaction mixture at 96°C for 
10 min, 2.5U Taq DNA polymerase (Cetus) was added to start cycling for 1 min at 
92°C, 1 min at 55°C and 1 min at 72°C for 35 cycles. To visualize the amplified 
fragments 2μ1 of the reaction mixture was added to 2μ1 sequencing dye and applied 
to a 6% PAA-gel and electrophoresis was carried out at 30 V/cm for 3 hrs, 
followed by autoradiography for 3-16 hrs. 
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RESULTS AND DISCUSSION 
Four of the eight (GCT)-derived cell lines contain one or more copies of the 
characteristic i(12p) (Germa-1, КГЖ, Ma-90, NT2/D1). Of the remaining four cell 
lines, Scha-1, TT34DA Tue, and TT34DA Tuj are characterized by the presence of 
multiple 12p-containing sequences cryptically present in derivative chromosomes. 
The other cell line, Haz-1, is derived from a near-diploid extragonadal GCT without 
chromosome 12 aberrations. This latter cell line was used as a negative control. 
By using polymorphic markers located on 12q (D12S4, D12S6, IGF1) we were able 
to demonstrate that in all cell lines analyzed, heterozygosity for at least one of these 
loci was retained, which indicates that both paternal and maternal chromosome 12 
alleles were present in these cell lines and their original tumors (not shown). 
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Figure 1: Southern blots of GCT-derived cell line DNAs cleaved with BgUI (A) and 
Xbal (B), hybridized with pvWFUOO. Hybridizing bands representing the 
polymorphic alleles for this locus are indicated by arrows. The remaining 
bands represent constitutively hybridizing fragments. 
In a previous study (Geurts van Kessel et al., 1989) very similar results were 
obtained with NT2/D1 and Scha-1. The present results further substantiate our 
previous observations and conclusion that during GCT development 
aneuploidization must precede i(12p) formation. Loss of a candidate tumor 
suppressor gene on 12q as the initial genetic change, as suggested by Chaganti and 
co-workers (see Rodriguez et al. 1992), does not appear to be a general mechanism. 
RFLP analysis using 12p-derived polymorphic markers (KRAS2, IAPP, F8VWF, 
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A2M, PRBl, D12S2) was performed to discriminate between a bi- or uniparental 
origin of the i(12p) chromosome in the different GCT-derived cell lines. The Ma-90 
cell line, which contains only one i(12p) in addition to two normal copies of 
chromosome 12, appeared to be particularly informative. As can be seen in Figs. 1 
and 2, in which the pvWFl 100 and pK42 probes were hybridized to Southern blots 
containing respectively Bglll, Xbal and StuI cleaved Ma-90 and other cell line 
DNAs, there is a clear overrepresentation of one allele over the other (Fig. 1A: 
pvWFl 100 9.0 kb > 7.4 kb; Fig. IB: 6.9 kb > 5.2 kb; Fig. 2B: pK42 2.5 kb > 8.7 
kb) as compared to the control Haz-1 and normal male blood cell DNAs (Fig. 1A, 
Fig. 2A). If i(12p) had resulted from the fusion of two different parental 12p arms, 
an equal allele-dose would be expected. Since, in contrast, an allele ratio of 
approximately 3:1 was observed (as estimated by densitometric scanning; not 
shown), we conclude that both p-arms of the i(12p) chromosome in Ma-90 are of 
identical parental origin (see also below) and that, as a consequence, i(12p) most 
likely originates from a misdivision of the centromere rather than from a 
translocation or a non-sister chromatid exchange as suggested by Mukherjee et al. 
(1991). A similar result was obtained with NT2/D1, which contains two i(12p) 
chromosomes and three copies of a normal chromosome 12. As can be seen in Fig. 
2, an even more pronounced difference in allele intensity was observed (Fig. 2A: 
2.5 > 8.7 kb), which is in agreement with the presence of additional 12p copy 
numbers. The i(12p)-positive GCTs Germa-1 and KDK, which carry 12p-containing 
markerchromosomes next to i(12p), show similar features (Germa-1: Figs. 1-3; 
KDK: Fig. 3, see below). Also, overall similar results were obtained using ¡APP-, 
A2M-, PRBl-, or D12S2-specific polymorphisms, for each of which at least one of 
the cell lines appeared to be informative (not shown). The results obtained from 
RFLP analyses of Ma-90 and other GCT-derived cell lines were compared with 
those obtained from analysis of the 12p-specific F8VWF-\'mked VNTRs using PCR. 
Fig. 3 shows that Ma-90 cells are heterozygous for one of these VNTRs (lane 4) 
and, again, one of the alleles seems to be overrepresented. Care must be taken not 
to overestimate these PCR results since they are difficult to quantify. However, in 
control Haz-1 cells both alleles are of equal intensity, suggesting a real difference 
for the allele ratios in the other cell lines (including Germa-1 and KDK). 
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Figure 2: Southern blots of control DNA from normal (male) blood cells and DNAs 
from GCT-derived cell lines cleaved with StuI, hybridized with pK42. 
Hybridizing bands representing the polymorphic alleles for this locus are 
indicated by arrows. 
1
 CM xz 
TO τ -
Φ re (3 χ 
i ¿ 
и 
* 
СС 
υ 
со 
Figure 3: F8VWF-VNTRs of various GCT-derived cell lines. Bands in each lane 
represent different 12p-alleles. NT2/D1 is homozygous, whereas other tumor 
cell line DNAs show 12p heterozygosity with different allele intensities, 
except for the control Haz-1. 
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Not only in i(12p)-positive, but also in i(12p)-negative GCTs (e.g., Scha-1, 
TT34DA Tue, and TT34DA Tuj) the additional 12p-sequences appear to be of 
uniparental origin (see Figs. 1 and 3). This observation might indicate that one of 
the 12p-arms confers a selective advantage over the other in human GCTs and, 
either by i(12p) formation or by some alternative mechanism (see also Suijkerbuijk 
et al., 1992), may lead to preferential outgrowth. In this manner, acquisition of 
multiple copies of these 12p sequences could lead to the greater likelihood of 
treatment failure as described by Bosl et al. (1989). The proposed selective 
advantage could result from a dominantly acting mutation somewhere on 12p 
occuring prior to i(12p) formation. Alternatively, one could argue that, if the 
supernumerary 12p sequences would in all cases be derived from one of the 
parental chromosome 12 homologs (i.e., maternal or paternal), genomic imprinting 
might account for another underlying mechanism. This option, however, does not 
seem very likely since our own preliminary observations and those of others (R.A. 
Lothe, personal communication) suggest both paternal and maternal origins. This 
latter alternative is currently subject to more detailed analysis. 
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Figure III. 1.2 on Colorplate 1 
Characterization of EGCTs 
ABSTRACT 
Two malignant extragonadal germ cell tumors are reported, histologically classified 
as immature teratomas, having pseudo-diploid karyotypes with complex structural 
rearrangements but lacking isochromosome 12p or other rearrangements involving 
12p. The absence of 12p material in structural rearrangements was confirmed by 
chromosome painting. In the two tumors the following common chromosomal 
breakpoints were found: 6p21, 6p22, 6q23 and 11 ql3. Exactly the same 
chromosomal regions 6p22::6q23 and 6p21 : : 11 q 13 were involved in fusions. The 
two tumors belong to a new entity of extragonadal immature teratomas of adults 
which may be located in the retroperitoneum and posterior mediastinum and are 
prone to blood borne metastasis. 
INTRODUCTION 
Human germ cell tumors (GCTs) are a heterogeneous group of neoplasms, located 
in the testis, the ovary and in extragonadal sites. Their pathogenesis, histological 
composition, cytogenetics, ploidy and degree of malignancy differ, depending on 
the anatomical site of the tumor and the patient's sex and age (Oosterhuis et al., 
1990) 
Extragonadal GCTs by themselves are a heterogeneous group of rare neoplasms. 
They occur in the midline of the body (pineal region, hypothalamic region, anterior 
and posterior mediastinum, retroperitoneum and sacral area), but also away from the 
midline (e.g. orbit, neck, stomach, placenta) (Oosterhuis et al., 1990). 
In adult males one has to exclude the possibility of a metastasis of a testicular GCT 
before assuming that the tumor is an extragonadal GCT, particularly in the case of 
retroperitoneal tumors (Daugaard et al., 1987). 
We report two pseudo-diploid extragonadal GCTs with common chromosomal 
abnormalities of the chromosomes 6 and 11. The two tumors seem to belong to a 
separate entity which is not only cytogenetically defined, but also by its 
pathological characteristics and clinical behaviour. Our cytogenetic data and 
published reports allow a cytogenetic classification of malignant extragonadal 
GCTs. It is possible that the cytogenetically different tumor types originate from 
different cell types and by different pathogenesis. 
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CASE REPORT 
Case 1 
A 65 year old man presented with a soft tissue mass in his left thigh, which he had 
first noticed six weeks before. A biopsy revealed tumor tissue with the histological 
appearance of immature teratoma composed of mesenchymal, epithelial and neural 
embryonal tissues. No other germ cell tumor components, such as embryonal 
carcinoma, yolk sac tumor, choriocarcinoma, or seminoma could be identified 
histologically. Clinical staging revealed no other tumor manifestations, in particular 
both testes were normal and no retroperitoneal or mediastinal tumors were 
identified. Serum alpha-feto-protein (AFP) and beta-human chorionic gonadotrophin 
(HCG) levels were normal. On the basis of the original histological classification of 
the tumor as a sarcoma an upper thigh amputation was performed. The amputation 
specimen showed an encapsulated tumor measuring 15x8x8 cm. The tumor was 
attached to the periosteum, but did not invade the bone. Its histology was similar to 
that of the biopsy. Three months later a retroperitoneal tumor became manifest and 
was resected. The specimen measured 6x4.5x4.5 cm and was composed of the same 
components as before. After another year an enlarged inguinal lymph node and 
retroperitoneal masses were noticed and a fine needle aspiration confirmed the 
recurrence of immature teratoma. The serum level of AFP was now slightly raised, 
HCG was in the normal range. Chemotherapy using carboplatin, etoposide and 
bleomycin caused regression of the tumor and normalization of the serum AFP 
level. Further surgery was deemed unfeasible. The patient died three months later, 
with extensive retroperitoneal tumor masses. 
Case 2 
The patient was a 39-year-old white male with a disseminated extragonadal GCT 
histologically classified as immature teratoma (Oosterhuis et al., 1985). The 
localization of the primary tumor in the posterior mediastinum was established 
beyond doubt at autopsy. Twelve months elapsed between the patient's presentation 
with a subcutaneous metastasis of the trunk and his death due to local and 
metastatic tumor growth. The first chemotherapy, consisting of a combination of 
cisplatinum, vinblastine, and bleomycin (PVB), resulted in a partial remission that 
lasted 5 months. Residual metastatic tumor in the lungs was surgically removed. A 
relapse of the disease was treated with salvage chemotherapy using VP16-213 and 
cyclophosphamide, followed by autologous bone marrow transplantation, which 
again resulted in a partial remission of 5 months. 
Following PVB, the residual tumor tissue consisted exclusively of mature teratoma. 
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Apart from that, all the tumor tissue, either surgically removed or found at autopsy, 
was histologically predominantly composed of immature teratoma with small foci of 
mature somatic tissue. Serum AFP levels were slightly elevated in the last two 
months. Serum levels for HCG, lactate dehydrogenase (LDH), and CEA were 
consistently in the normal range. Minute amounts of AFP were 
immunohistochemically demonstrated in the immature teratoma component of the 
tumor. 
MATERIALS AND METHODS 
Cytogenetic analysis 
In case 1 cytogenetic analysis was carried out on two tumors (from the left thigh 
and the retroperitoneum respectively ) after short term culture (5-7 days) as 
described previously (Castedo et al., 1989). The karyotype of the tumor of case 2 
has been published before (Oosterhuis et al., 1985). By using another banding 
method and elongated chromosomes, a better morphology of the chromosomes was 
achieved, which allowed us to refine the earlier karyotype description. 
In situ hybridization 
Bicolor double FISH experiments were carried out basically as described before 
(Suijkerbuijk et ai, 1992, 1993; Olde Weghuis et al., 1994). In short, DNAs from 
the chromosome 6, 7, 11 and 12 specific plasmid libraries (i.e., pBS-6, -7, -11, 
and -12: Collins et ai, 1991) were labeled with biotin-14-dATP (Life Technologies, 
Breda) or digoxigenin-11-dUTP (Boehringer Mannheim, Germany) following 
standard nick-translation. The labeled DNAs of pBS-6 and -11, and pBS-7 and -12, 
respectively, were coprecipitated with 15 χ Cot-1 DNA, preannealed for 15 minutes 
and 37 °C and, subsequently, used as a hybridization mix on metaphase spreads of 
tumor cells. Chromosomes and chromosomal segments hybridizing to biotin- or 
digoxigenin-labeled probes were visualized using a layer of fluorescein 
isothiocyanate (FITC)-conjugated avidin (Vector Laboratories, Burlingame, CA) and 
alternating layers of rabbit anti-FITC and FITC conjugated mouse anti-rabbit 
(Jackson ImmunoResearch, West Grove, PA) or Rhodamin-conjugated sheep anti-
digoxigenin antibodies (Boehringer Mannheim) and Texas Red-conjugated donkey 
anti-sheep antibodies (Jackson ImmunoResearch), respectively. Conterstaining of the 
chromosomes was performed with the blue DNA-specific dye DAPI (Sigma, St. 
Louis, MO). Chromosomes were studied under a Zeiss Axiophot epifluorescence 
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microscope, equipped with appropriate filters for the visualization of FITC. 
Rhodamin/Texas Red and DAPI fluorescence, as well as the simultaneous 
visualization of FITC and Texas Red fluorescence (Omega double filter, Omega 
Optical, Inc., Battleboro, VT). Acquisition of separate digital images (for Texas 
Red, FITC and DAPI, respectively) was established using a Photometries high-
performance CH250/A cooled CCD-camera (Photometries, Tucson, AZ) interfaced 
onto a Macintosh Quadra 900 computer. The images were superimposed and 
displayed on red-green-blue pseudocolors on the computerscreen by means of the 
BDS-Image ™ FISH software package (Biological Detection Systems Inc., 
Rockville, MD). Photographs were made from the computer screen on Kodak EPP 
100 plus colorslide film using a Polaroid Quickprint. 
RESULTS 
Karyotyping 
In both tumors of case 1 (left thigh and retroperitoneum) a total number of 10 cells 
was analyzed. All analyzed metaphases from case 1 showed the same karyotype 
with the description: 
46, XY, der(6)t(6;ll)(p21;ql3)t(6;6)(q23;p22), der(7)t(6;7)(p21;p22)t(6;6)(p22;q23), 
del(ll)(ql3). 
Because of improved banding and high resolution techniques we could refine the 
karyotype description of the earlier published extragonadal GCT with abnormal 
chromosomes 6 and 11 (case 2)(Oosterhuis et al., 1985). All metaphases analyzed 
showed the same karyotype with the revised description: 
46, XY, der(6)t(6;6)(q21;ql6), der(6)t(6;6)(p22;q23)t(6;l I ) (q l6 ;q l3 ) , 
der(ll)t(6;ll)(p21;ql3). 
The two tumors have the following common chromosomal breakpoints: 6p21, 6p22, 
6q23 and 1 lql 3. The same chromosome regions, 6p22::6q23 and 6p21 : : 11 q 13 are 
involved in fusions in both tumors (Fig. 1). 
Peripheral blood from both patients showed a normal 46,XY karyotype. 
FISH analysis 
Bicolor double FISH analysis was carried out on both tumors, using chromosome 7 
and 12 or 6 and 11 specific paints. In case 2 the chromosomes 7 and 12 appeared to 
be normal, as expected. Positive signals for the chromosomes 6 and 11 were present 
according to the der(6)t(6;6), the der(6)t(6;6)t(6;l 1), the der(l l)t(6;l 1) and one 
normal copy of chromosome 11. In case 1 two normal copies of chromosome 12 
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were present. Positive signals for chromosome 6 and 11 were present according to 
one normal copy of chromosome 6, the der(6), the der(7), the del(ll) of the 
t(6;7;ll) and one normal copy of chromosome 11. In Fig. 2 the normal 
chromosomes 7 and 12 of case 2 (Fig. 2A) and the t(6;7;ll) of case 1 (Fig. 2B) are 
shown. 
DISCUSSION 
Cytogenetics 
The published, complete karyotypes of seven malignant extragonadal germ cell 
tumors (Dal Cin et al., 1989; Chaganti et al., 1989; Mann et al, 1983; Oosterhuis 
et ai, 1991; de Bruin et al., 1994; Shen et ai, 1990; Albrecht et al, 1993) in 
addition to the present case and the revised karyotype of our previously reported 
case (Oosterhuis et al., 1985), are listed in Table 1. The karyotypes of four more 
mediastinal GCT's have been reported: two by Samaniego et al. (1990), and two by 
Rodriquez et al. (Rodriguez et al. (1992). Because of the limited available clinical 
data, these cases were not included in the table. However, they are considered in the 
discussion. 
Cases 1 and 2 are pseudo-diploid and show complex chromosomal translocations, 
with common breakpoints in the chromosomes 6 and 11. They lack isochromosome 
12p or other rearrangements involving 12p as convincingly demonstrated by FISH. 
Cases 3 through 9 lack the specific translocations of cases 1 and 2, and may have 
an isochrome 12p, the specific chromosomal abnormality frequently found in 
gonadal GCTs (Atkin and Baker, 1982; de Jong et al., 1990). It is present in cases 
3, 4 and 7, and probably also in case 5 (Dal Cin et al., 1989). The tumors lacking 
i(12p) may have amplification of 12p in other chromosomal rearrangements similar 
to the pattern found in "i(12p)-negative" germ cell tumors of the adult testis. These 
tumors have extra copies of 12p hidden in various marker chromosomes, as 
demonstrated by painting of metaphase spreads (Suijkerbuijk et al., 1992). The 
tumors of this second category may be (near)diploid or polyploid and may have non 
random numerical abnormalities (e.g. +7, +21 and -13) similar to those found in 
testicular GCTs (de Jong et al., 1990). In testicular GCTs the breakpoints of cases 1 
and 2 are rare, and the fusions 6p22::6q23 and 6p21::llql3 have not been 
demonstrated in our material of 95 cases (unpublished data). 
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Figure 1: Karyotype and partial karyotype and schematic representation of the 
structurally abnormal chromosomes of case 1 (A) and case 2 (B). Both 
tumors show common breakpoints: 6p21, 6p22, 6q23 and llql3, with the 
same chromosomal regions 6p22::6q23 and 6p21::llql3 involved in fusions. 
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Cytogenetic classification 
The available karyotypic data on malignant extragonodal GCTs reviewed above, allow the 
following cytogenetic classification: 
Type 1. Diploid tumors with specific structural chromosomal abnormalities of the 
chromosomes 6 and 11 (cases 1 and 2) 
Type 2. Near-diploid or polyploid tumors which may have i(12p), and multiple non 
random numerical abnormalities, similar to the chromosomal abnormalities found in 
testicular germ cell tumors (cases 3 through 9). The four mediastinal GCTs reported by 
(Samaniego et al. (1990) and Rodriguez et al. (1992) are all type 2 tumors. All four have 
one or more copies of i( 12p), three are polyploid. 
Clinical pathological correlation 
The two tumors of type 1 occurred in male patients who were old as compared to 
the four patients with type 2 extragonadal GCTs of the anterior mediastinum. Both 
presented with blood borne metastasis to the soft tissues (lower extremity and 
trunk). The primary tumors were localized in the retroperitoneum (case 1) and in 
the posterior mediastinum (case 2). Both patients developed slight elevation of AFP 
after multiple recurrences. Other serum tumor markers were negative. 
Notwithstanding extensive locoregional and systemic treatment both patients died of 
their tumors. Primary tumors and untreated metastases of both patients were 
composed of immature teratoma. Minute amounts of AFP could be demonstrated in 
the tumor tissue of the second patient shortly before death (Oosterhuis et al., 1985). 
Four of the seven listed tumors of type 2 occured in young adults, and were 
localized in the anterior mediastinum. The tumors in the three youngest patients 
were localized in the midline of the brain. The patients presented with complaints 
from the primary tumors, without manifest metastatic disease. The serum tumor 
markers, most often AFP and HCG, were elevated at presentation. Six tumors were 
histologically classified as nonseminomatous GCTs with the same mixed histology 
which is encountered in testicular GCTs of adults, including the presence of a 
seminoma/germinoma component in some tumors (cases 3 and 8). Case 9 was 
histologically classified as a germinoma. One of the patients with GCTs of the 
midline of the brain is alive without evidence of disease after a combination of 
radiotherapy and chemotherapy (follow up 21 months). The four patients with 
mediastinal tumors died, notwithstanding extensive surgery and chemotherapy, two 
of them with secondary leukemias, an established risk of extragonadal GCTs of the 
anterior mediastinum (Changanti et al., 1989). 
Histogenesis 
The remarkable resemblance in terms of histological composition and chromosomal 
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constitution, between testicular GCTs of adults (and certain ovarian GCTs), and the 
extragonadal GCTs of type 2, suggests that they have a similar histogenesis, and 
similar cells of origin. 
It is now generally accepted that the common precursor of all GCTs of the adult 
testis with the exception of spermatocytic seminoma, is carcinoma in situ 
(Skakkebaek et ai, 1987), composed of tumor cells which are the neoplastic 
counterparts of primordial germ cells. Type 2 extragonadal GCTs are probably also 
derived from primordial germ cells, which have migrated, by an as yet unclarified 
mechanism, to the anterior mediastinum/thymus, and the midline of the brain. One 
could argue that the presence of i(12p), in type 2 extragonadal GCTs, is the best 
evidence yet that primordial germ cells do migrate to the midline of the brain and 
the thymus. The fact that they survive in these anatomical localizations through 
childhood and adult life suggests that they are more than embryonal vestiges, but 
have an as yet obscure functional meaning (Friedman, 1987). 
It is possible that type 1 tumors are also derived from germ cells. Immature 
teratomas of the ovary which have a very similar histology and may behave as 
frankly malignant tumors, are derived from germ cells. Ovarian immature 
teratomas, however, are karyotypically different from type 1 extragonadal GCTs 
(Surti et al., 1990). Alternatively type 1 tumors are derived from pluripotent 
embryonal cells, analogous to what is considered for sacral teratomas and teratomas 
of the head and neck of infants (Gonzales-Crussi, 1982). Too few of these tumors 
have been karyotyped to allow a comparison with type 1 extragonadal GCTs 
(Oosterhuis et al., 1990). 
Animal models of teratoma/teratocarcinoma and yolk sac tumor in the mouse and 
the rat could support either hypothesis on the cellular origin of type 1 tumors. 
Testicular teratomas in 129 mice (Stevens, 1973) and ovarian teratomas of the LT 
mouse strain (Stevens and Varnum, 1974) are derived from germ cells. However, 
tumors with almost identical histology produced in mice by embryo transplantation 
(Damjanov and Solter, 1974) and in rats by fetectomy (Sobis et ai, 1982), are 
derived from pluripotent embryonal cells. 
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Characterization of EGCTs 
Diagnosis of the New Entity 
Suspicion of a case of type 1 extragonadal GCT should be raised by the clinical 
presentation, in particular the relatively high age of the patient, and by the diploid 
character of the lesion. The only way to prove a case as yet is by karyotyping. Lack 
of involvement of chromosome 12 in interphase cytogenetics (in situ hybridization 
for the centromere of #12 (Looijenga et al., 1990)) argues against a type 2 and for 
a type 1 tumor. In the future it may be possible to demonstrate the specific 
chromosomal fusion regions with molecular techniques (Sinke et αι., 1994). 
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ABSTRACT 
The molecular characterization of a recurring complex chromosomal translocation 
involving 6p21, 6p22, 6q23, and 11 q 13 in two independent but similar extragonadal 
germ cell tumors was initiated using fluorescence in situ hybridization (FISH) and 
pulsed field gel electrophoresis (PFGE) techniques. By using a series of specific 
probes from the 1 lql3 region, the translocation breakpoint in this chromosomal 
band could be located within a long-range restriction enzyme map in between the 
markers D11S457 and DllS546.In addition, aberrantly hybridizing fragments were 
revealed by PFGE in both tumors, indicating that the breakpoint region must be 
located within a distance of at maximum 200 kilobase pairs (kb) from the nearest 
DNA marker (D11S546). 
INTRODUCTION 
During the past decade it has become evident that chromosomal abnormalities play 
an important role in the pathogenesis of malignant disorders (Sandberg, 1990; 
Mitelman, 1990). Sofar, most evidence for this statement has come from studies on 
specific chromosomal transloctions that are encountered in hematopoietic tumors 
(Rowley,1990; Strubblefield and Sandford, 1987). As yet, little is known still about 
the role of specific chromosomal anomalies in solid tumors. Although breakpoints 
tend to cluster to specific regions, it appears that they are frequently accompanied 
by the occurrence of complex cytogenetic aberrations. Therefore, it has often been 
difficult to point out the most important primary changes (Teyssier, 1989). 
Nevertheless, to date some consistent recurring chromosomal anomalies have 
succesfully been identified in a few solid tumor types (Sandberg, 1990; Fletcher et 
al., 1991). 
Human germ cell tumors (GCTs) comprise a heterogeneous group of neoplasias that 
occur in the testes, ovary, or, alternatively, in extragonadal sites (Mostofi et al., 
1973; Scully et al., 1979). The only consistent structural chromosomal aberration 
found in these tumors so far is an isochromosome of the short arm of chromosome 
12 (Atkin and Baker, 1982, 1983; de Jong et ai, 1990; Suijkerbuijk et ai, 1991, 
1992). This highly characteristic marker chromosome has been observed in all 
histlogic varieties of GCTs in more than 80% of all cases. Very recently, a new 
subgroup of extragonadal GCTs was defined (Oosterhuis and de Jong, unpublished 
results). Whereas the earlier described extragonadal GCTs frequently contain a 
seminoma component and, in addition, are usually highly aneuploid and i(12p) 
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positive, this new subgroup comprises tumors that lack seminoma components, are 
diploid, and lack the i(12p) marker chromosome. Instead, they are characterized by 
recurring complex chromosomal translocations involving the chromosomes 6 and 
11. Exlragonadal GCTs are thought to originate from primordial germ cells which 
have migrated, by an as yet unclarified mechanism, to the anterior 
mediastinum/thymus and midline of the brain. Alternatively, these tumors may have 
derived from some other pluripotent embryonal or extra-embryonal stem cell. Thus, 
different subgroups of extragonadal GCTs may originate from different cell types 
following distinct pathogenetic pathways. 
The first patient from this newly defined subgroup of i(12p)-negative extragonadal 
GCTs was described in 1985 by Oosterhuis et al. (1985), presenting as a 
mediastinal immature teratoma with a complex t(6;6;ll) as sole cytogenetic 
anomaly. More recently, another patient of this catagory was encountered with a 
complex t(6;6;7;ll), again as sole cytogenetic aberration. This tumor turned out to 
be an immature teratoma from the retroperitoneum. In both patients the 
translocations were only found in the primary tumors and their metastases, but not 
in the normal peripheral blood lymphocytes. Particularly, the chromosomal 
breakpoints at 6p21, 11 ql3, 6p22 and 6q23 are shared by both tumors, suggesting a 
specific role for these genomic regions in the pathogenesis of this subgroup of 
tumors. 
By using fluorescent in situ hybridization (FISH) techniques we have started out to 
characterize the translocation in both patients in detail. Because the 11 q 13 region is 
involved in many malignancies (Tsujimoto et al., 1985; Larsson et al., 1988; 
Schuuring et al., 1991; Brookes et al., 1991) and, therefore, is relatively well 
characterized (Janson et al, 1991; Tanigami et al., 1992), we selected this region as 
the starting point for our FISH studies. In addition, we have used pulsed field gel 
electrophoresis (PFGE) techniques to identify the breakpoint in further detail. 
Breakpoint analysis at the molecular level may, finally, lead to the identification of 
(onco-) genes that are located at or near these breakpoints. This may provide a clue 
to the origin of these and other germ cell tumors. 
MATERIALS AND METHODS 
Tumor Cell Lines 
Haz-1 is a cell line derived from a metastasis of an extragonadal (mediastinal) 
human germ cell tumor (GCT) (Oosterhuis et al., 1985), carrying a t(6;6;ll) as sole 
cytogenetic anomaly (Fig. 1). Bos-1 is a cell line derived from a similar diploid 
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extragonadal (retroperitoneal) human GCT, carrying a complex t(6;7;ll) 
(Oosterhuis and de Jong unpublished data). Chromosomal breakpoints in bands 
6p21, 6p22, 6q23, and l l q l 3 are shared by the two tumors. Both cell lines are 
cultured on RPMI 1640-medium, supplemented with penicillin/streptomycin (100 
μg/ml), L-Glutamine (2 mM) and fetal calf serum (15%). Metaphase spreads were 
prepared following standard protocols. Because Haz-1 cells grow relatively slow, 
thes cells were synchronized using a thymidine block (2 mM24 hrs) prior to 
harvesting and preparation of metaphase spreads. As controls, chromosome 
preparations from normal human blood lymphocytes were used. 
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Figure 1: G-banded karyotype of the extragonadal GCT Haz-1 showing the complex 
t(6;6;ll). The different translocation chromosomes are indicated by arrows 
(see also Oosterhuis et al., 1985). 
Fluorescent In Situ Hybridization 
FISH procedures used were essentially as described elsewhere (Landegent et al., 
1991; Suijkerbuijk et ai, 1991, 1992). Briefly, relevant probes were labeled with 
biotin-14-dATP (Life Technologies) or digoxigenin-11-dUTP (Boehringer-
Mannheim) using a nick translation kit (Life Technologies). Repetitive sequences 
present in these probes are competed out with Cot-1 DNA (2.5 μg/50 ng probe; 
Life Technologies) and/or sonicated total human DNA (10 pg/50 ng probe) at 37°C 
for 20 min and 2-3 hrs, respectively. After hybridization at 37°C for 20-24 hrs and 
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subsequent washings, immunocytochemical detection was carried out and the slides 
were analyzed under a Zeiss Axiophot epifluorescence miroscope. Fluorescent 
images were captured using a high performance CH250/A CCD-camera 
(Photometries Ltd, USA) coupled to a Macintosh Ilei computer equipped with a 
Polaroid Quickprint photocamera. 
Southern Blot Analysis 
Cell line DNAs, 10-15 μg, were digested to completion with restriction 
endonucleases (Life Technologies), electrophorised in 0.8% agarose gels and 
transferred to Gene Screen Plus nylon membranes (DuPont) using standard 
procedures (Sambrook et ai, 1989). Filters were hybridized at 65°C in a buffer of 
0.5 M sodium phosphate, 7% SDS, 1 mM EDTA. Relevant DNA inserts were 
labeled with a-32P-dCTP (Amersham International) by random priming (Feinberg 
and Vogelstein, 1984). After hybridization, filters were washed in 40 mM sodium 
phosphate, 0.1% SDS at 65°C, and exposed to X-ray film (X-OMAT-S; Kodak) at -
70°C for 1 to 3 days using intensifying screens. 
Pulsed Field Gel Electrophoresis 
Haz-1 and Bos-1 cells were suspended in 0.5% Incert agarose (FMC BioProducts) 
at a concentration of 7.5 χ IO6 cells per ml. Agarose blocks containing 5-7 χ 105 
cells were incubated at 37°C for 16-20 hrs, in a solution containing 1% sodium 
lauryl sarcosinate, 0.5 M EDTA and 40 μg/ml pronase (from Streptomyces griseus; 
Boehringer-Mannheim), and washed repeatedly in 10 mM Tris-HCl, pH 7.4, 0.5 
mM EDTA containing 0.1 mM phenylmethylsulfonylfluoride (PMSF). Blocks were 
stored in 0.5 M EDTA at 4°C until required and washed several times with distilled 
H 2 0 before use. The DNA was digested in situ with 20 units of restriction enzym 
for 16-24 hrs and, subsequently, the agarose blocks were then embedded at the 
origin of a 1.0% agarose gel (Seakem ME; FMC BioProducts). The gels were 
electrophorised at 15°C for 24 hrs in a contour-clamped homogeneous electric field 
(CHEF) at 200 V with a pulse time of 15-50 seconds. Concatamers of phage 
lambda DNA and Saccharomyces cerevisiae chromosomes were used as size 
markers. The DNA was then depurinated by immersing the gel in 0.25 M HCl for 
10 min (or, alternatively, by UV irradiation), denatured for 2 χ 15 min in 0.4 M 
NaOH, neutralized for 15 minutes in 0.5 M Tris-HCl/1.5 M NaCl pH 7.5, washed 
for 10 minutes in 10 χ SSC, and transferred to nylon filters (Hybond N Plus; 
Amersham) (Sambrook et al., 1989). These filters were then placed on a drop of 
0.4 M NaOH, with the DNA side up, for 5 minutes, rinced in 2 χ SSC70.2 M Tris-
HCl pH7.5, and dried at 65°C for 1 hour. Hybridization was carried out as above. 
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Probes 
For the FISH experiments we used 18 cosmid (C) and/or plasmid (P) probes 
derived from the llql3 breakpoint region For the identification of the different 
translocation derivatives, two cosmids from the llpl5 region and two plasmids 
specific for the centromeric (alphoid) regions of chromosomes 6 and 11, 
respectively, were included. Additional cDNA and (cosmid-derived) single copy 
probes were used for Southern blot and PFGE analysis. A summary of the probes 
used is given in table 1. A schematic physical map of the 11 q 13 region with the 
most relevant loci is presented in Figure 3. 
Table 1. Characteristics of the DNA probes used in this study. 
Locus Probe Type Chromosomal Reference 
Localization 
D11S431 
D11S466 
D11Z1 
D11S449 
PGA 
PYGM 
D11S427 
D11S457 
D11S546 
D11S460 
PPP1A 
DI1S807 
D11S97 
D11S146 
BCL1 
PRAD1 
ΓΝΤ2 
EMS 
SEA 
cCIll-10 
cCIH-280 
pCLUA 
cCll 1-219 
pSOM187 
CCLGW567 
pSOMI84 
cgHGP18 
cCLI5 
cCIIl-4 
cCll 1-247 
247 B4 
cCll 1-363 
363.S2 
cCI 11-254 
cCLPPlA 
HL1/1 
CCLGW39 
cos! 53 
cos6 7 
cCL59 
cCLBCLl 
622 
cosHul 5 
Ems-1 
p6-2 
С 
С 
Ρ 
С 
Ρ 
С 
Ρ 
с 
с 
с 
с 
Ρ 
с 
Ρ 
с 
с 
Ρ 
с 
с 
с 
с 
с 
с 
с 
с 
Ρ 
11р152-р153 
11р153 
1 Icen 
l l q l 3 l-ql3 2 
11 q 13 
l l q l 3 
I l q l 2 - q l 3 2 
I l q l 2 - q l 3 2 
l l q l 3 1-q13 4 
l l q l 3 l - q l 3 3 
l l q I 3 l-ql3 3 
l l q l 3 
11 q 12-q 13 2 
I l q l 3 
H q l 2 - q l 3 2 
l l q l 3 3 
I l q l 3 
l l q l 3 
l l q l 3 
l l q l 3 
a 
a 
a 
a 
b 
a 
a 
a 
a 
a 
a 
a 
a 
a 
a 
a 
a 
a 
с 
a 
a Human Gene Mapping 11 (1991) 295-336, 459-554 
b Larsson et al unpublished results 
с Schuuring et al (1992) Oncogene 7 355-361 
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RESULTS AND DISCUSSION 
We have initiated the characterization of a recurring complex chromosomal 
translocation in two patients with similar extragonadal GCTs (Bos-1 and Haz-1) 
using FISHs, starting from the llql3 region. Double hybridizations with either 
llpl5-specific probes (cCIll-10: D11S431; cCIll-280: D11S466) or probes 
specific for the centromeric regions of chromosomes 6 (p308: D6Z1) and 11 
(pLCHA: D11Z1) (HGM11,1991) were performed in order to verify and confirm 
the presence and nature of the different translocation chromosomes in the two 
tumor-derived cell lines. An example of these hybridizations is shown in Figure 2. 
By using probes for the relatively distant PGA and SEA loci (HGM 11,1991) we 
were able to confirm the cytogenetic localization of the breakpoint within this 
region in both tumors, i.e., PGA being proximal and SEA being distal to it. 
14 
13 
12 
II 
12 
a 
14 
21 
22 
23 
24 
25 
Figure 3: Schematic representation of part of the physical map of chromosome band 
llql3 according to literature data; the position of the breakpoint region is 
indicated by an arrow. 
Initially, we considered SEA to be one of the most telomeric loci known within 
band 1 lq 13. In the course of our experiments, however, new mapping data became 
available that positioned SEA centromeric to the BCL1 locus. Because we localized 
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the tumor breakpoint between the markers PGA and SEA, these data excluded 
BCL1 and other more distal loci from being involved (see Fig. 3). By subsequent 
hybridizations with cosmid probes specific for llql3 loci coming from the 
telomeric site, we found that in both patients the breakpoint must be centromeric to 
the markers EMS1-D11S546. Coming from the centromeric site towards the 
telomere it turned out that all markers tested including D11S449-D11S457 map 
proximal to the breakpoint, again in both tumors (Fig. 3). Thus, the breakpoint is 
located in interval V of the physical map of the 1 lq 13 region as reported previously 
by Tanigami et al. (1992). In addition, several probes were used (Larsson et al., 
1980; Schuuring et al., 1992; Barker et ai, 1990) that were not contained within 
this map. Again, the FISH results with these markers were found to be the same in 
both tumors: cCLGW567 maps proximal and cCLPPlA (PP1A), cCLGW39 
(D11S807), cos 1.53/67 (D11S97), 622 (PRAD1), and ems-1 (EMS1) map distal to 
the breakpoint (not shown). Clearly, the markers D11S457 and D11S546 bracket 
the smallest currently identifiable breakpoint region (Tanigami et al., 1992). 
Long-Range Mapping Around the Hql3 Breakpoint Using Pulsed Field Gel 
Electrophoresis 
To further extend the characterization of the llql3 breakpoints in these two 
extragonadal germ cell tumors further, we performed PFGE analysis of the tumor-
derived cell lines using subcloned single copy fragments as probes. These subclones 
(247.B4 and 363.S2) were obtained after cleavage of the 11 q 13 breakpoint 
bracketing cosmid clones cCI 11-247 (D11S457) and cCI 11-363 (D11S546) with 
BamHI and SauIIIA, respectively, and ligation of these fragments into the BamHl 
site of the plasmid vector pT7T3 19U (Pharmacia). Probe 247.B4 detects single 
wildtype Mlul, Nrul, and Sail restriction fragments in the different germ cell 
tumors tested (not shown). Probe 363.S2 also detects the normal Mlul fragment in 
the different germ cell tumors but, in contrast, additional aberrant Nrul and Sail 
fragments were detected. In both Bos-1 and Haz-1 differently sized Nrul fragments 
of 170 and 200 kb are present, respectively, in addition to the wildtype band (Fig. 
4A). Furthermore, in Bos-1 an additional Sail fragment of about 190 kb is present 
(Fig. 4B) which is absent in Haz-1. In the control i(12p)-positive cell line NT2/D1, 
no shifts in bands were observed, as expected. 
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Figure 4: PFGE analysis of Bos-1, Haz-1 and NT2/D1 DNAs cleaved with Nrul (A) and 
Sail (B). Filters were hybridized with 363.S2. The wild type and aberrantly 
hybridizing fragments are indicated by their estimated molecular weights. 
Southern Blot Analysis Using Candidate Markers 
In order to determine whether one of the breakpoint region-bracketing markers airad 
detects the breakpoint, we used their corresponding cDNAs, pSOM184 
(CCLGW567) and HLI/1 (cCLPPlA), or single copy fragments, 247.B4 (cCIl 1-247) 
and 363.S2 (cCIll-363), as probes on Southern blots containing Bos-1 and Haz-1 
DNA, in addition to DNAs extracted from three other [i(12p)-positive] GCT cell 
lines (Sinke et ai, 1992). No differences in the hybridization patterns in either of 
the DNAs were detected. Very similar results were obtained when the 
corresponding whole cosmids were used as probes (not shown)> Therefore, we 
conclude that none of these markers, as yet, identifies the breakpoint at the 
Southern blot level. 
Taken together, we have been able to characterize in detail a complex chromosomal 
translocation in two patients with diploid i(12p)-negative extragonadal GCTs. The 
recurring breakpoint in the 11 ql3 region appeared to be very similar in both 
tumors, with the markers D11S449-D11S457 being proximal, and the markers 
D11S546-EMS1 being distal to the breakpoint. Subsequent PFGE analysis enabled 
us to detect aberrantly hybridizing fragments with the DllS546-derived 363.S2 
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probe. This result indicates that the 11 ql3 breakpoint must be located within a 
distance of at maximum 200 kb from this latter marker (D11S546). The observation 
of differently sized aberrant bands in Bos-1 and Haz-1 indicates the presence of two 
spatially separated breakpoints, possibly representing distinct breaks within the 
same, as yet, unidentified gene. 
Based on these mapping data we have been able to exclude most presently known 
candidate genes in the llql3 region from being directly involved in the 
development of this subgroup of extragonadal germ cell tumors. This includes the 
gene encoding the ^ay-related antigen-1 that we recently localized in band llql3 
(Sinke et al., 1993). 
Furthermore, our results have provided additional mapping data concerning the 
order of some of the 11 ql3 loci: cCLGW567 is located on the der(ll) chromosome 
and therefore located proximal of D11S456; PPP1A, which previously was mapped 
distal to D11S427 (Janson et ai, 1991) is probably located even more distal below 
D11S546. 
Experiments to clone the breakpoint by the identification of corresponding 
breakpoint-spanning yeast artificial chromosomes (YACs) and, subsequently, cosmid 
cloning and walking, are in progress. 
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Characterization of EGCTs 
Recently, we started the molecular characterization of a recurring complex 
chromosomal translocation, involving breaks in 6p21, 6p22, 6q23 and l l q l 3 , 
specific for a newly defined subgroup of human extragonadal germ cell tumors 
(EGCTs) (van Echten et ai, 1995). Band l l q l 3 was chosen as starting point for 
our experiments. By using FISH, we were able to narrow down the breakpoint 
region to an interval between the loci D11S457 and D11S546 (Sinke et al., 1994). 
In order to generate new probes, we subcloned a number of single copy BamHI 
fragments from three cosmids corresponding to the breakpoint spanning D11S457-
D11S546-D11S460 region (cCIl 1-247, cCIl 1-363 and cCIl 1-254, respectively) in a 
pT7T3 19U vector (Pharmacia). Subsequently, sequence tagged sites (STSs) were 
identified by partially sequencing these clones on an automated DNA sequencer 
(ABI 373A), using the Taq Dye Deoxy Terminator Cycle Sequencing kit (Applied 
Biosystems). The STSs corresponding to the breakpoint flanking loci, D1IS457 and 
D11S546, respectively, were used for screening of a total human YAC library 
(СЕРН; Albertsen et ai, 1990). This resulted in one positive clone, designated 
255H9, 300 kb in size, with the STS primer set generated from cosmid cCIl 1-247 
(D11S457). Attempts to identify YACs with the cCIll-363-derived primer set in 
other total human (ICI, St. Louis) and chromosome 11 -specific (Shows, Buffalo) 
YAC libraries either failed or resulted in YACs with relatively small (<40 kb) 
inserts. FISH analysis confirmed that the 255H9 YAC maps to l lq l3 and, in 
addition, revealed only one specific hybridization signal, indicating that this YAC is 
non-chimeric. For further genome walking experiments, we isolated the endclones 
of YAC 255H9 via Л/и-vector PCR. These endclones were sequenced in order to 
obtain new STSs. The primer set generated from the most telomeric side was used 
again to screen the YAC libraries mentioned before. Again, only small YACs were 
identified. All STS-sequences were subjected to a database search for the 
identification of homologies to already known sequences (genes). 
Within subclone 254B2, isolated from cCIl 1-254 (D11S460), we encountered a 
stretch of DNA (133 nucleotides; Fig. 1) that matches perfectly with the 5' end of 
the known cDNA sequence for the human Fos-like antigen-1 (FOSLI) (Matsui et 
al., 1990). This match comes to an abrupt end at nucleotide 328, which coincides 
with a perfect splice donor site (Fig. 1, bar) (Mount, 1982). At position 231 an 
ATG codon (translation initiation) was found. From these data we conclude that 
position 328 marks the boundary of the first exon of the FOSLI gene. Homology of 
this same region with the rat FOSLI cDNA sequence is ± 70% (not shown) (Cohen 
and Curran, 1988). Thus, the human FOSLI gene maps to region V of a long range 
contig map of l l q l 3 as defined by Tanigami et al. (1992). The localization of 
FOSLI on chromosome 11 was confirmed by hybridizing the FOSLI containing 
fragment to a panel of somatic cell hybrids (not shown). 
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2 54B2 196 AGCCGTGTACCCCGCAGAGCCGCCAGCCCCGGGCATGTTC 
**************************************** 
F0SL1 1 AGCCGTGTACCCCGCAGAGCCGCCAGCCCCGGGCATGTTC 
254B2 236 CGAGACTTCGGGGAACCCGGCCCGAGCTCCGGGAACGGCG 
**************************************** 
F0SL1 41 CGAGACTTCGGGGAACCCGGCCCGAGCTCCGGGAACGGCG 
2 54B2 276 GCGGGTACGGCGGCCCCGCGCAGCCCCCGGCCGCAGCGCA 
**************************************** 
F0SL1 81 GCGGGTACGGCGGCCCCGCGCAGCCCCCGGCCGCAGCGCA 
2 54B2 316 GGCAGCCCAGCAGGTGAGTGG 
************* 
F0SL1 121 GGCAGCCCAGCAGAAGTTCCA 
Figure 1: Alignment of parts of the sequences of 254B2 and the Human FOSL1 cDNA. 
The splice consensus sequence in 254B2 is overlined. 
Also, one of the endclones (L73) of YAC 255H9 appeared to contain sequences 
homologous to a known, but so far unassigned, gene. Here, we found a stretch of 
DNA completely homologous to positions 1000-1250 of the human 
phosphatidylinositol-specific phospholipase С beta3 (PLCB3) cDNA (Carozzi et al., 
1992). In addition, this endclone was used to screen a flow sorted chromosome 11 
cosmid library (Zehetner and Lehrach, 1994). This resulted in four overlapping 
cosmids that, again, could be localized in the l l q l 3 region using FISH. Together, 
these observations unambiguously map the corresponding gene within chromosome 
band 11 q 13. However, so far only part of the PLCB3 cDNA was cloned and 
sequenced. The 5'-end of the cDNA, encoding approximately 180 amino acids, was 
still missing (Carozzi et al., 1992). Since phospholipases are involved in cellular 
signaling and as such are thought to play a role in differentiation and proliferation 
processes (Meldrum et al., 1991), we considered the PLCB3 gene as a candidate in 
the development of EGCTs. Therefore, we used the L73 clone to screen a human 
fetal brain lambda ZAP cDNA library (Stratagene). This resulted in five 
independent clones. Here, we report the remaining 5'-cDNA sequence of the 
PLCB3 cDNA (Fig. 2A). In addition, a comparison of the putative protein sequence 
with known sequences of two other members of the beta family of phospholipase С 
is provided (Fig. 2B). 
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A. 
-132 
TCCGCCCGGG 
CGCGGTGGGA 
CCTGGCCGGG 
ACCGTGGTGG 
AGTCGGAACC 
CCCAACATGG 
TACGCCCGCC 
GCCCGGCTGG 
TTCTTGAACT 
AAGCTGGCTA 
TACACGAAGC 
TGTTCTCAGC 
ACTGACTGGC 
GCAGCGGCGC 
+ 1 
CCATGGCGGG 
ACACCCTGCG 
TGGTGACCCT 
AGGTGGACAC 
TGCCCAAGGA 
AGGAGAAGCT 
TCATGGCCGT 
TGAACATCCT 
TGAAGCTGCA 
+ 549 
AGACAAGAAG 
GGGCGGGCGG 
CGTCGGTCCC 
CGCCCAGCCC 
GCGCGGGAGT 
GCGTGTGGAC 
ACTGGACATC 
GGGGAAGATC 
GATGACGGTG 
GCAGGATGAC 
GGCTCAGAAC 
GGTGAACCAG 
CGGGTGGAGA 
GCACTGACGC 
CGTCAGGGCT 
GGCGTCCACG 
AAGTTCATCA 
CCCAATGGCT 
AGTTCCATCA 
CGGGAAGTTC 
GTGTCTGGGC 
ACAGCCAAGG 
GCCTCCCGGA 
GATGGTTCCC 
CGCGGGGCCG 
CCGTGGGTCC 
CGCTGCAGTT 
AATGGGACGA 
TCTTCTTGTA 
GGGACACACG 
TGGGCTTTGG 
CAGACCCGGT 
TCTGGTCTGA 
ACACCTTCCT 
CGTCATGAAC 
GAGCGGGCCG 
CCGACCCGCC 
GGAGCCGCCC 
GGAGACCTCC 
CTGGACGGGC 
GACAGGCCGG 
GGGTCCCGAT 
GAACACAGTG 
GGAGCTATTC 
GCGCAAAGCA 
ATCCTGAAGA 
plcblb magaqpgvhalqlkpvcvsdslkkgtkfvkweddstwtpulrtdpqgf f fywtdqnke 
plcb2h msllnpv llppkvkaylsqgerflkwddettvaspvilrvdpkgyylywtyqske 
plcb3h magaqpgvhalqlepptwdtlrrgskflkwdeetssrnlvtlrvdpngfflywtgpnme 
plcblb 
plcb2h 
plcb3h 
plcblb 
plcb2h 
plcb3h 
telldlslvkdarcgkhakapkdpklrelldvgnig-rlehrmitwygpdlvnishlnl 
raeflditsirdtrfgkfakmpksqklrdvfnmdfpdnsfllktltwsgpdmvdltfhnf 
vdtldissirdtrtgryarlpkegkirevlgfggpdarleeklmtwsgpdpvntvfInf 
++* ++* 
vafqeevakewtnevfslatnllaqnmsrdaflekaytklklqvtpegriplkniyrlfs 
vsykenvgkawaedvlalvkh.pl tanasrstf ldkilvklkmqlnsegkipvknf fqmfp 
mavqddtakvwseelfklamnilaqnasrntflrkaytklklqvnqdgripvmnilkmfs 
plcblb 
plcb2h 
plcb3h 
adrkrvetaleac 
adrkrveaalsac 
adkkrvetálese 
Figure 2: (A) 5'-sequence of cDNA clone c7 The translation initiation site is printed 
bold The position where the previously known PLCB3 sequence begins 
(Carozzi et al, 1992) is underlined (B) Aminoacid alignment of the N-
termmal regions of the three Phosphatidylinositol-specific phospholipases С 
PLCB1, PLCB2, PLCB3 The astenkses below the sequences indicate 
identical amino acids, the dots indicate conservative changes The position 
where the previously known PLCB3 sequence begins (Carozzi et al, 1992) 
is underlined 
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Based on this comparison three of our clones probably contain the full length 
cDNA. The degree of homology turned out to be high, especially when comparing 
ßl and ß3 sequences. By using the entire cDNA as a probe on a poly A+ Northern 
blot (Clontech), a major transcript of approximately 5.5 kb was detected in all 
tissues tested, with additional transcripts (of unknown origin) in heart and skeletal 
muscle (Fig. ЗА). The 5.5 kb mRNA was also detected on Northern blots 
containing RNA isolated from several germ cell tumor-derived cell lines including 
EGCTs (not shown). Southern blot analysis using, again, the entire cDNA as a 
probe once more confirmed the chromosomal localization of the PLCB3 gene (Fig. 
3B, lane 1). No aberrantly hybridizing fragments were observed in EGCT DNAs 
(Fig. 3B, lanes 4 and 5). 
kb 1 2 3 4 5 6 7 8 m 1 
115 f 
48 45" 
HP 
в 
Figure 3: (A) Northern blot analysis of poly A+ RNA from different human tissues 
using the human PLCB3 cDNA as a probe. Lanes 1-8, heart, brain, placenta, 
lung, liver, skeletal muscle, kidney, and pancreas, respectively. The major 
5.5 kb transcript is indicated by an arrow. (B) Southern blot analysis of 
EcoRI digested DNAs using the human PLCB3 cDNA as a probe. Lanes 1-5, 
chromosome 11-only hybrid, hamster, mouse, human, and EGCT, 
respectively. 
The subchromosomal localization of FOSL1 and PLCB3 to 11 ql3 adds another two 
putative proto-oncogenes to this restricted genomic region which, besides 
extragonadal germ cell tumors, appears to be involved in a variety of neoplastic 
disorders as e.g. multiple endocrine neoplasia type 1 (MENI), breast cancer, 
squamous cell tumors of head and neck, esophageal carcinoma, hepatocellular 
carcinoma, melanoma, bladder carcinoma, and some hematopoietic malignancies 
(Oosterhuis et al., 1985; Lammie and Peters, 1991; Brookes et al., 1992; Tanigami 
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et al., 1992; Sinke et ai, 1993; Schuuring, 1995). Thus, the specific localization of 
these genes automatically turns them into candidate genes for either one of these 
neoplastic disorders. As for our extragonadal germ cell tumors, the FISH results, 
together with the Southern and Northern blot analyses, indicate that the two genes 
identified here, FOSL1 and PLCB3, can be excluded as candidates in the 
development of these tumors. Obviously, the possible involvement of either of these 
two genes in the other malignancies mentioned still needs to be verified. 
In addition, the strategy described here, leading to the identification of known 
sequences (genes) using probes of which the localization was already known, 
provides a nice example of what could be called "reverse mapping". 
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ABSTRACT 
In a previous study we have defined a subgroup of malignant extragonadal germ 
cell tumors (EGCTs) that carries a complex translocation involving chromosomes 6 
and 11. Subsequently, the 1 lq 13 breakpoint region was narrowed down to an 
interval between the DNA markers D11S457 and D11S546 using physical mapping 
strategies. Here we report (i) the use of pulsed field gel electrophoresis (PFGE) and 
direct visual hybridization (DIRV1SH) techniques to assess the physical distance 
between the nearest breakpoint flanking markers, and (ii) the construction of a 
phage library, enriched for this particular chromosomal segment to facilitate 
genomic walking towards the breakpoint. In order to identify possible breakpoint 
spanning clones, fluorescent in situ hybridization (FISH)- and Southern blot 
analyses were carried out on two independent EGCT-derived cell lines. In addition, 
genomic fragments were screened for the presence of conserved sequences, 
indicative for coding regions (genes), and when positive, used for the isolation of 
corresponding cDNAs. This approach enabled us to isolate five different cDNA 
clones in the breakpoint spanning region which were, subsequently, characterized in 
detail using both Southern- and Northern blot analyses to assess their putative 
involvement in the development of EGCTs. 
INTRODUCTION 
Human germ cell tumors (GCTs) are thought to originate from pluripotent primitive 
germ cells. They constitute a heterogeneous group of neoplasms: GCTs display a 
great diversity in histology and, in addition, occur in diverse anatomical locations, 
both gonadal and extragonadal (Moslofi and Price, 1973; Scully, 1979; Gonzales-
Crussi, 1982). To date, most studies have been concentrated on the characterization 
of testicular GCTs of adults (TGCTs). By now there is a consensus that these 
tumors originate from dysplastic primordial germ cells (Skakkebask, 1972). The 
histogenesis of the extragonadal germ cell tumors (EGCTs), however, is less clear. 
EGCTs represent only a limited fraction of all GCTs. Histologically they display 
the same heterogeneous spectrum as the gonadal GCTs (Gonzales-Crussi, 1982; 
Nichols and Fox, 1991), but their behaviour is more aggressive. Most patients with 
malignant gonadal GCTs respond well to surgical resection followed by a combined 
chemo- and radiotherapy. In the case of malignant EGCTs the patients' prognosis is 
worse and the estimated survival rate is only 40-50% (Toner et ai, 1991; Goss et 
ai, 1993). 
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Recent cytogenetic analyses have led to the definition of at least two different 
classes of malignant EGCTs (van Echten et al., 1995): 
Type 1. Diploid tumors with specific structural abnormalities of chromosomes 
6 and 11. 
Type 2. Near-diploid or polyploid tumors which may have an i(12p) 
chromosome in addition to multiple non-random numerical 
abnormalities, similar to those found in TGCTs. 
Both the histologic and cytogenetic resemblances of type 2 EGCTs with TGCTs 
suggest that also these tumors may have been derived from dysplastic primordial 
germ cells that have migrated, by an as of yet unclarified mechanism, to their 
extragonadal locations. Based on their histology, type 1 EGCTs may originate from 
primordial germ cells too. However, based on their strikingly different cytogenetic 
characteristics, it cannot be excluded that they are derived from another pluripotent 
embryonal stem cell. 
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Figure 1: Schematic representation of the location of the EGCT-specific translocation 
breakpoint within chromosome band llql3. 
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In order to characterize the type 1 EGCTs in more detail, we recently initiated the 
molecular characterization of a recurring complex (6,11) translocation in these 
tumors (Sinke et al, 1994) By using fluorescent in situ hybridization (FISH), with 
cosmids from the 11 ql3 region as probes on tumor-derived cell lines, we were able 
to narrow down the breakpoint region to an interval between the markers Dl 1S457 
andDHS546 (Figi) 
Here we report a further refinement of the map around the llql3 breakpoint region 
by (1) using pulsed field gel electrophoresis (PFGE) and direct visual hybridization 
(DIRVI SH) techniques to assess the physical distance between the breakpoint 
flanking markers, and (2) constructing a phage library enriched tor this particular 
chromosomal region to carry out genome walks Also, new cDNAs isolated from 
this region have been characterized and their putative involvement in the 
pathogenesis of these tumors is discussed 
MATERIALS AND METHODS 
EGCT-denved cell lines 
Bos-1 and Haz-1 are cell lines derived from two independent human extragonadal 
germ cell tumors (EGCT) (Oosterhuis et al, 1985, van Echten et al, 1995) 
Chromosomal breakpoints in bands 6p21, 6p22, 6q23 and 11 q 13 are shared by Bos-
1 and Haz-1 Both cell lines were cultured in RPMI 1640-medium supplemented 
with penicilhne/streptomycin (100 u/ml), L-Glutamin (2 mM) and fetal calf serum 
(15%) Metaphase spreads were prepared following standard protocols As controls, 
chromosome preparations from normal human blood lymphocytes were used 
Fluorescent in situ hybridization 
The fluorescent in situ hybridization procedures used were essentially as described 
elsewhere (Sinke et al, 1994, Suijkerbuijk et al, 1994) Briefly, relevant probes 
(cosmids or phages) were labeled with biotin-14-dATP (Life Technologies) or 
digoxigenin-11-dUTP (Boehnnger Mannheim) using a nicktranslation kit (Life 
Technologies) Repetitive sequences present in these probes were competed out with 
Cot-1 DNA (2 5μg/50ng probe, Life Technologies) and/or sonicated total human 
DNA (10μg/50ng probe) at 37°C for 20 min and 2-3 hrs, respectively After 
hybridization at 37°C for 16-48 hrs and subsequent washings, immunocytochemical 
detection was carried out and the slides were analyzed under a Zeiss Axiophot 
epifluorescence miroscope Fluorescent images were captured using a high 
performance CH250/A CCD-camera (Photometries) coupled to a Macintosh Quadra 
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650 computer equipped with a Polaroid Quickprint photocamera. 
Direct Visual Hybridization (DIRVISH) 
For DIRVISH experiments preparations were made according to Parra and Windle 
(1993). Briefly, normal human lymphocytes were lysed in a buffer of 0.5% SDS/50 
mM EDTA/200 mM Tris-HCl (pH 7.4) on a microscope slide which was then tilted 
slowly, allowing the DNA to run down the slide as long threads. Upon drying these 
preparations were subjected to standard FISH protocols (see below). This technique 
has a much higher resolution than FISH on metaphase spreads since the DNA 
strands are linearly extended. 
Cosmid- and Phage Libraries 
A gridded flow-sorted chromosome 11-specific cosmid library (Zehetner and 
Lehrach, 1994), spotted in duplo on two 22x22 cm nitrocellulose filters, was kindly 
provided by Drs. Lehrach and Zehetner (Max-Planck Institute, Berlin, Germany). 
To construct a phage library enriched for the region encompassing D11S457-
D11S546 (Fig.l), 33 plugs of Sa//-digested Bosl DNA were prepared. These were 
applied to a 1% low melting point agarose preparative CHEF gel (Seakem GTG, 
FMC BioProducts) and electrophoresed at 10CC for 24 hours at 200 V with a pulse 
time of 15 seconds. As size markers, concatamers of phage lambda DNA and 
Saccharomyces cerevisiae chromosomes were applied at both sides. Subsequently, 
both the left and right sides of the gel containing the size markers and one lane of 
digested Bosl DNA were cut off, stained with ethidium bromide and blotted 
following protocols described before (Sinke et al., 1994). These blots were 
hybridized with the 363 S2 probe in order to (1) check the Sail digestion for 
completion, and (2) mark the position of the correct size (245 kb; Sinke et al., 
1994) of the fragments that were to be cloned. Next the gel was cut into slices of 
0.5 cm. To unambiguously identify the correct slice, DNA was isolated from end-
fragments of each slice using the geneclean kit (Bio 101), spotted onto Genesereen 
Plus nylon membranes (DuPont), and hybridized again with the 363S2 probe. The 
363S2-positive slice was washed extensively with distilled H 2 0 and equilibrated 
with \\MboI restriction buffer. Partial Mbol digestion of the DNA was 
accomplished in situ by cutting the slice in three parts and incubating these parts 
overnight at 4°C in 500 μΐ enzyme mixture containing 0.003, 0.0045 and 0.006 
units Mbol per 0.5 cm slice, respectively. Subsequently, the samples were incubated 
for 30 min. at 37°C. The digestion was stopped by cooling the samples and adding 
EDTA to a final concentration of 50 mM The agarose was removed using gelase 
(Epicentre) and, subsequently, the DNA was precipitated and dissolved in 50 μιΐ 
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H20. 4 μΐ of each sample was loaded on a test gel to monitor the extent of partial 
digestion. To avoid insertion of multiple DNA fragments into the same phage arms, 
we used the Lambda Fix II partial fill-in system (Stratagene). The DNA fragment 
ends were filled in with dATP and dGTP using Klenow polymerase, whereas the 
Xhol digested vector-arms were filled-in with dCTP and dTTP. This results in a 
compatible 2 bp overhang. Upon phenol/chloroform extraction and precipitation, the 
DNA was dissolved and pooled in 5 μΐ distilled H20, of which 0.5 μΐ was loaded 
on a test gel to assess the DNA concentration. Finally, ligation was performed by 
incubating 400 ng of insert DNA and 1 μg of vector DNA in a total volume of 5 
μΐ, using 1 unit of T4 DNA ligase (Life Technologies), for 16 hours at 4°C. 1 μΐ of 
this ligation mixture was packaged using the Gigapack Gold packaging kit 
(Stratagene), resulting in a phage library of about 140.000 pfu. The whole library 
was plated on 4 (0 15 cm) petridishes, and quadraduplicate filters (Hybond N+) 
were made to be used in our hybridization experiments. 
Southern blot analysis 
Cell line DNAs, 10-15 μg, were digested to completion with restriction 
endonucleases (Life Technologies), electrophoresed in 0.8% agarose gels and 
transferred to Gene Screen Plus nylon membranes (DuPont) using standard 
procedures (Sambrook et ai, 1989). For single copy probes, filters were hybridized 
at 65°C in a buffer of 0.5 M sodium phosphate, 7% SDS, 1 mM EDTA. For 
genomic probes containing repetitive sequences, filters were hybridized in a buffer 
containing 0.125 M Sodiumphosphate, 0.25 M NaCl, 1 mM EDTA, 7% SDS and 
10% PEG6000 (Blonden et ai, 1989). DNA probes were labeled with a-32P-dCTP 
(Amersham International) by random priming (Feinberg and Vogelstein, 1984). To 
compete out any repetitive sequences, genomic probes were denatured together with 
200 μg sonicated total human DNA and prehybridized at 65°C in 2 ml 
hybridization buffer for 1.5 hr. After hybridization, filters were washed in 40 mM 
sodium phosphate, 0.1% SDS at 65°C, and exposed to X-ray films (X-OMAT-S or 
X-OMAT-AR; Kodak) at -70°C using intensifying screens. 
Pulsed field gel electrophoresis 
Preparation of agarose plugs containing GCT-derived high molecular weight DNAs, 
digestion, electrophoresis and blotting were performed essentially as described 
before (Sinke et al., 1994). Hybridizations were carried out as described above. 
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Northern blot analysis 
Cell line RNAs (15 μg) were electrophoresed in 1% paraphormaldehyde gels and 
blotted according to Fourney et ai, 1988. Filters were hybridized at 65°C in a 
buffer containing 1 M NaCI, 1% SDS and 10% Dextran Sulphate. After 
hybridization, filters were washed in 2xSSC, 1% SDS and in lxSSC, 1% SDS at 
65°C. Labeling of probes and exposure of filters were performed as described 
above. 
RESULTS AND DISCUSSION 
PGFE analysis 
Previous PFGE experiments revealed that the chromosome 11 breakpoints in the 
EGCT-derived cell lines Bos-1 and Haz-1 are located within a limited segment of 
band ql3, but at distinct positions. Using a single copy probe (363S2), 
corresponding to the D11S546 locus (Chapter III.2), we found that both breakpoints 
most likely reside within a single Nrul fragment of approximately 250 kb. The 
same probe (363S2) consistently detects aberrantly hybridizing Sail fragments in 
Bos-1 DNA (Fig.2A). These analyses were extended using the L73 endclone of 
YAC 255H9, corresponding to D11S457 (Chapter III.3). Interestingly, in addition to 
a wildtype Sail fragment of 245 kb, which is of similar size as the Sail fragment 
detected by 363S2, L73 detects aberrantly hybridizing Sail fragments in Haz-1 
(Fig.2B). This can best be explained by assuming that there are two adjacent Sail 
fragments, together spanning the breakpoint region in Bos-1 and Haz-1. 
Consequently, we now estimate that the breakpoins must be contained within a 
genomic interval of at maximum 500 kb. 
DIRVISH 
To confirm the above PFGE results that indicate a physical distance between the 
breakpoint flanking markers of at most 500 kb, we performed DIRVISH. To this 
end we used two neighbouring cosmids (ICRFcl07B0945 and ICRFcl07C1274) 
isolated with the proximal L73 probe and one cosmid (ICRFcl07A0515) isolated 
with the distal 363S2 probe, on linearized DNA preparations of normal human 
lymphocytes. The position of these two neighbouring cosmids on the same DNA 
strand is unambiguously confirmed (Fig.3A). In addition, the breakpoint flanking 
cosmids (lCRFcl07B0945 and ICRFcl07A0515) can both be detected on a single 
DNA strand (Fig.3B). 
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Figure 2: PFGE analysis of Control, Haz-1 and Bos-1 DNAs (lanes 1-3, respectively) 
cleaved with Sail. Filters were hybridized with 363 S2 (A) and L73 (B), 
respectively. Next to the wild type fragment of 245 kb (WT) aberrantly 
hybridizing fragments can be detected (arrows). 
Estimation of the physical distance between these two cosmids indicates that they 
are separated by approximately 5 cosmid signal equivalents, corresponding to about 
200 kb of DNA, assuming an average size of the cosmids of 40 kb. Thus, these 
results are in agreement with and extend our PFGE data, now limiting the 
breakpoint region to an interval of approximately 200 kb. 
Construction of a phage library and genomic walking 
In order to saturate the genomic interval between the breakpoint flanking cosmids 
with new probes, we set out to constuct a phage library enriched for this region. To 
this end, we made use of our PFGE data, from which we concluded that in Bos-1 
and Haz-1 the breakpoints are located within two adjacent 245 kb Sail fragments. 
Based on this, we prepared a gel containing Sa/Z-digested Bos-1 DNA. Following 
the identification of the 245 kb fragment-containing slice, partial Mbol digestions 
were carried out in situ, whereafter the DNA was isolated from the agarose slice 
and ligated into the Lambda Fix II vector arms, using a partial fill-in technique to 
avoid co-ligation of multiple inserts. Subsequent packaging and transformation 
resulted in a library of about 140.000 pfu that was used for subsequent genomic 
walking experiments. 
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1. Phage walking from the proximal D11S457 side. 
Since we were able to orient the 255H9 YAC and the cosmids isolated using the 
L73 endclone as a probe, a unidirectional walk could be performed, starting with an 
endfragment of cosmid ICRFcl07C1274 (CI2; Fig.4). Initially, two positive phage 
clones could be identified. The overlap of these clones was confirmed via 
rescreening with the cosmid probe. Based on this hybridization, and by comparing 
EcoRJ and EcoRIINotI digestion patterns of the different clones, they were placed in 
order. Using endfragments of the most telomeric extending phage SF35, again two 
clones could be isolated which, in tum, were used to isolate several new phages. All 
together these cosmid and phage clones (cB51-SF92) encompass a contig of about 
100 kb. 
1 1 q 1 3 
NFKB3 KRT8 
363C1 JR19 
Figure 4: Schematic representation of the 1 lql3-interval encompassing the EGCT-
specific translocation breakpoints in Haz-1 and Bos-1. The different cosmid 
and phage clones composing the contigs are indicated by solid bars. The 
positions of the isolated cDNA clones are indicated below by open bars. N 
= Noti, S = Sali. 
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2. Phage walking from the distal D11S546 side. 
In contrast to the proximal side of the breakpoint region, at the distal side the 
orientation of the DNA fragments is unknown and, therefore, a bidirectional walk 
was performed. After the generation of starting clones from the cosmids isolated 
using 363S2 as a probe (ICRFcl07C0I21 and ICRFcl07A0515, denoted as cC21 
and cA51 respectively), a contig of 4 overlapping phage clones was generated from 
ICRFcl07C0121, whereas from ICRFcl07A0515 3 overlapping clones were 
identified. At the latter point, the contig (Fig.4) comes to an end, since no 
overlapping clones could be detected in the phage library by further hybridization 
experiments using the endclones of the most extreme phage (SF70) as a probe. 
Presumably this represents one end of the 245 kb Sail fragment used for the 
construction of the library. Subsequently, we used a flow-sorted chromosome 11 
cosmid library (see Materials and Methods) in an attempt to further extend the 
contig. With probes from both SF89 and SF70 two new clones could be identified 
(ICRFcl07F0360 and ICRFcl07B09173, denoted as cF60 and cB31, respectively), 
thereby adding another 30 kb. Taken together, these clones compose a contig of 
about 180 kb. 
In order to determine which one of the isolated clones already detects the 
breakpoint in one of our EGCT-derived cell lines, we used both FISH and Southern 
blot analyses. So far, all clones tested map either proximal or distal to the 
breakpoints, depending on the contig from which they originate. Furthermore, 
Southern blot analyses did not reveal any aberrantly hybridizing fragments in the 
tumor-derived cell lines tested (Fig.5). 
cDNA isolation and characterization 
Some of the filters used for the above Southern blot analyses contained, next to the 
human DNAs, also DNAs from hamster, mouse and a human chromosome 11-only 
hybrid cell line to confirm that the isolated fragments were actually chromosome 
11-derived (not shown). These analyses revealed that several of the phage clones 
tested contain conserved sequences. This prompted us to screen a cDNA library 
(fetal brain; Clontech) in order to identify expressed sequences. This screening 
effort resulted in five independent cDNAs (363C1, JR1, JR9, JR16 and JR26, 
respectively) that were partially sequenced. Subsequently, database sequence 
comparisons were performed to search for possible homologies to known genes. 
This search revealed that JR1 is homologous to the human transcription factor 
NFKB3 (p65 subunit) gene (Lyly et ai, 1994) for 95% over 550 nucleotides; JR9 
displays significant homology to a rat homologue of the Drosophila melanogasler 
pecanex gene (Gilbert et al., 1989); JR26 shows partial homology to the human 
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keratin KRT8 gene (+/- 80% over 400 bp); finally, the JR19 and 363C1 sequences 
diplay homologies to two anonymous cDNA clones. 
i ^^^^^^B ,-*fthÏhiÏiitfife W H S 1 
• H È «•№ 
• • Ρ «gip* чиш»1 
Figure 5: Southern blot analysis of Ps/Z-digested DNAs using phage clone SF 17 as a 
probe. Lanes 1-4, Normal Human control, Bos-1, Haz-1, and i(12p)-positive 
TGCT NT2D1, respectively. 
Furthermore, by hybridizing these cDNA clones back onto filters containing DNA 
of the different phage clones, they could be mapped precisely within the contigs 
(Fig.4). Since JR9 and JR19 were located closest to the EGCT breakpoints, they 
were used as probes on Northern and Southern blots to assess a possible 
involvement of the corresponding genes in the development of these tumors. But, as 
yet, no aberrantly hybridizing fragments could be detected (Fig.6). Based on these 
results we tentatively exclude these genes as candidates in EGCT development. 
In conclusion, based on the characterization of about 20 cosmid and 100 phage 
clones, we have constructed contigs of overlapping clones on either sides of the 
l l q l 3 breakpoint region in our EGCTs Bos-1 and Haz-1. These contigs, of about 
100 kb at the proximal side and about 150 kb at the distal side, further narrow 
down this breakpoint region considerably. Furthermore, we were able to select an 
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additional five cDNAs using genomic clones from the distal contig. One of these 
corresponds to the NFKB3 gene, which was previously mapped to chromosome 
band llql3. However, it was positioned near the ROM I gene (van Heyningen and 
Little, 1995), and thus centromeric to the localization of NFKB3 within our phage 
contig. 
Based on preliminary Northern and Southern blot analyses we have tentatively 
excluded all of the corresponding genes as candidates to be involved in this 
malignancy. However, they still should be considered as candidates for either one of 
the other malignancies associated with this genomic interval on chromosome 11 
(Larsson et al., 1980; Tsujimoto et al., 1985; Brookes et al., 1992; Schuuring et al., 
1992; Sinke et al, 1994; Schuuring, 1995; van Echten et al., 1995). 
Figure 6: Southern blot analysis of £coÄ/-digested DNAs using cDNA clone JR9 as a 
probe. Lanes 1-5, chromosome 11-only somatic cell hybrid, control hamster, 
Bos-1, Haz-1, and normal human control, respectively. 
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General Discussion and Future Perspectives 

General Discussion 
Testicular Germ Cell Tumors 
More than 80% of all testicular germ cell tumors (TGCTs) are characterized by the 
presence of an i(12p) chromosome. This highly specific marker appears to arise 
early in the development of TGCTs secondary to an initial aneuploidization event. 
There is a consensus now that the i(12p) chromosome should be considered as a 
progression marker, conferring a specific growth advantage to the cells in which it 
occurs. In this respect the situation differs from the only other disorder in which an 
i(12p) chromosome is consistently found: the Pallister Killian Syndrome (Reynolds 
et al, 1987). This clinical syndrome is associated with multiple recognizable 
congenital anomalies. Here, an i(12p) chromosome can be observed in multiple cell 
types or tissues, including fibroblasts, lymphocytes, lung, liver, spleen and testis 
(Priest et al., 1992). However, Pallister Killian patients do not seem to develop 
germ cell tumors and, moreover, there is an apparent selection against this marker 
during in vitro cell culture (Speleman et al, 1991; Thornburg Reeser and Wenger, 
1992). Thus, teleologically it can be hypothesized that in TGCTs the i(12p) 
chromosome carries a specific growth promoting mutation(s) which is absent in the 
Pallister Killian-associated i(12p). 
FISH Analysis of 12p-anomalies in TGCTs 
Cytogenetically, the i(12p) chromosome presents as a relatively small metacentric 
chromosome which can easily be mistaken for e.g. a 12q- or an i(21q). Also, the 
highly aneuploid chromosomal constitution of TGCTs and the frequent occurrence 
of multiple structural anomalies may interfere with a reliable identification of this 
clinically significant marker. Through the development of chromosome painting 
techniques (Cremer el al, 1988; Pinkel et al, 1988; Kievits et al, 1990; 
Suijkerbuijk et al, 1992b), however, it became feasible to apply single- and bicolor 
double FISH techniques on TGCT preparations. This resulted in the unambiguous 
identification of the TGCT-specific marker as an i(12p) chromosome (Suijkerbuijk 
et al, 1992a). Interestingly, these experiments revealed that, in addition to i(12p), 
other markers involving 12p are frequently encountered. Further chromosome 
painting experiments allowed us to show that also in the remaining group of so 
called i(12p)-negative TGCTs chromosomal anomalies affecting 12p-sequences can 
consistently be found. In addition, in one of these tumors a clonal karyotypic 
evolution was observed, resulting in increasing amounts of 12p-derived sequences 
(Chapter II.2). This finding is in agreement with the notion that the occurrence of 
additional 12p copies is associated with tumor progression (Delozier-Blanchet et al, 
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1987; Castedo et ai, 1989; Bosl et al., 1989). In order to provide the necessary 
tools to delineate these additional 12p sequences in further detail, we constructed a 
panel of 12p-derived radiation reduced somatic cell hybrids (RRHs)(Chapter II. 1). 
Examples of the use of these RRHs as probes on metaphase spreads of TGCTs are 
provided in Chapter 1.3 and Figure IV. 1, respectively. In the latter case, 
chromosome painting with a 12p-specific probe revealed an abnormal chromosome 
12 with extra material added onto the p-arm, part of which is 12p-positive. 
Subsequent analysis with 12p-specific RRHs showed that the extra 12p-material is 
composed of two copies of an almost entire p-arm fused in opposite orientations, 
thereby resembling a cryptic intrachromosomal i(12p). 
Conclusively, 12p amplification, through isochromosome formation or otherwise, 
appears to be a general characteristic of TGCTs. The frequent involvement of the 
(almost) entire 12p arm indicates that multiple genes along this chromosomal arm 
may contribute to tumor development (Grigor and Skakkebask, 1993). 
Searching comprehensively for TGCTs with only minimal 12p aberrations, we 
encountered a metastasis of an i(12p)-negative seminoma with an abnormally 
banding region (ABR) on one of the chromosome 12 homologs. Chromosome 
painting showed that this ABR was composed almost entirely of 12p material. 
Further FISH experiments indicated that in this case the genomic region involved 
was limited to 12pll-pl2 (Chapter II.3). Via two 12p-specific YACs this region 
could be narrowed down further to distal 12pl 1 - proximal 12pl2. To localize and 
define the size of the region involved more precisely, we used comparative genomic 
hybridization (CGH; Kallioniemi et al., 1992; Du Manoir et ai, 1993). This 
powerful technique enabled us to confirm and refine the localization of the 
overrepresentation to the 12pll.2-pl2.1 region. Very similar results were obtained 
in 2 out of 20 additional tumors analyzed similarly, including a SE and a CT (M. 
Mostert, personal communication). In another CGH study (M. Korn, personal 
communication) again very similar results were obtained in two tumors (1 SE, 1 
NS). Together, these findings point at the presence of a gene(s) in the chromosome 
12 subregion pll.2-pl2.1 important in the development of TGCTs. Further 
positional cloning strategies should lead to a delineation of a minimal critical region 
and, finally, the identification of the gene(s) involved. 
Molecular Analysis of 12p-anomalies in TGCTs 
To obtain more information on the origin and mechanism of i(12p) formation, we 
performed RFLP analyses. By doing so, we were not only able to show that i(12p) 
is a genuine isochromosome presumably generated via a mitotic error but, 
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moreover, that all supernumerary 12p-sequences in TGCTs are uniparental in origin 
(Chapter II.4). Thus, it can be hypothesized that a dominantly acting mutation on 
one of the 12p arms confers a selective advantage over the other in human GCTs. 
This, in turn, may lead to clonal outgrowth and decreased treatment success as 
described by Bosl et al. (1989). Furthermore, we observed a retention of 
heterozygosity for 12q-loci, once again indicating that i(12p) formation must be 
preceded by an aneuploidization event (Geurts van Kessel et al., 1989). Similar 
results were obtained by Peltomäki et al. (1992). In addition, these latter 
investigators concluded that a role for genomic imprinting of 12p loci must be 
excluded since either paternal or maternal 12p alleles can be involved in different 
cases. These observations once again strengthen the notion that specific 12p 
sequences confer a growth advantage to the tumor cells in a dominant fashion, 
probably via the action of one or more activated oncogenes. 
One possible way to identify such sequences from the aforementioned critical 
chromosome 12 subregion pll.2-pl2.1 may be to transfect corresponding DNA 
fragments (in e.g. YACs or cosmids) into rat gonocytes and/or differentiated 
spermatogonia. Its effects on cell behaviour, i.e. proliferation and differentiation, 
may subsequently be studied both in vitro (tissue culture) and in vivo after 
transplantation of the cells into the testis of host rats. 
The observation that both DNA amplification (see above) and DNA loss (Chapter 
1.1.3) may occur in human tumors has prompted several investigators to study the 
involvement of candidate proto-oncogenes and tumor suppressor genes, respectively, 
in GCT development. 
1. Proto-oncogenes. 
The identification of supernumerary 12p-sequences and other DNA amplifications in 
human GCTs has led to the analysis of a variety of candidate genes. The first proto-
oncogene to be mapped on the short arm of chromosome 12 was KRAS. Several 
authors examined the prevalence of KRAS mutations in human GCTs. Although 
mutations could indeed be detected in several cases, no correlation with histologic 
subtypes was found. In addition, tumor heterogeneity was detected after flow-
sorting of tumor-derived nuclei obtained from different regions within individual 
TGCTs (Mulder et al., 1989; Moul et al ., 1992; Shuin et ai, 1993). These latter 
results indicate that KRAS mutations may represent relatively late secondary events 
in the development of GCTs. Also, KRAS could be excluded from the amplicon 
present in one of our tumors, suggesting that the gene does not seem to play an 
overall role in the progression of TGCTs (Chapter II.3). So far, only one candidate 
gene has been mapped to the 12pl 1.2-pl2.1 region included in the afore mentioned 
amplicon. Interestingly this gene, PTHLH, appears to display a tumor specific 
expression pattern in seminomas and choriocarcinomas (Shimogaki et ai, 1993). 
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However, so far Northern blot analyses failed to reveal aberrant expression in this 
and other tumor RNA samples (not shown). Moreover, similar amplicons have also 
been found in non-seminomatous germ cell tumors and in EC compartments of 
combined tumors (see above), in which no PTHLH expression is expected 
(Shimogaki et ai, 1993). Therefore, the PTHLH gene must currently be ruled out 
as a candidate gene too. 
Based on the hypothesis that all TGCTs are derived from neoplastic primordial 
germ cells (PGCs), also genes involved in survival and/or differentiation of PGCs 
may be of particular interest. These genes include MGF (Pesce et al., 1993), МУС, 
FOS, JUN, KIT, and MOS (Coucouvanis and Jones, 1993). Analysis of only MGF 
and KIT revealed deregulation of gene expression, but no consistent associations 
with specific tumor types could be found so far (Strohmeyer et al., 199la; Murty et 
al., 1992). In addition, many other genes were studied including the various RAS-
and Л/УС-genes, FGF3, FGF4, INT2, MYB, ERBBl, ERBB2, MDR1, GLI, FMS, 
RAF, ABL and PDGFA. Although occasionally variable expression patterns were 
observed, for none of them consistent alterations could be detected. 
So far, only for the PDGF receptor a gene aberrant transcripts were detected in 
human teratocarcinoma cells (Mosselman et al., 1994). Here, undifferentiated Tera-
2 cells two transcripts of 1.5 and 5.0 kb are encountered whereas a single 6.4 kb 
transcript is present in differentiated Tera-2 cells. The significance of this shift in 
expression for the growth characteristics of Tera-2 cells and GCTs in general still 
remains to be determined. 
2. Tumor suppressor genes. 
Preliminary loss of heterozygosity (LOH) studies in TGCTs suggest the 
involvement of specific loci on chromosomes 3p, 6p, lip and 12q. From these, 
only the 1 lp region harbors a known tumor suppressor gene: WTl. However, so far 
no rearrangements of the WTl gene have been observed in TGCTs (Looijenga et 
al., 1993). Several authors have claimed a critical role for putative tumor suppressor 
genes present on 12q, based on the observed (homozygous) deletions in the 12ql3 
and 12q22 regions (Murty et al., 1990; Samaniego et al., 1990; Rodriguez et ai, 
1992). Since these deletions could not be confirmed by others using the same 
probes (Radice et al., 1989; Geurts van Kessel et ai, 1989; Peltomäki et al., 1990; 
Looijenga et al., 1994), the actual role of 12q sequences in TGCT development 
remains a matter of dipute. Also the analysis of the tumor suppressor genes RBI 
and TP53 failed to reveal any structural rearrangements (Strohmeyer et al., 1991b; 
Peng et ai, 1993). For both genes the expression levels seem to be altered but the 
precise effects of these alterations on GCT development remain unclear. 
In a large study, Murty et al. identified various loci showing LOH (Murty et ai. 
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1994). However, since the extent of LOH in teratomas is much higher than in 
embryonal carcinomas, this observation may merely be a reflection of the genetic 
instability of GCTs and, accordingly, be regarded as a consequence rather than as a 
cause of tumor progression. Alternatively, these findings may point at the 
deregulation of genes controlling the differentiation route, as for example the NME 
genes (Backer et al., 1994). 
In addition to the studies mentioned above, we screened several other genes on 12p 
that are involved in cellular signaling and/or cell cycle control, for gross structural 
rearrangements. These include GNB3 (G-protein), GNAI2L (G-protein-related), 
PTPN6/PTPJC (protein tyrosine phosphatase), CCND2 (cyclin), FGF.6 (fibroblast 
growth factor) and TNFR1 (tumor necrosis factor receptor). So far only gene copy 
changes reflecting differences in 12p-amplification status could be detected. No 
structural rearrangements were observed, indicating that none of these genes appears 
to be involved in the development of TGCTs. 
Linkage Analysis 
In parallel to the strategies mentioned above, linkage analyses may also provide 
clues to the question where candidate genes may be located. Although little is 
known about inherited susceptibility to germ cell tumor development, some familial 
cases have been described (Tollerud et al., 1985; Forman et ai, 1992; Heimdal et 
al., 1993). Preliminary linkage analysis of 35 of these families points at four 
chromosomal sites for the location of a putative testicular cancer susceptibility 
gene(s): lp, 4q, 5q, and 18q, respectively (Leahy et al., 1995). Interestingly, several 
tumor suppressor genes have been mapped to these chromosomal regions: NB1 and 
CMM at lp36, APC at 5q21 and DCC at 18q21. Also, 4q is the region where c-kil 
and PDGF receptor a, which are implicated in early embryonic development, are 
located. However, as of yet there is no clear indication for the direct involvement 
of either one of these genes (see also above). Finally, the mouse Ter gene, 
conferring susceptibility to testicular teratomas, maps to chromosome 18 (Asada et 
al., 1994) in a region of conserved synteny with human chromosome 5q, close to 
one of the regions of linkage. Accordingly, the Ter gene may currently be 
considered as a candidate involved in the development of human (testicular) germ 
cell tumors. 
In conclusion, the genetic basis of TGCT formation appears to be complex and, as 
yet, poorly understood. Genomic instability, presumably caused by the inactivation 
of a specific tumor suppressor gene and giving rise to a broad spectrum of 
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differentiation pathways, is an important feature of TGCTs. The key elements 
controlling the transition of SE to NS, if existing, still have to be identified. The 
development of seminoma cell lines (Oosterhuis et al., personal communication) 
will pave the way for in vitro differentiation studies, and may provide clues to 
possible mechanistic relationship(s) between SE and NS. In addition, if all TGCTs 
develop through a SE stage, LOH studies focussed on SE may lead to the 
identification of a gene(s) of crucial importance for all TGCTs, without obscuring 
secondary effects resulting from the multiple different developmental pathways seen 
in NS and CT. Furthermore, through the application of CGH techniques the search 
for a specific gene(s) on 12p that, by amplification, confers a specific growth 
advantage to the tumor cells has to be persued. As yet, the possibility should be 
considered that CGH and linkage studies may reveal additional chromosomal sites 
important in the development of TGCTs. 
Extragonadal Germ Cell Tumors 
The classification of extragonadal germ cell tumors (EGCTs) is still provisional and 
needs further improvement. As a group, EGCTs are heterogeneous in several 
aspects: (a) they occur at anatomically different locations, both in children and in 
adults, (b) they display a variety of histological subtypes, similar to those found in 
TGCTs. Although most EGCTs behave benign the malignant tumors, that are found 
mainly in the anterior mediastinum and midline of the brain in adults, seem to 
behave different from the TGCTs. They are much more aggressive and, as a result, 
the patients' prognosis is considered to be relatively poor. Another indication for a 
biological difference between these tumors emerges from the observed association 
of mediastinal GCTs with hematologic disorders. These disorders (leukemias) most 
probably arise as a result of a specific malignant differentiation of the yolk sac 
component of the original primary mediastinal GCT. Such a secondary 
differentiation has never been observed in TGCTs. 
In an attempt to better classify malignant EGCTs, cytogenetic analysis was used and 
a new group that is characterized by a diploid chromosome content and, in addition, 
the occurrence of a specific complex translocation involving chromosomes 6 and 11 
(Chapter III. 1 ) could be defined. To determine a possible relationship between these 
and other EGCTs, and to obtain clues concerning the pathogenesis of these tumors, 
we initiated a molecular characterization of the translocation breakpoint region 
within chromosome band 11 ql3. Again, FISH turned out to be particularly powerful 
for rapid fine-mapping of the breakpoint region within the genomic interval flanked 
by the loci D11S457 and D11S546 (Chapter III.2). By using DIRVISH with 
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cosmids corresponding to these loci we were able to assess the actual physical 
distance between these breakpoint flanking markers. By subsequent subcloning of 
this genomic region into phages, followed by genomic walking, we were able to 
limit the breakpoint region to less than 200 kb (Chapter III.4). 
In course of these positional cloning efforts we (1) excluded several candidate genes 
assigned to the 1 lql3 region so far, and (2) identified several Hql3-corresponding 
cDNAs, some of which were shown to encode known genes that had not yet been 
mapped within this particular chromosomal region (Chapters III.3 and III.4). Based 
on their relative positions to the tumor-associated breakpoint, all of them could be 
excluded as candidate genes to be involved in the development of these EGCTs. 
Still, they may be considered as such for either one of the other neoplastic disorders 
that have been mapped to this genomic region as, for instance, the MENI syndrome 
and some hematopoietic and solid tumors. 
As for the pathogenetic pathway by which the EGCTs develop, there are basically 
two possibilities: (1) EGCTs resembling the TGCTs of adults are derived from 
dysplastic PGCs, and (2) EGCTs resembling the GCTs of the infantile testis are 
derived from either PGCs or some other pluripotent embryonal stem cell. The 
theories, based on a PGC-derived origin, raise the question whether EGCTs arise 
from neoplastic PGCs that normally have a function in specific extragonadal 
locations, or whether EGCTs result from aberrant migration of an activated PGC. 
Supportive of the former possibility is the study of Hofmann and Millan (1993), 
who showed the presence of germ cell alkaline phosphatase (GCAP)-positive cells 
in the thymic region of a human fetus. Whether these cells indeed are PGCs and 
whether such PGCs may also be found at other extragonadal locations, as for 
instance the midline of the brain, still needs to be confirmed. 
Another interesting observation was made by Pesce et al. (1993), who showed that 
extragonadal PGCs in mouse embryos express tissue transglutaminase, which is 
indicative for apoptosis. Consequently, it can be hypothesized that in specific 
extragonadal locations apoptosis is prevented, either by signals produced by the 
surrounding somatic cells or, alternatively, by a mutation in a gene related to e.g. 
TP53 or BCL2, which have been shown to have anti-apoptotic potentials (Barr and 
Tornei, 1994) in activated PGCs. This may result in the survival of the activated 
PGCs and, finally, in further progression towards the development of invasive 
tumors. It should be anticipated that further analysis of larger series of EGCTs and 
detailed characterization of their specific chromosomal anomalies will ultimately 
lead to a better understanding of, and discrimination between, these alternative 
pathogenetic pathways. 
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Summary 
Molecular Characterization of Chromosomal Aberrations in Human 
Germ Cell Tumors. 
The entity human germ cell tumors (GCTs) comprises a heterogeneous group of 
neoplasms. They can be found at various anatomical localizations: in the testis, the 
ovary, but also in extragonadal sites. In recent years, a fundamental role for specific 
chromosomal aberrations in the process of neoplastic transformation has been well 
established. This notion has led us to initiate the molecular characterization of such 
anomalies in two different classes of GCTs. 
1. testicular germ cell tumors (TGCTs) of adolescents and young adults. 
In most TGCTs one or more copies of a highly specific marker chromosome 
[i(12p)] can be found. This i(12p) chromosome appears early in the development of 
TGCTs, following an initial aneuploidization event. In the remaining i(12p)-
negative TGCTs structural rearrangements of 12p are frequently found. The 
introduction of chromosome painting techniques allows a reliable identification of 
the i(12p) chromosome, and, in addition, opens ways to investigate the observed 
12p rearrangements in detail. In chapter II. 1 the generation of a panel of radiation 
reduced hybrids (RRHs) encompassing the entire short arm of chromosome 12 is 
described. These RRHs proved to be useful in the detailed delineation of 12p 
anomalies in TGCTs. In chapter II.2 a series of eleven i(12p)-negative TGCTs was 
investigated, again by using chromosome painting strategies. Also in these tumors 
this analysis revealed distinct overrepresentations of 12p sequences. These findings 
once more strenghten the idea that supernumerary 12 copies contribute to the 
process of tumor development. Subsequently, chapter II.3 describes the 
identification of a subregion on 12p which is amplified in a metastasis of an i(12p)-
negative TGCT. Here, a combination of comparative genomic hybridization and the 
use of RRHs and YAC clones in FISH experiments pinpointed 12pl 1.2-pl2.1 as the 
amplified genomic interval which may harbor gene(s) of significant relevance for 
the development of TGCTs. In chapter II.4 RFLP analysis was used to obtain more 
information on the origin and mechanism of i(12p) formation. From these results 
we concluded that both arms of the i(12p) chromosome are of uniparental origin 
which indicates that this isochromosome most likely arises from a misdivision of 
the centromere rather than from a translocation or a non-sister chromatid exchange. 
Moreover, also in i(12p)-negative tumors the supernumerary 12p-sequences 
appeared to of uniparental origin. Therefore, we hypothesize that probably one of 
the 12p arms carries a dominantly acting mutation that confers a selective advantage 
over the other 12p arm in TGCT development. 
2. malignant extragonadal germ cell tumors (EGCTs). 
EGCTs by themselves again are a heterogeneous group of neoplasms, displaying the 
whole spectrum of histologic variants of TGCTs They occur in the midline of the 
body but also away from the midline. Not only histologically but also 
cytogenetically most EGCTs descibed so far resemble the TGCTs, they are usually 
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highly aneuploid and i(12p)-positive. Therefore, it is generally accepted that EGCTs 
are derived from dysplastic primordial germ cells, which have migrated to 
extragonadal sites. In chapter III. 1 a new entity of malignant EGCTs is defined. 
These EGCTs are found in relatively older patients and display pseudo-diploid 
karyotypes with complex structural rearrangements involving chromosomes 6 and 
11. In chapter III.2 the molecular characterization of this recurrent complex 
chromosomal translocation is initiated. By using FISH and pulsed field gel 
electrophoresis (PFGE) techniques the specific 11 q 13 breakpoint could be located 
within the genomic interval between D11S457 and D11S546. In chapter III.3 the 
fine-mapping of the FOSL1 and PLCB3 genes, identified through these positional 
cloning strategies, and their localization relative to the EGCT-specific llql3 
breakpoint is reported. Finally, chapter III.4 describes the subcloning of the EGCT-
specific breakpoint interval. Via preparative PFGE a phage library enriched for this 
particular genomic region was constructed and used for genomic walking. This 
approach resulted in the identification of conserved sequences in several clones and, 
subsequently, in the isolation of five different cDNA clones. Three of these clones 
appeared to represent the NFKB3 gene, a KRT8-l\ke gene, and a human homolog of 
the Drosophila pecanex gene. Altogether, the critical breakpoint region could be 
narrowed down to a genomic interval of less than 200 kb. In addition, all genes that 
were mapped within band llql3 could be excluded as candidates to be involved in 
the development of these EGCTs. 
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Moleculaire Karakterisatie van Chromosomale Afwijkingen in Humane 
Kiemceltumoren. 
Humane kiemceltumoren vormen een heterogene groep van tumoren. Men vindt ze 
op verschillende anatomische locaties: in de testis, het ovarium, maar ook op 
extragonadale plaatsen. De afgelopen jaren is er bewezen dat specifieke 
chromosomale afwijkingen een fundamentele rol spelen in het ontstaan van 
tumoren. Dit heeft ertoe geleid om te beginnen met de moleculaire karakterisatie 
van dergelijke afwijkingen in twee verschillende klassen kiemceltumoren. 
1. testiculaire kiemceltumoren van adolescenten en jonge volwassenen. 
In de meeste testiculaire kiemceltumoren kunnen er één of meerdere kopieën van 
een zéér specifiek marker chromosoom, i(12p), worden gevonden. Dit i(12p) 
chromosoom verschijnt vroeg in de ontwikkeling van testiculaire kiemceltumoren, 
na een initiële aneuploidisatie gebeurtenis. In de overige, i(12p)-negatieve, 
testiculaire kiemcellumoren worden frequent andere structurele afwijkingen van 12p 
gevonden. De introductie van "chromosome painting" technieken maakt een 
betrouwbare identificatie van het i(12p) chromosoom mogelijk en biedt tevens 
mogelijkheden om de waargenomen 12p afwijkingen in detail te bestuderen. In 
hoofdstuk II. 1 wordt de constructie van een panel van bestralingshybriden, die de 
hele korte arm van chromosoom 12 omvatten, beschreven. Deze bestralingshybriden 
bleken bruikbaar in de gedetailleerde ontrafeling van 12p afwijkingen in testiculaire 
kiemceltumoren. Hoofdstuk II.2 beschrijft de analyse van een elftal i(12p)-negatieve 
kiemceltumoren, wederom via "chromosome painting" technieken. Ook in deze 
tumoren bleek er sprake te zijn van een opvallende oververtegenwoordiging van 12p 
sequenties. Deze bevindingen bevestigen nogmaals het idee dat extra 12p kopieën 
bijdragen aan het proces van tumorvorming. Hoofdstuk II.3 beschrijft vervolgens de 
identificatie van een subregio op 12p die geamplificeerd is in de métastase van een 
i(12p)-negatieve testiculaire kiemceltumor. Een combinatie van "comparative 
genomic hybridization" en het gebruik van bestralingshybriden en YAC klonen in 
fluorescentie in situ hybridisatie (FISH) experimenten leidde tot de nauwkeurige 
identificatie van 12pl 1.2-12.1 als het geamplificeerde genomische interval, dat 
genen kan bevatten die van significant belang zijn voor de ontwikkeling van 
testiculaire kiemceltumoren. In hoofdstuk II.4 werd RFLP analyse gebruikt om meer 
informatie te verkrijgen over de origine en het mechanisme van i(12p) vorming. Uit 
deze resultaten concluderen wij dat beide armen van het i(12p) chromosoom van 
uniparentale afkomst zijn, hetgeen aangeeft dat dit isochromosoom waarschijnlijk 
ontstaat door een foutieve deling van het centromeer en niet door een translocatie of 
een niet-zuster Chromatide uitwisseling. Bovendien bleken de extra 12p sequenties 
in i(12p)-negatieve tumoren eveneens van uniparentale afkomst te zijn. Daarom 
veronderstellen wij dat één van de 12p armen waarschijnlijk een mutatie met een 
dominant karakter draagt, die een selectief voordeel oplevert, ten opzichte van de 
andere 12p arm, tijdens de ontwikkeling van testiculaire kiemceltumoren. 
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2. maligne extragonadale kiemceltumoren. 
Extragonadale kiemceltumoren vormen ook weer een heterogene groep van tumoren 
die het hele spectrum van histologische varianten van testiculaire kiemceltumoren 
vertonen. Ze komen zowel langs de as van het lichaam, als ook verwijderd van deze 
middellijn voor. Niet alleen histologisch maar ook cytogenetisch lijken de meeste 
tot nu toe beschreven extragonadale kiemceltumoren op testiculaire kiemceltumoren: 
ze zijn meestal sterk aneuploid en i(12p)-positief. Mede daarom is het algemeen 
aanvaard dat extragonadale kiemceltumoren ontstaan uit dysplastische primordiale 
kiemcellen, die naar extragonadale locaties zijn gemigreerd. In hoofdstuk III. 1 
wordt een nieuwe groep van maligne extragonadale kiemceltumoren gedefinieerd. 
Deze tumoren worden gevonden in relatief oudere patiënten en hebben pseudo-
diploide karyotypes met structurele afwijkingen van de chromosomen 6 en 11. 
Hoofdstuk III.2 beschrijft de eerste moleculaire karakterisatie van deze vaker 
voorkomende complexe chromosomale translocatie. Via FISH en "pulsed field gel 
electrophoresis" (PFGE) technieken kon het specifieke l lq l3 breukpunt 
gelocaliseerd worden in het genomische interval tussen D11S457 en D11S546. De 
precieze localisatie van de FOSL1 en PLCB3 genen, geïdentificeerd via deze 
positionele klonerings strategieën, en hun ligging ten opzichte van het 1 lq 13 
breukpunt is beschreven in hoofdstuk III.3. In hoofdstuk III.4, tenslotte, wordt de 
subklonering van het extragonadale kiemceltumor-specifieke breukpunt-interval 
beschreven. Via preparatieve PFGE werd er een faagbank, verrijkt voor deze 
genomische regio, gemaakt en gebruikt voor "genomic walking". Deze aanpak 
resulteerde in de identificatie van geconserveerde sequenties in meerdere klonen en, 
vervolgens, in de isolatie van vijf verschillende cDNA klonen. Drie van deze klonen 
bleken het NFKB3 gen, een OTS-achtig gen, en een humane homoloog van het 
Drosophila pecanex gen te vertegenwoordigen. Uiteindelijk is het kritische 
breukpunt gebied teruggebracht tot een genomisch interval van minder dan 200 kb. 
Bovendien zijn alle genen die in band 11 ql3 gelocaliseerd zijn, uitgesloten als 
kandidaten betrokken bij de ontwikkeling van deze extragonadale kiemceltumoren. 
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Legends to the Figures on Colorplate 1 
Figure II. 1.2: Localization of human fragments present in the WgM hybrids on human 
chromosome 12 using Alu element-mediated PCR (BK33) products as 
probes for chromosome painting (A) WgM6B, (B) WgM8B, (C) 
WgM22C and (D) WgM28 1 Signals are shown in yellow, R-banded 
human chromosomes are shown in red Images were made using confocal 
scanning laser microscopy 
Figure II.2.2: Results of multicolor FISH using the chromosome 12 centromere-specific 
alphoid repeat pal2H8 (red) and the 12p-specific "paint" M28 (green) as 
probes on metaphase spreads of i(12p)-negative TGCTs (A) Case 10-
denved cell line tuj showing three copies of a normal chromosome 12 
(arrows) and three marker chromosomes (marl-3) containing 12p-positive 
material, (B) case 1 with, besides three copies of a normal chromosome 
12 (arrows), two 12p-positive chromosomes (mar 1-2) of which marl has 
been enlarged (insert) See Table 3 and text for full description of 
chromosome 12 abnormalities 
Figure II.2.3: Presentation of five different stages (1-5, corresponding to A-Ε) of the 
cytogenetically defined add(12)(pl3) chromosome of case 5 (see Table 
2), illustrating the presumed karyotypic evolution of this chromosome 
Chromosome 12-specific centromenc and ρ arm sequences are visible in 
red and green, respectively Arrows indicate the 12pll-12pl3 orientation 
ot the 12p-sequences in this chromosome The occurrence of the different 
karyotypic stages (1-5) in the tumor cell population was 6%, 10%, 42%, 
35%, and 1%, respectively, in 6% of the cells only an extra copy of a 
normal chromosome 12 was present (N-331) 
Figure II.2.4: Premature chromosome separation (PCS) of sister chromatids of a normal 
chromosome 12 in case 9, revealed by FISH using pal2H8 and 
chromosome 12-specific library pBS-12 as probes (A) Selected part of 
an informative metaphase spread (chromosome 12 in green, centromere in 
red), (B) magnification of another PCS of chromosome 12 (red/orange), 
in which the"kinetochonc bridge" (see text) is indicated by arrows 
(alphoid sequences m green) 
Figure II.3.3: Results from FISH and CGH analyses A Chromosome 12-specific 
library pBS-12 (green) and 12-centromeric probe pal2H8 (red) 
hybridized onto a tumor-derived metaphase spread, revealing two copies 
of a normal chromosome 12 (arrows) the add(17) chromosome (small 
arrowhead), and the add(12) (large arrowhead) Chromosomes were 
couterstained in blue The respective chromosomes are similarly marked 
in В and С В Hybridization patterns of 12p-specific paint M28 and 
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ρα12Η8 in green and red, respectively С Hybridization of YAC 5 onto 
tumor-derived metaphase chromosomes (signals in yellow) Note that the 
add(17) chromosome shows three regions of hybridization (small 
arrowhead), whereas the add(12) chromosome displays multiple 
hybridization sites (large arrowhead) Normal chromosome 12 homologs 
single spots (arrows) For contrast, chromosomes are shown in red D 
Tumor-derived interphase nuclei hybridized with YAC 5, showing 
multiple hybridization signals in yellow Approximately 25-35 double 
spots (each representing one hybridization locus) can be observed per 
area E Representative CGH result with differently labeled tumor (red) 
and reference (69,XXY,green/yellow) DNAs onto a normal human 
metaphase spread (46,XY) Chromosomes were counterstained in blue 
Red signals are visible on the short arm of both chromosome 12 
homologs (arrowheads) F Example of CGH analysis on one of the 
chromosome 12 homologs shown in E The measured intensity profiles 
for tumor and reference DNA are represented by the red and green lines 
in the graphic, respectively The blue line represents the CGH ratio 
profile The overrepresentation of 12p sequences in the tumor DNA can 
easily be discerned (peak value at 12pl 1 23) 
Figure III.1.2: FISH analysis of tumors of case 2 (A) and case 1 (B) using chromosome 
7 (yellow-green) and 12 (red) or 6 (yellow-green) and 11 (red)-specific 
paints The differently labeled normal and translocation-denved 
chromosomes are marked The chromosomes 7 and 12 appear to be 
normal in A (case 2), as expected (see text), whereas a clear t(6,7,l 1) is 
visualized in В (case 1) 
Figure 111.2.2: FISH analysis of metaphase (A, C) and interphase (B) spreads of Haz-1 
using cosmids proximal and distal to the 11 q 13 breakpoint (A) Double 
hybridization of D11S460 and D11S466 cosmids Arrow normal 
chromosome 11, large arrowhead der(ll), small arrowhead der(6) (B) 
Double hybridization of BCL1 and D6Z1 probes Large arrowhead 
normal chromosome 6, small arrowhead normal chromosome 11, arrow 
der(6) (C) Double hybridization of D11S457 and D11Z1 probes Arrow 
normal chromosome 11, arrowhead der(ll) 
Figure III.4.3: DIRVISH analysis using two flanking cosmids (A) or two EGCT-
translocation breakpoint flanking cosmids (B) as probes on preparations 
of normal human lymphocyte DNA 
Figure IV.l: FISH analysis of a chromosome 12-denved marker in an i(12p)-negative 
TGCT A Hybridization patterns of 12p-specific M28 and 12 
centromere-specific pal2H8 probes in green and red, respectively В 
Hybridization of 12p 13-specific RRH WgM8B in yellow The results are 
in agreement with the presence of a "cryptic" intrachromosomal i(12p) 
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